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6 Abbreviations 
Abbreviations 
   
2xYT  Double amount of yeast extract and tryptone 
Å  Angström (1 Å = 10-10 m) 
A280nm  Absorption at 280 nm 
ADP  Atomic displacement parameters 
Ala  Alanine 
APS  Ammonium peroxydisulfate 
Arg  Arginine 
Asn  Asparagine 
Asp  Aspartate 
bcc  Bond charge correction 
BSA  Bovine serum albumin 
B. taurus Bos taurus  
C  Celsius 
CAC  Critical aggregation concentration 
CaDA  Cationic dummy atom 
clog P  Calculated logarithm of the octanol-water partition coefficient 
cpm  Counts per minute 
CSD  Cambridge Structural Database 
CYM  Anionic form of cysteine in MD simulations 
Cys  Cysteine 
∆G0  Gibbs free energy 
∆H0/∆Hbind Enthalpy of binding 
∆Hion  Heat of ionization 
∆Hobs  Observed enthalpy of binding not corrected for heat of ionization 
∆S0  Entropy of binding 
d  Distance 
D  Diffusion coefficient 
Da  Dalton 
DAQ  2,6-diamino-3H-quinazolin-4-one 
dd  Double distilled 
DD/AA  Donor-donor/acceptor-acceptor motif 
d(H)   Hydrodynamic diameter 
 
7 Abbreviations 
DLS  Dynamic light scattering 
DMSO  Dimethylsulfoxide 
ds  Double stranded 
DTT  1,4-Dithiothreitol 
E. coli  Escherichia coli 
ECY2  Unmodified Escherichia coli tRNATyr 
EDTA  Ethylenediaminetetraacetate 
f-  femto- 
FAE  Follicle-associated epithelium 
FBLD  Fragment based lead discovery 
Fc  Calculated structure factor amplitudes 
Fo  Observed structure factor amplitudes 
g  gramm 
GA  Genetic algorithm 
gaff  General amber force field 
GE  Group efficiency 
Gln  Glutamine 
Glu  Glutamate 
Gly  Glycine 
HABA  2-(4-Hydroxyphenylazo)-benzoic acid 
H-bond  Hydrogen bond 
Hepes  2-(4-(2-Hydroxyethyl)-1-piperazinyl)-ethanesulfonic acid 
HID  Histidine with its hydrogen at δ-position in MD simulations 
HIE  Histidine with its hydrogen at ε-position in MD simulations 
HIN  Anionic form of histidine in MD simulations 
His  Histidine 
HPLC  High performance liquid chromatography 
HTS  High Throughput Screening 
Hz  Hertz 
IFN  Interferone 
IL  Interleukine 
Ile  Isoleucine 
IPTG  Isopropyl-β-D-thiogalactopyranoside 
IQR  Interquartile range 
ITC  Isothermal titration calorimetry 
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K  Kelvin 
kB  Boltzmann constant (1.380 650 ∙ 10
-23 J ∙ K-1) 
kb  Kilo-base pair 
kcal  Kilocalorie 
kcat  Catalytic constant 
Kd  Dissociation constant 
Ki  Inhibitory constant 
kJ  Kilojoule 
KM  Michaelis-Menten constant 
LB  Luria-Bertani 
LE  Ligand efficiency 
Leu  Leucine 
Lys  Lysine 
m  Meter 
m-  milli-   
µ-  micro- 
M  Molarity (mol ∙ l-1) 
MD  Molecular dynamics 
MES  2-(N-Morpholino)ethanesulfonic acid 
Met  Methionine 
min  Minute 
l  Litre 
MR  Molecular replacement 
MWCO  Molecular weight cut-off 
n-  nano- 
NMR  Nuclear magnetic resonance 
OD600  Optical density at 600 nm 
p-  pico- 
PAMPA  Parallel artificial membrane permeability assay 
PCR  Polymerase chain reaction 
PDB  Protein data bank 
PDB ID  Protein data bank identifier 
PEG  Polyethylene glycol 
PEOE  Partial equalization of orbital electronegativities 
pH  Negative decimal logarithm of the hydrogen ion activity 
 
9 Abbreviations 
Phe  Phenylalanine 
pKa  Negative decimal logarithm of the acid dissociation constant 
PME  Particle Mesh Ewald 
Pro  Proline 
PyBOP  Benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate 
Q1/Q3  First/third quartile 
rpm  Rounds per minute 
s/sec  Second 
SAR  Structure-activity relationship 
SDS page Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Ser  Serine 
SPR  Surface plasmon resonance 
T  Temperature in Kelvin 
TCA  Trichloroacetic acid 
TEMED  Tetramethylenediamine 
TGT  tRNA-guanine transglycosylase 
Thr  Threonine 
TLS  Translation/libration/screw-motion 
Tricine  N-(Tris(hydroxymethyl)methyl)glycine 
Tris  2-Amino-2-(hydroxymethyl)-propane-1,3-diol 
tRNA  Transfer ribonucleic acid 
Trp  Tryptophane 
Tyr  Tyrosine 
UV  Ultraviolet   
V  Volume 
v0  Initial velocity 
Val  Valine 
vmax  Maximal velocity 
v/v  Volume per volume 
W  Watt 
WT  Wild type 
w/v  Weight per volume 
Z. mobilis Zymomonas mobilis 
η  Viscosity  
°  Degree 
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14 1. Introduction and Motivation 
1. Introduction and Motivation 
1.1 Structure-Based Drug Design 
Structure-based drug design is an important tool in the development of novel drugs and 
represents the basis for the rational design of new drugs. Thereby, the setup of experiments 
relies on the knowledge of macromolecular target structures mainly derived by X-ray 
crystallography or NMR spectroscopy. With their help complex interaction patterns of 
potential drug candidates within the binding pocket can be visualized in the early stage of 
lead structure generation as well as in further optimization steps. Metaphorically speaking, 
this procedure provides a three-dimensional model to find the right key (ligand) that 
optimally fits the lock (target protein) [Klebe, 2009]. The number of crystal structures 
available in the protein data bank (PDB) increases drastically. Up to date, nearly 100’000 
structures are deposited of which more than 90’000 were determined by X-ray 
crystallography [PDB, April 2014].  
However, information concerning the driving forces for binding affinity cannot be 
derived from structural data alone. Therefore, the concept of shape-complementarity has to 
be expanded by thermodynamic data, which have been shown to be an essential 
complement to crystal structure analyses [Henry, 2001]. In this context, isothermal titration 
calorimetry (ITC) is not only able to elucidate the potency of a ligand but also its enthalpic 
contribution and the stoichiometry of the binding process within one experiment.    
Taking all these data together, structure-based drug design is able to produce highly 
potent and selective drug candidates, thus, saving a tremendous amount of time, money and 
laboratory animals. 
The enzyme tRNA-guanine transglycoslase (TGT) is one example to which the method 
of structure-based drug design was applied. TGT plays a key role in the pathogenicity of 
Shigella, the causative agent of shigellosis [Durand et al., 1994]. The crystal structure of the 
binary complex containing the closely similar TGT from Z. mobilis and preQ1, one of its 
natural substrates, served as a starting point. After initital computational approaches and 
subsequent iterative optimization cycles lin-benzopurines were found to be highly potent 
inhibitors of TGT [Hörtner et al., 2007; Stengl et al., 2007; Kohler et al., 2009; Barandun et 
al., 2012]. Unfortunately, lin-benzopurines show unsatisfying membrane permeation ability 
and therefore, need further optimization [Barandun et al., 2012]. 
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1.2 Aims of the thesis 
In the framework of this thesis different aspects concerning the optimization of the highly 
potent lin-benzopurines should be analyzed. These comprised the setup of new 
methodologies as well as subsequent investigations with respect to bioavailability, resistance 
development, binding mode predictions by computational approaches as well as fragment-
based lead discovery of new inhibitor classes: 
 A method was established to obtain the thermodynamic signature of lin-
benzopurines binding to TGT via isothermal titration calorimetry (ITC). Subsequently, 
the robustness of this method was analyzed with respect to organic and inorganic 
ligand impurities as well as protein impurities (Chapter 2). 
 Based on the observation that lin-benzopurines exhibit a poor ability to penetrate 
through cell membranes, the protonation states of lin-benzoguanines and lin-
benzohypoxanthines in solution and in the TGT-bound state were investigated by pKa 
calculations and ITC measurements. Potential protonation sites were verified using 
site-directed mutagenesis and crystal structure analysis (Chapter 3). 
 A proposed entropic term of a series of 2-amino-lin-benzoguanines and 2-amino-lin-
benzohypoxanthines with varying substituents in 2-position that were shown to 
exhibit an increased flexibility was analyzed using ITC. Screening for modified 
crystallization conditions gave insight in the so far unknown binding mode of the 2-
substituent and allowed a correlation of thermodynamic properties to the substrate 
recognition mechanism and pocket cross-talk of TGT (Chapter 4).  
 Mutagenesis combined with affinity measurements should show whether a binder 
with high residual mobility can avoid a loss in binding affinity compared to a binder 
adopting one ordered binding mode and therefore achieve an advantage as a more 
competent antibiotic less affected by resistance mutations (Chapter 5). 
 MD simulations were used to predict the binding mode of a new series of extended 
2-amino-lin-benzoguanines. Crystal structure analysis of these ligands revealed a so 
far novel binding mode occupying further subpockets of TGT (Chapter 6). 
 In a fragment-based approach a new class of ligands with expected improved 
bioavailability and synthetic accessibility based on a 5-azacytosine scaffold was 
investigated in a comprehensive in-silico and in-vitro study (Chapter 7). 
 
16 1. Introduction and Motivation 
1.3 Shigellosis 
Shigellosis is an infectious bowl disease that predominantly occurs in developing countries. 
The uptake of only 10 to 100 organisms of the causative agent Shigella is sufficient to result 
in a severe infection affecting over 165 million people annually with 1.1 million fatalities 
[DuPont et al., 1989; Kotloff et al., 1999], although more recent estimates suggest a reduced 
case-fatility of 90 million cases with 108’000 fatalities each year [WHO, 2009]. A remarkably 
high number of incidents, namely 70% of all episodes and 60% of all deaths, affect children 
under the age of five years [Niyogi, 2005]. However, a rising number of episodes is also 
found in the industrialized world, especially among military troops and travellors.  
Humans represent the only natural host for Shigella. The disease is transmitted by 
the faecal-oral route mainly via contaminated food and water or due to person-to-person 
contact [Niyogi, 2005]. Recently, also the transmission via house flies (Musca domestica) has 
been reported [Levine and Levine, 1991]. Therefore, the occurrence of shigellosis is primarily 
restricted to poor populations with insufficient hygiene standards and sanitation but also to 
settings of large crowds, political revolutions or natural disasters . 
The etiopathology of the disease depends on several factors, i. e. the infecting 
species of Shigella, the age of the host, the presence of further risk factors and the immune 
state of the patient. Shigellosis is often self-limiting in healthy humans, who will usually 
recover within five to seven days, if no further complications manifest. Within this period an 
initially appearing watery diarrhoea with abdominal cramps is quickly followed by fever, pain 
and tenesmus, which is characterized by bloody, mucoid and purulent stools [Niyogi, 2005]. 
With high prevalence shigellosis turns into a life-threatening situation in malnourished 
infants and children due to the occurrence of intestinal complications, metabolic 
dysfunctions, anaemia in form of the haemolytic uremic syndrome, pneumonia, and diverse 
inflammatory reactions [Sack et al., 2001].  
 
1.4 Therapy of Shigellosis 
As a life-saving first step in the treatment of shigellosis the World Health Organization 
(WHO) recommends oral rehydration and an overall improvement in nutrition [Niyogi, 
2005]. The prescription of antibiotics depends on several factors like the severity of the 
disease, the age of the patient and the likelihood of further transmission. For risk groups an 
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early microbial therapy is advised in order to reduce the duration of illness and thus the risk 
of complications and transmission. Disappointingly, the treatment becomes more and more 
challenging due to the increasing resistance of Shigella to current antibiotics (Figure 1.1) 
[Sack et al., 1997]. Strains resistant to sulfonamides, tetracycline, ampicillin, and TMP-SMX 
exist worldwide. It has been shown that drug resistance is mediated by mobile plasmids 
encoding “resistance factors”, which are transferred by conjugation [Sack et al., 2001].   
Currently, the WHO recommends the use of ciprofloxacin as first-line antibiotic for 
patients of all ages [WHO, 2005]. Major concerns about the use of fluoroquinolones in 
children exist due to the potential side-effects of arthropathy. However, in view of life-
threatening complications caused by shigellosis this risk is accepted. Alternatives to 
ciprofloxacin include cephalosporins (cefixime, ceftriaxone), azithromycin, and pivmecillinam 
but the use of these alternatives exhibits problems concerning costs, formulation, and 
efficacy [Mandal et al., 2012]. 
Vaccination offers an additional alternative to the antimicrobial therapy. Thereby, 
immunity is directed to the O-somatic antigen, which is narrowly type specific. Up-to-date, 
there is no vaccine available on the market. Vaccines under development include 
polysaccharide conjugate and live-attenuated vaccines focusing on the Shigella species S. 
flexneri type 2a, S. sonnei and S. dysenteriae type 1 [WHO, 2009]. 
 
 
Figure 1.1 Resistant antibiotics in the antimicrobial therapy of shigellosis. A) Antibiotics affected by resistance 
development of Shigella (red) and current alternatives. B) Mechanism of resistance in strains of Shigella. 
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1.5 Classification of Shigella Bacteria 
Shigella bacteria belong to the family of Enterobacteriacae [Sansonetti, 2001]. They are 
characterized as nonsporulating, facultative anaerobic Gram-negative rods that are 
unencapsulated and non-motile. The name Shigella results from its discoverer Kiyoshi Shiga, 
who first reported about this bacterium in Japan, 1898 [Niyogi, 2005]. Based on DNA 
hybridization analyses, Shigella cannot be distinguished from Escherichia coli on the 
polynucleotide level, however, it can be differentiated on the virulence phenotype. 
Biochemically, both species share a high similarity and thus, Shigella is often referred to as 
enteroinvasive E. coli (EIEC) [Escobar-Páramo et al., 2004]. The genus Shigella comprises four 
different species whose classification is based on biochemical and serological variations of 
their O-polysaccharide portion of their LPS (Table 1.1) [Sansonetti, 2001]. 
 
Table 1.1 The four Shigella species and their characteristics in order of their frequency. 
Species # serotypes Geographical distribution Etiopathology 
S. flexneri 6 
Worldwide, mainly in            
the developing world 
Less severe 
S. sonnei 1 Central Europe Less severe 
S. boydii 8 
Indian and North             
African subcontinent 
Harmless 
S. dysenteriae 16 Tropic and subtropic regions 
Most pathogenic due to 
shigatoxin (subtype 1) 
 
1.6 Molecular and Cellular Pathogenicity of Shigella 
Shigella bacteria are unable to enter the epithelial cells of the colon directly form the apical 
side (Figure 1.2). Contrary, the basolateral side can be efficiently invaded by the bacteria. 
Thus, they have to choose specific areas to translocate the epithelium in order to infect the 
host cells [Sansonetti, 2001].  
M-cells belong to the follicle-associated epithelium (FAE). Their task is to transport 
lumenal antigens across the epithelium and present them to mucosa-associated lymphoid 
follicles filled with lymphocytes and macrophages, which then initiate a mucosal immune 
reaction. These cells offer Shigella the oppurtunity to translocate to the basolateal pole. 
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Once invaded into M-cells the bacteria escape from the endocytic vacuole without damage 
and reach the associated macrophages, where it gets phagocytosed. Within the macrophage 
Shigella bacteria activate the cysteine protease caspase 1, which in return causes apoptosis 
of the invaded immune cells. In its second function caspase 1 activates the proinflammatory 
signaling by hydrolyzing (IL)-1β and pro-IL-18 to their mature forms IL-1β and IL-18, 
respectively [Sansonetti, 2001]. The release of the bacteria and mature interleukins out of 
the macrophages leads to a severe inflammation. IL-1β triggers the loss of integrity of the 
epithelial barrier causing further diffusion and invasion of Shigella. IL-18 acts as an interferon 
(IFN)-γ inducer targeting natural killer cells and T lymphocytes. 
At the basolateral side of the epithelium free Shigella bacteria enter the host cells via 
macropinocytosis. After having escaped from the phagocytic vacuole into the cytoplasm, the 
bacteria are able to spread intra- and intercellularly and thus, colonize the epithelium. The 
infected cells release IL-8 that in combination with IL-1β recruits polymorphonuclear 
leukocytes (PMNs) in subepithelial tissues [Sansonetti, 2001; Jennison and Verma, 2004]. On 
the one hand, PMNs are, contrary to macrophages, able to phagocytose and kill Shigella 
bacteria. On the other hand, however, they simultaneously increase their M-cell 
independent invasion to the basolateral side by facilitating transmigration through the 
epithelial cells due to tissue destruction.  
 
 
Figure 1.2 Invasion mechanism of Shigella into epithelial cells of the colon and involved virulence factors 
modified according to Sansonetti and Bergounioux, 2008. 
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For the apoptotic death of macrophages, the invasion of Shigella bacteria into the 
eukaryotic cells of the colon and the cell-to-cell spread several virulence factors are required 
[Nhieu et al., 2000; Fernandez and Sansonetti, 2003].  
The macrophage-induced apoptosis depends on the secretion of IpaB, which is 
responsible for the activation of caspase 1. For the invasion of epithelial host cells the 
bacteria form a pore into the cytoplasmic membrane via a Shigella type III secreton 
[Sansonetti, 2001]. This tube-like apparatus contains a hydrophobic complex composed of 
IpaB and IpaC proteins. Its function is firstly the secretion of various proteins into the 
cytoplasm of the host cell and secondly the induction of internalization of shigellae due to a 
signalling cascade leading to polymerization and depolymerization of the actin tubuli via the 
C-terminal domain of IpaC. The maturation of the thus formed cell extension underlies then 
the control of IpaA and IpgD. Cell-to-cell spread of Shigella bacteria also relies on actin 
polymerization and is achieved by the surface-exposed virulence factor IcsA (VirG). 
The complete sequence of the S. flexneri virulence plasmid is known. Most of the 
invasion genes are present within a 30-kb region of the 214-kb virulence plasmid, which is 
named Shigella pathogenicity island (PAI) [Dorman and Porter, 1998]. The expression of its 
chief components is kept under the control of the virF and virB gene products (Figure 1.2). 
VirB is directly involved in the transcription of a large number of pathogenicity genes, while 
VirF regulates this process indirectly by controlling the concentration of VirB. In addition, 
VirF directly activates transcription of the icsA (virG) gene. Therefore, VirF exhibits a major 
role in the pathogenicity cascade of Shigella.  
Interestingly, a certain threshold level of VirF is a prerequisite for the transcription of 
virulence factors. This level within the bacterial cell is influenced by several factors like 
nutrition factors, temperature, pH value, and osmolarity [Durand et al., 2000]. Optimal 
conditions comprise a temperature of 37°C at pH 7.4 and a moderate osmotic level similar to 
physiological saline as well as the presence of the free amino acids arginine and methionine. 
However, the expression of VirF can also be effected on the translational level since for the 
ribosomal translation of VirF-mRNA modified tRNA is required. These modifications 
comprise two positions within the tRNA: Firstly, guanine-34 in the wobble position of the 
anticodon has to be exchanged against the highly modified base queuosine. Secondly, the 
modified nucleoside 2-methylthio-N6-isopentenyladenosine has to be incorporated at 
position 37. The relevance of the thus derived tRNA in respect to the VirF concentration has 
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been tested in gene-knock-out experiments. The modification in position37 depends on the 
miaA gene product. Mutational changes of the miaA gene decrease the intracellular 
concentration of VirF to 10% resulting in a drop of haemolytic activity to 10 – 20% compared 
to the wild type. The incorporation of a queuine precursor in position 34 of the tRNA is 
catalyzed by the tgt (vacC) gene product. Mutation of the corresponding gene reduces the 
VirF concentration and the haemolytic activity to 50 – 60% compared to the wild type 
[Durand et al., 1994; Durand et al., 1997; Durand et al., 2000]. 
These investigations demonstrate that the above-named tRNA-modifying enzymes 
represent promising drug targets leading to a significant decrease in the pathogenicity of 
Shigella. Potent inhibitors exhibit the potential to act as selective antibiotics potentially less 
affected by resistance development. The tgt gene product tRNA-guanine transglycosylase 
isolated from E. coli is well characterized in diverse studies. Zymomonas mobilis TGT serves 
as a model system sharing a sequence identity of 60.4% with the orthologue of S. flexneri 
[Reuter and Ficner, 1995]. As expression and crystallization protocols are available for this 
system, it can be used as the basis for structure-based drug design [Reuter and Ficner, 1995; 
Romier et al., 1996; Romier et al., 1996].  
 
1.7 Biosynthesis of Queuine in Prokaryotes 
Until today, over 70 modifications in nucleobases of transfer RNA have been identified 
[Hoops et al., 1995]. One of these modified nucleobases is queuine, which replaces the 
genetically encoded guanine in position 34 (the “wobble” position) of particular tRNAs. 
Remarkably, queuine is the sole RNA base in which the parent basic ring system is modified. 
It is present in almost all eucaryotes and bacteria. Rare exceptions are Saccharomyces 
cerevisiae and some Actinobacteria (Mycobacerium, Corynebacerium, Streptomyces, 
Bifidobacterium) [Reader et al., 2004]. The base exchange reaction in which guanine is 
substituted against the queuine precursor preQ1 is catalyzed by the enzyme tRNA-guanine 
transglycosylase (Figure 1.3) [Hoops et al., 1995]. In only four different tRNA variants the 
incorporation of queuine can be observed. As a prerequisite they have to exhibit the 
anticodon sequence U33G34U35N36 where N represents adenine, cytosine, guanine, or uracil. 
This sequence is found in tRNAs specific for the amino acids histidine, tyrosine, aspartate, 
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and asparagine. Recognition of this motif is achieved by interactions to Arg286 and Arg289 
[Xie et al., 2003]. 
 
 
Figure 1.3 Biosynthesis of Q-34-tRNA out of GTP and involved enzymes according to Biela et al., 2013. 
  
For this purpose preQ1 is obtained in a multistep reaction out of guanosine 5’-
triphosphate (GTP). Its synthesis involves diverse enzymes, namely the GTP cyclohydrolase I 
(FolE) [Phillips et al., 2008], 6-carboxy-5,6,7,8-tetrahydropterin synthase (QueD) [McCarty et 
al., 2009], an S-adenosyl-L-methioninedependent organic radical-generating enzyme (QueE), 
preQ0 synthetase (QueC) [McCarty et al., 2009] and a nitrile reductase (QueF) [Lee et al., 
2007]. After preQ1 is incorporated it is further modified to queuine in two following 
reactions: Firstly, a ribosyl moiety is added to preQ1 by the S-adenosylmethionine:tRNA 
ribosyltransferase/isomerase (QueA) [Van Lanen et al., 2003]. Secondly, the generated 
epoxide is reduced by the coenzyme B12-dependent epoxyqueuosine reductase (QueG) [Frey 
et al., 1988]. 
Also in eukaryotes, tRNAs harboring the above-mentioned recognition sequence are 
modified in position 34. Contrary to bacteria, eukaryotes do not have the ability to 
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synthesize queuine or its precursor molecule de novo. Therefore, its incorporation 
mechanism differs significantly. After queuine is assimilated as a nutrient from diet, it is 
directly inserted into tRNA within a single reaction performed by the eukaryotic TGT [Okada 
and Nishimura, 1979; Chen et al., 2011]. It is known that queuosine is further transformed 
by glycosylation of the hydroxyl groups of the pentenyl moiety but the related enzymes of 
these reactions are not yet sufficiently explored [Iwata-Reuyl, 2003].  
 
1.8 Base Exchange Mechanism of TGT 
The base exchange of guanine in position 34 of the tRNA against the modified base preQ1 
follows a ping-pong mechanism (Figure 1.4) [Xie et al., 2003].  
  
 
Figure 1.4 Base exchange mechanism of G-34 against preQ1 catalyzed by TGT according to Biela et al., 2013. 
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In the first step of the reaction Asp280 attacks nucleophilically C(1) of ribose-34 after 
tRNAHis,Tyr,Asp,Asn is bound to the enzyme (Figure 1.4A). Thereby, a covalent TGT∙tRNA 
intermediate is formed (Figure 1.4B). The cleaved guanine molecule is released from the 
binding site after picking up a proton. The origin of this proton is not finally clear. While Xie 
et al. discuss Asp102 to release the proton, recent considerations of Biela et al. suggest a 
close-by water molecule as the likely proton donor. As an argument for the latter serves the 
irreversibility of the base exchange: By-products of the above-described reaction are a 
hydroxide ion (Figure 1.4B) and an oxonium ion (Figure 1.4D). Mutual neutralization detracts 
both ions from equilibrium and thus, prevents a reaction in the reversionary direction.  
Subsequently, preQ1 enters the empty binding site (Figure 1.4C). Interestingly, this 
step induces a backbone flip of the carboxamide group between Leu231 and Ala232 
changing its donor functionality to that of an acceptor. This orientation of the backbone is 
stabilized by Glu235, which is able to interact with both backbone orientations depending on 
its protonation state [Brenk et al., 2003]. The exocyclic amino function of preQ1 displaces the 
previously described water molecule within the recognition site and experiences a hydrogen 
bond to the backbone C=O function of Leu231, which in its new position faces the binding 
pocket. Finally, the distance between the covalently bound ribose-34 located within the 
TGT∙tRNA complex and preQ1 is lowered due to repulsive interactions between Val45, Leu68 
and the ribose moiety enabling the nucleophilic attack of preQ1 to C(1) of ribose-34. Most 
likely, the released proton originating from N(9) of guanine’s imidazole moiety is accepted by 
a neighbouring water molecule. The covalent bond to TGT is subsequently broken and the 
modified tRNA leaves the catalytic site (Figure 1.4D). 
 
1.9 Structure of Z. mobilis TGT 
1.9.1 Secondary Structure 
The crystal structure of Z. mobilis TGT exhibits the typical sequence of α-helices and β-sheets 
classifying it as member of the family of the (β/α)8-barrel enzymes, also known as TIM-
barrels (Figure 1.5A and 1.6) [Brenk et al., 2003]. A prominent member of this family is 
triose-phosphate isomerase for which this fold was first discovered.  
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Figure 1.5 TGT’s primary and secondary structure (A) as well as a topology diagram of secondary structure 
elements (B). The typical TIM-barrel structure elements are colored in blue (β-sheets) and red (α-helices). 
 
Contrary to the commonly found folding pattern, various deviations in the sequence 
of secondary structure elements can be observed for Z. mobilis TGT (Figure 1.5B) [Brenk et 
al., 2003; Immekus et al., 2012]. These comprise an antiparallel three-stranded β-sheet 
located at the N-terminus of the enzyme, a beta3-alpha3 insertion as well as a subdomain 
offering a binding site for a zinc ion by tetrahedral coordination to the amino acids Cys318, 
Cys320, Cys323, and His349. Thereby, the zinc binding site involves helix α8 of the TIM-
barrel. Both, the beta3-alpha3 insertion and the zinc binding domain are involved in the 
βA βB βC β1 β2 α1 α2a 
α2b α2c β3 αA βD βE βF α3 β4 
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recognition of tRNAHis,Tyr,Asp,Asn. Helix αB acts as a linker connecting the TIM-barrel domain 
with the zinc binding domain. The active site of Z. mobilis TGT is located at the C-terminus of 
the barrel motif [Okada and Nishimura, 1979; Curnow and Garcia, 1995]. 
 
1.9.2 Dimeric Assembly 
From detailed studies it is known that TGT is only active as a homodimer in which the two 
monomers are related by a 2-fold symmetry (Figure 1.6) [Xie et al., 2003; Stengl et al., 2007].  
    
 
Figure 1.6 Secondary structure and dimeric assembly shown for TGT apo structure 1PUD [Romier et al., 1996]. 
The structure contains one monomer in the asymmetric unit. Thus, the crystal mate was generated using the 
program PyMOL. 
 
Upon dimerization an interface with the size of 1667 Å2 is formed [Ritschel et al., 
2009]. Contrary to apo structures and TGT∙ligand complexes where the complementary 
monomer has to be generated by symmetry operations, the deposited structures of 
TGT∙tRNA complexes (PDB ID: 1Q2R, 1Q2S [Xie et al., 2003]) exhibit the dimeric state in the 
asymmetric unit. The homodimer is stabilized by diverse hydrogen bonds, salt bridges and 
van der Waals interactions occurring twice in the homodimer due to the observed C2 
symmetry. Interestingly, the amino acid residues involved in dimer formation are highly 
conserved among various prokaryotic organisms [Stengl et al., 2007]. While initially the focus 
was set on the strong polar interactions Lys52 ∙∙∙ Glu339’, Lys55 ∙∙∙ Glu348’, and                 
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Lys85 ∙∙∙ Glu309’, recent studies reveal the aromatic cluster Trp326, Tyr330, Phe92', and 
His333 to be the key motif for dimer stabilization [Ritschel et al., 2009; Jakobi, 2013].   
Based on crystal structure analysis as well as non-denaturing mass spectrometry 
experiments a 1:1 binding stoichiometry between the tRNA and the TGT homodimer is 
suggested (Figure 1.7A) [Xie et al., 2003; Ritschel et al., 2009]. While the base exchange of 
guanine against the modified base preQ1 is performed at the active site of the first 
monomer, the second monomer stabilizes the ternary complex most likely via its beta3-
alpha3 insertion. In this part of the protein several positively charged amino acid residues 
are present at the protein surface offering the ability to form strong polar interactions to the 
negatively charged phosphate backbone of the tRNA. 
 
1.9.3 Active Site 
TGT specifically recognizes the tRNA nucleobases uracil-34, guanine-34, and uracil-35 [Okada 
and Nishimura, 1979; Curnow and Garcia, 1995]. While both uracil nucleobases bind to 
rather undefined, largely solvent-exposed pockets, guanine-34 is buried in a tunnel-shaped 
binding site offering two openings of which one is closed upon substrate binding. Thereby, 
guanine-34 is sandwiched between Tyr106 and Met260 forming π-stacking interactions to 
both residues (Figure 1.7B).  
 
 
Figure 1.7 Crystal structure of the 1:1 ternary complex of TGT∙tRNA (PDB ID: 1Q2S *Xie, Liu et al., 2003]). The 
crystal structure contains two TGT monomers in the asymmetric unit. A) While the base exchange reaction is 
performed at the guanine-34 binding site of the first monomer (red), the second monomer (blue) stabilizes the 
complex via its beta7-alpha6 insertion. B) Binding mode of preQ1 within the guanine-34 recognition site. 
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Furthermore, the substrate is recognized by hydrogen bonds to Asp102, Asp156, 
Gln203, and a water-mediated one to Leu231. Except of Tyr106, which is substituted by 
phenylalanine in TGT of S. flexneri, all residues are identical between the TGTs of S. flexneri 
and Z. mobilis [Grädler et al., 2001]. 
Depending on the pH value and the ligand bound in the active site, its constitution 
alters: Firstly, the carboxyamide group located between Leu231 and Ala232 is able to flip its 
donor/acceptor functionality. Secondly, Asp102 resting in the apo state within the protein 
rotates towards the binding site once a substrate is bound [Brenk et al., 2003].   
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2. Impact of Protein and Ligand Impurities on ITC-derived 
Protein-Ligand Thermodynamics 
 
2.1 Introductory Remarks 
The following chapter has been published in the scientific journal Biochimica et Biophysica Acta – General 
Subjects.
1
 TGT compounds were synthesized by Luzi Jakob Barandun and Christoph Hohn (ETH Zürich). Studies 
on trypsin were performed by Stefan Grüner (Philipps-Universität Marburg). Trypsin ligands were prepared by 
Frank Sielaff (Philipps-Universität Marburg). All studies on TGT binding were executed by the author of this 
thesis. The paper was drafted by Grüner and Neeb. 
 
 
 
2.2 Abstract 
The thermodynamic characterization of protein-ligand interactions by isothermal titration 
calorimetry is a powerful tool in drug design, giving valuable insight into the interaction 
driving forces. Isothermal titration calorimetry is thought to require protein and ligand 
solutions of high quality, meaning both the absence of contaminants as well as accurately 
determined concentrations. Ligands synthesized to deviating purity and protein of different 
pureness were titrated by isothermal titration calorimetry. Data curation was attempted also 
considering information from analytical techniques to correct stoichiometry. We used 
                                                          
1 Grüner, Neeb et al. (2014). Impact of Protein and Ligand Impurities on ITC-derived Protein-Ligand Thermodynamics. Biochimica et 
Biophysica Acta 1840, 2843-2850. 
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trypsin and tRNA-guanine transglycosylase (TGT), a tRNA modifying enzyme, together with 
high affinity ligands to investigate both the effect of errors in protein concentration as well 
as the impact of ligand impurities on the apparent ligand binding thermodynamics. We 
found that errors in protein concentration of up to 33% did not change the thermodynamic 
properties obtained significantly. However, most ligand impurities led to pronounced 
changes in binding enthalpy. In cases where protein binding of the respective impurity would 
not have been expected, the actual ligand concentration was corrected for and the thus 
revised data compared to thermodynamic properties obtained with the respective pure 
ligand. Even in these cases, we observed differences in binding enthalpy of about 
4 𝑘𝐽 ∙ 𝑚𝑜𝑙−1, which is considered as significant. In summary, our results indicate that the 
ligand purity is the critical parameter to monitor if accurate thermodynamic data of a high 
affinity protein-ligand complex are to be recorded. Furthermore, artificially changing fitting 
parameters to obtain a sound interaction stoichiometry in the presence of uncharacterized 
ligand impurities may lead to thermodynamic parameters significantly deviating from the 
accurate thermodynamic signature. 
 
2.3 Introduction 
Thermodynamic characterization of protein-ligand interactions by isothermal titration 
calorimetry (ITC) has become a routinely used method in understanding interactions of 
biomolecules with naturally occurring binding partners as well as a powerful tool in drug 
design [Freyer and Lewis, 2008]. The obtained thermodynamic data of an interaction are 
most valuable to complement structural information resulting from X-ray crystallography or 
NMR spectroscopy methods in order to rationally improve a lead compound in structure-
based drug design [Chaires, 2008]. However, ITC experiments usually require substantial 
amounts of the interacting partners, both being of high purity. Successful production of high 
amounts and purity might be possible with well-selected model systems for which an 
efficient expression and purification protocol is available and ligands result from simple 
synthesis. This becomes, however, increasingly difficult if real drug targets and ligands from 
multistep synthesis are considered. To investigate the impact of impurities present in both 
the protein and ligand solution focusing on relevant drug discovery cases, we characterized 
binding of several competitive inhibitors to B. taurus trypsin and Z. mobilis tRNA-guanine 
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transglycosylase (TGT) by ITC, taking into account different amounts of protein impurities 
and using ligand preparations containing organic and inorganic impurities, respectively. 
Trypsin is a well-studied serine protease involved in digestive processes and serves 
frequently as a surrogate for actual drug targets in the design of protease inhibitors or to 
learn about specificity and selectivity discrimination [Rauh et al., 2002; Rauh et al., 2003; 
Rauh et al., 2004]. However, being an extracellular mammalian protein, it is difficult to 
obtain in high amounts in its active form by heterologous production in simple expression 
systems such as E. coli. Similar issues arise for other proteins relevant to drug development 
such as thrombin [Yonemura et al., 2004]. For some of these proteins, natural sources are 
abundantly available but material might be contaminated with impurities and is usually 
supplied in lyophilized form which is known to contain hydrate water [Wang, 2000]. Protein 
concentration is then routinely determined by spectrophotometric measurements, which 
are often calibrated via an easily calculated extinction coefficient [Gill and Hippel, 1989]. 
However, the provided extinction coefficient may differ from the actual one, thereby 
falsifying the protein concentration systematically. This difference is especially pronounced 
for trypsin’s precursor trypsinogen and amounts to 11% [Gill and Hippel, 1989]. Therefore, 
trypsin was an ideal candidate to investigate how errors in protein concentration and 
possible impurities affect the thermodynamic characterization of ligand binding determined 
by ITC. 
The tRNA modifying enzyme tRNA-guanine transglycosylase is known to play a key 
role in the pathogenicity of Shigella, the causative agent of Shigellosis [Sansonetti, 2001]. It 
catalyzes a base exchange of guanine by a modified base in position 34 of the tRNA-
anticodon loop [Xie et al., 2003]. This exchange is essential to produce virulence factors 
necessary for cell invasion. Thus, blocking the enzymatic activity of TGT prevents invasion of 
Shigella [Durand et al., 2000]. The expression protocol in E. coli is well established and yields 
due to favorable solubility features protein of high purity as confirmed by mass 
spectrometry, SDS page, and dynamic light scattering measurements [Reuter and Ficner, 
1995; Romier et al., 1996]. However, the highly potent 6-amino-1,7-dihydro-8H-imidazo[4,5-
g]quinazolin-8-ones (lin-benzoguanines) exhibit unfavorable solubility and polarity issues 
complicating the synthesis of compounds with high purity [Hörtner et al., 2007]. Hence, TGT 
was selected as a second real case example to study the influence of organic and inorganic 
impurities in ligand preparations on ITC measurements.  
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2.4 Material and Methods 
2.4.1 Protein Preparation and Quantification. Bovine pancreas trypsin from natural source 
was purchased as ethanol precipitate from Sigma (product number: T8003). Dry weight 
determination was performed in duplicate to estimate the amount of associated volatile 
substances, i.e. mainly hydrate water. The protein precipitate was dried at 378 K at normal 
atmospheric pressure and recurrently weighted after cooling in a desiccator until stable 
weight was reached [Kupke and Dorrier, 1978]. Protein concentration was determined by 
two methods. Firstly, the micro-biuret method was used, measuring absorbance at 545 nm 
after trichloroacetic acid/desoxycholate precipitation and using bovine serum albumin as 
reference protein [Goa, 1953; Bensadoun and Weinstein, 1976]. Secondly, UV 
spectrophotometry at 280 nm (A280nm) was employed, using an experimental absorbance 
coefficient of 1.54 𝑚𝑔 ∙ 𝑚𝐿−1 at 280 nm and a molecular weight of 23305 Da as calculated 
by ProtParam for cationic bovine trypsin (UniProt-ID: P00760), giving 𝜖280 = 35890 𝑀
−1 ∙
𝑐𝑚−1 [Robinson et al., 1971; Koeppe and Stroud, 1976; Gasteiger et al., 2005]. The 
extinction coefficient of trypsin at 280 nm was 𝜖280 = 37650 𝑀
−1 ∙ 𝑐𝑚−1 as directly 
calculated by ProtParam. Percentage errors in protein concentration refer to the deviation 
from the concentration determined by the micro-biuret method. 
Z. mobilis TGT was expressed and purified as described in detail elsewhere [Reuter 
and Ficner, 1995; Romier et al., 1996]. The protein concentration was determined firstly by 
UV spectrophotometry at 280 nm (A280nm).  An absorption of 0.778 (10 mm path) 
corresponds to 1 𝑚𝑔 ∙ 𝑚𝐿−1 (23.4 µM) as suggested by ProtParam [Gasteiger et al., 2005]. 
Secondly, a Bradford assay was applied on the basis of protein-dye binding using bovine 
serum albumin as a standard [Bradford, 1976]. Both methods resulted in a closely similar 
protein concentration.  
 
2.4.2 Isothermal Titration Calorimetry. ITC experiments were performed using an iTC200 
microcalorimeter (GE Healthcare Europe GmbH, Freiburg, Germany). All experiments were 
performed at 25°C using filtered solutions only. The reference cell contained demineralized 
water. The trypsin precipitate was dissolved in ITC buffer (50 mM Tris/HCl, 100 mM NaCl, 
0.1% (w/v) polyethylene glycol 8000, pH 7.8) supplemented with 3% (v/v) DMSO and stored 
on ice. The protein solution was freshly prepared daily. No measurable trypsin autodigestion 
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occurred as judged by the interaction stoichiometry remaining stable for at least 12 hours 
under the applied protein concentrations. The final protein concentration in the sample cell 
was 15 µM based on weight, 12.3 µM based on dry weight measurements and 11.3 µM 
based on micro-biuret and spectrophotometric measurements. Ligand stock solutions of 1 
and 2 of 10 mM were prepared by weight in 100% (v/v) DMSO, subsequently diluted to 
concentrations ranging from 250 to 400 µM with ITC buffer and adjusted to 3% (v/v) DMSO 
prior to the experiment. TGT was dissolved in the experimental buffer containing 50 mM 
Hepes, 200 mM NaCl, and 0.037% (v/v) Tween 20, pH 7.8 to a final concentration of 10 µM 
containing 3% (v/v) DMSO. Due to their low solubility, ligands 3a and 4a were first dissolved 
in 100% (v/v) DMSO and diluted with buffer solution to a final DMSO concentration of 3%.  
Ligand concentration in the syringe was adjusted to 200 – 245 µM with experimental buffer. 
The ligand solution containing syringe was stirred at 1000 rpm and injection started after a 
stable baseline had been established. A first injection of 0.3 µL was followed by 15 injections 
of 1.1 to 2.2 µL. All injections were spaced by 120 s to 180 s intervals. Raw data were 
collected as released heat per time. The collected data were analyzed using ORIGIN Software 
7.0 (Microcal Inc.). The area under each peak was integrated, followed by correction for 
heats of dilution and mixing by subtracting the final baseline, which consisted of small peaks 
of comparable size. The data point resulting from the first injection was deleted after 
integration as it is error prone [Mizoue and Tellinghuisen, 2004]. A single-site-binding 
isotherm that yields the enthalpy of binding Δ𝐻0 and the dissociation constant 𝐾𝑑  was fitted 
to the data [Wiseman et al., 1989]. Each experiment was performed at least in triplicate. For 
representative curves see Figure 2.1. 
 
2.4.3 Dynamic Light Scattering. Potentially aggregation behavior of Z. mobilis TGT in the 
absence and presence of an inhibitor was determined by Dynamic Light Scattering (DLS) 
using a Zetasizer Nano ZS (Malvern Instruments, Herrenberg, Germany) equipped with a 10 
mW HeNe laser at a wavelength of 633 nm at 25°C. Scattered light was detected at a 173° 
angle with laser attenuation and measurement position adjusted automatically by the 
software. The same conditions as in ITC experiments were used (10 µM protein in ITC buffer, 
3% DMSO, addition of 28 µM (= 20 injections of 2 µl) of ligand 4a). The given data comprised 
three measurements of at least 10 runs.  
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Figure 2.1 Representative ITC thermograms for 1  and 2 directly titrated to trypsin (A) as well as 3a and 4a 
directly titrated to TGT (B). Shown are titrations of impure preparations, which were partially re-fitted for 
ligands 2, 3a and 4a to a more reasonable stoichiometry according to data from pure ligand 2 and to 
elementary analysis for 3a and 4a, respectively. 
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2.5 Results 
2.5.1 Errors in Protein Concentration Did Not Affect the Thermodynamic Profiles of High 
Affinity Protein-Ligand Binding 
To investigate the impact of impurities present in the protein preparation on the 
thermodynamic characterization of a protein-ligand interaction, binding of two competitive 
inhibitors (Figure 2.2A) to trypsin was studied by ITC.  
 
 
Figure 2.2 Chemical structures of the studied ligands. A) Ligands binding to trypsin. B) Ligands binding to TGT. 
 
First, varying degrees of impurities present in the trypsin preparation were taken into 
account during modeling of thermodynamic data to study protein impurity-related 
deviations. The amount of hydrate water present in the protein precipitate was estimated by 
using the dry weight method. It revealed a hydrate water content of 18% (w/w). Therefore, 
the actual protein concentration would have been overestimated by 22%, if it was solely 
determined by weighing. However, all thermodynamic parameters only showed subtle, if 
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any, changes on considering hydrate water content in data modeling (Table 2.1). The only 
fitting parameter that changed was the interaction stoichiometry n. It increased to values 
closer to 1, the expected value for the interactions investigated. This supports the idea that 
considering the water content reveals the more correct model for the interaction, even in 
the absence of other changes in thermodynamic parameters. Hence, ignoring the water 
content of the used solid protein preparation did not influence the thermodynamic 
characterization of ligand binding. Next, the actual protein concentration was determined by 
a colorimetric and a spectrophotometric method, the micro-biuret and A280nm-assay, 
respectively. Both techniques yielded very similar values, if the experimentally determined 
extinction coefficient of trypsin was used for the A280nm-assay. If the determination of 
protein concentration was based on weight, it deviated from the actual protein 
concentration by 33%. The difference between the calculated and previously experimentally 
determined extinction coefficient of trypsin resembled the already known difference for 
trypsinogen [Gill and Hippel, 1989]. The difference in protein concentration to dry weight 
determination is probably due to low molecular weight substances such as salts. Nucleic 
acids were not present in the precipitate. Despite this rather large deviation of 33%, 
modeling based on the actual protein content also did not significantly change the values of 
thermodynamic parameters obtained by ITC experiments but interaction stoichiometries 
approximated much closer to 1, confirming that a better model was fitted (Table 2.1). 
 
2.5.2 Organic Ligand Contaminations Can Affect Thermodynamic Profiles of Protein-
Ligand Binding Significantly 
In order to study how impurities in ligand preparations impact the obtained thermodynamic 
parameters, two preparations of each trypsin-binding ligand 1 and 2 of different purities 
were used, referred to as the “impure” and “pure” preparation, respectively. The impure 
preparation of ligand 1 contained a by-product of its synthesis with similar retention 
behavior in HPLC, constituting about 20% of the ligand preparation based on HPLC-coupled 
UV-spectrophotometry. Thermodynamic characterization revealed a high-affinity interaction 
with an interaction stoichiometry larger than one, indicating that less ligand than assumed 
was present (Table 2.2, Figure 2.3). ITC experiments using a purified ligand preparation 
resulted in a slightly improved standard free binding energy as well as standard binding 
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enthalpy (∆∆𝐺0 = −1.9 𝑘𝐽 ∙ 𝑚𝑜𝑙−1, ∆∆𝐻0 = −2.3 𝑘𝐽 ∙ 𝑚𝑜𝑙−1) and an interaction 
stoichiometry n of reasonable value (1.0).  
 
Table 2.1 Thermodynamic parameters of ligand binding as determined by ITC and modeling with different 
protein impurity levels. 
Ligand Correction[a] n[b] ∆𝑮𝟎(𝒌𝑱 ∙
𝒎𝒐𝒍−𝟏)[b] 
∆𝑯𝟎(𝒌𝑱 ∙
𝒎𝒐𝒍−𝟏)[b] 
−𝑻∆𝑺𝟎(𝒌𝑱 ∙
𝒎𝒐𝒍−𝟏)[b] 
1 none 0.75 ± 0.02 -45.9 ± 1.5 -27.5 ± 1.1 -18.4 ± 1.8 
 hydrate 0.92 ± 0.02 -45.9 ± 1.6 -27.5 ± 1.1 -18.4 ± 1.9 
 protein 1.00 ± 0.02 -46.0 ± 1.6 -27.5 ± 1.2 -18.4 ± 2.0 
2 none 0.68 ± 0.01 -46.3 ± 0.9 -20.4 ± 0.7 -26.0 ± 1.1 
 hydrate 0.83 ± 0.01 -46.2 ± 0.7 -20.4 ± 0.7 -25.8 ± 1.0 
 protein 0.90 ± 0.01 -46.1 ± 0.7 -20.4 ± 0.7 -25.7 ± 1.0 
a
Correction states the method by which the protein concentration used for thermogram modeling was 
determined: none – concentration as calculated by protein weight (33% deviation); hydrate – hydrate water 
content was considered (22% deviation); protein – concentration as determined by micro-biuret/A280nm. 
Deviations are relative to concentration measured by micro-biuret assay. 
b
Given errors are standard deviations 
of at least triplicates. 
 
Ligand 2 was contaminated in its impure form with an organic compound. It was 
mass spectrometrically identified as 1,1’,1’’-phosphinylidtrispyrrolidin (CAS-no. 6415-07-2), 
which is a reaction product of benzotriazol-1-yl-oxytripyrrolidinophosphonium 
hexafluorophosphate (PyBOP), a peptide coupling agent used during synthesis. 
Characterizing ligand binding with the impure preparation showed a high-affinity interaction 
with trypsin (𝐾𝑑 = 11 𝑛𝑀, Table 2.2), which was apparently dominated by its entropic 
component, contributing almost 70% to the overall standard free binding energy. However, 
an abnormally high interaction stoichiometry of about 1.5 indicated considerable ligand 
purity issues. Further purification of the ligand and additional ITC experiments showed that 
the actual affinity of the pure ligand was slightly stronger (𝐾𝑑 = 8 𝑛𝑀). Therefore, the ligand 
purity did not strongly influence the measured binding affinity. In contrast, the obtained 
interaction stoichiometry approached values closer to the theoretically expected one (0.9).  
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Table 2.2 Thermodynamic parameters of ligand binding and impact of ligand impurities. 
Ligand Purity n ∆𝑮𝟎(𝒌𝑱
∙ 𝒎𝒐𝒍−𝟏) 
𝑲𝒅(𝒏𝑴) ∆𝑯
𝟎(𝒌𝑱
∙ 𝒎𝒐𝒍−𝟏) 
−𝑻∆𝑺𝟎(𝒌𝑱
∙ 𝒎𝒐𝒍−𝟏) 
1 pure[a] 1.00 ± 0.02 -46.0 ± 1.6 9 ±   6 -27.5 ± 1.2 -18.4 ± 2.0 
 impure 1.15 ± 0.03 -44.1 ± 1.0 19 ±   8 -25.2 ± 0.3 -18.9 ± 1.0 
2 pure[a] 0.90 ± 0.01 -46.1 ± 0.7 8 ±   2 -20.4 ± 0.7 -25.7 ± 1.0 
 impure 1.48 ± 0.05 -45.5 ± 1.9 11 ±   8 -14.6 ± 0.7 -30.9 ± 2.0 
 impureM[b] 0.89 ± 0.02 -46.8 ± 1.8 6 ±   5 -24.2 ± 0.8 -22.6 ± 2.0 
3a pure 0.73 ± 0.05 -41.6 ± 0.1 52 ±   2 -74.8 ± 1.8  33.2 ± 1.8 
 Impure 1.16 ± 0.01 -40.3 ± 0.3 86 ± 12 -48.3 ± 0.4    8.0 ± 0.5 
 impureM-C[c] 0.84 ± 0.00 -41.2 ± 0.2 60 ±   8 -66.1 ± 0.5 24.9 ± 0.6 
 impureM-N[d] 0.76 ± 0.00 -41.2 ± 0.4 61 ±   9 -74.5 ± 0.6 33.3 ± 0.7 
4a pure 0.68 ± 0.00 -42.2 ± 0.4 41 ±   6 -78.3 ± 1.2  36.1 ± 1.2 
 impure 2.23 ± 0.01 -42.4 ± 0.4 38 ±   5 -27.3 ± 0.1 -15.1 ± 0.4 
 impureM-C[c] 0.73 ± 0.00 -45.6 ± 0.7 11 ±   3 -81.4 ± 0.7  35.8 ± 1.0 
a
Results from pure ligand preparations as in Table 1 shown for ease of comparability. 
b
Thermograms resulting 
from impure preparation were used and fitted to reach the same interaction stoichiometry n as thermograms 
obtained with pure preparation. 
c
Thermograms resulting from impure preparation were used and fitted based 
on the corrected ligand concentration deduced from the carbon value of elementary analysis. 
d
Thermograms 
resulting from impure preparation were used and fitted based on the corrected ligand concentration deduced 
from the nitrogen value of elementary analysis. 
 
Furthermore, the standard binding enthalpy drastically improved (∆∆𝐻0 = −5.8 𝑘𝐽 ∙
𝑚𝑜𝑙−1). Consequently, the entropic contribution to binding decreased by a similar 
magnitude (−𝑇∆∆𝑆0 = 5.2 𝑘𝐽 ∙ 𝑚𝑜𝑙−1) and afforded then only about 55% of the total 
standard free binding energy. Re-fitting of the thermograms obtained with the impure ligand 
was done with a corrected ligand concentration giving similar interaction stoichiometries as 
the pure ligand (“impureM”). Correcting the ligand concentration yielded a concentration 
40% less than originally assumed. The obtained thermodynamic data of these corrected 
fittings were compared to the data resulting from the pure ligand preparation. Whereas the 
standard free binding energies were in close agreement (∆∆𝐺0 = −0.7 𝑘𝐽 ∙ 𝑚𝑜𝑙−1), the 
enthalpic and entropic contributions still differed significantly by −3.8 𝑘𝐽 ∙ 𝑚𝑜𝑙−1 and 
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3.1 𝑘𝐽 ∙ 𝑚𝑜𝑙−1, respectively [Holdgate, 2001]. Hence, the thermodynamic profile of the 
ligand resulting from the impure, newly modeled preparation did not reasonably agree with 
the profile obtained from a pure preparation. 
 
 
Figure 2.3 Thermodynamic properties for ligands 1 and 2 from impure and pure preparations as determined by 
ITC. Shown are mean values and standard deviations as error bars of at least triplicates. Purity: impure – ligand 
preparations containing a contaminant were used for experiments with no correction for actual ligand content; 
pure – repurified ligand preparations were used; impureM – ligand preparations containing a contaminant 
were used for experiments and actual ligand content was taken into account for modeling. 
 
Additionally, the impact of an organic impurity on the thermodynamic profile of TGT 
ligand 3a (Figure 2.2B) was investigated by analyzing the ligand before and after HPLC 
purification. Unfortunately, the exact chemical composition of the impurity could not be 
identified. Elementary analysis revealed that the values for carbon and nitrogen are affected 
differently (Table 2.3). Considering the determined carbon value, an actual purity of 
approximately 73% was estimated. In the case of the found value for nitrogen, purity 
appeared to be further lowered to around 66%. ITC measurements characterized 3a in its 
impure form as a potent inhibitor of TGT (𝐾𝑑 = 86 𝑛𝑀) with a mainly enthalpic contribution 
to binding (Table 2.2).  
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Table 2.3 Elemental analysis of the impure lin-benzoguanines after precipitation. 
Ligand  C: H: N: 
     3a 
        
calcd: 52.17 4.38 36.50 
found: 37.86 4.48 23.92 
     4a 
2  
calcd:[a] 44.78 5.26 24.37 
found: 14.69 2.29   7.78 
        a
The calculation assumes 4a to be present as dihydrochloride. 
 
Accompanied by the described deviations found in elementary analysis, the 
interaction stoichiometry is increased to a value of 1.16. Re-fitting of the data for the impure 
ligand following the elementary analysis resulted in small changes of the standard free 
binding energy (∆∆𝐺0 = −0.9 𝑘𝐽 ∙ 𝑚𝑜𝑙−1). However, the thermodynamic profile shows a 
more pronounced enthalpy term of ∆∆𝐻0 = −17.8  to −26.2  𝑘𝐽 ∙ 𝑚𝑜𝑙−1. The difference 
between the two newly fitted data sets is significantly increased, especially for ∆𝐻0 
(∆∆𝐻0 = 8.4 𝑘𝐽 ∙ 𝑚𝑜𝑙−1). As a consequence, the entropic term shifts to more unfavorable 
values. The interaction stoichiometry improved to reasonable values of 0.84 and 0.76, 
respectively, taking into account that expression and purification did not yield fully active 
protein. To get a hint about the impurity’s composition, the values were compared to those 
of 3a in its pure state, after further purification steps via HPLC. ∆𝐺0 remained the same 
within the range of error compared to the re-fitted value (∆∆𝐺0 = −1.3 𝑘𝐽 ∙ 𝑚𝑜𝑙−1), similar 
to refitting data of the impure ligand. The enthalpic term drastically increased compared to 
the batch of 3a before HPLC purification (∆∆𝐻0 = 26.5  𝑘𝐽 ∙ 𝑚𝑜𝑙−1). Contrary to that, the 
values are in excellent agreement with the re-fitted values for a purity of approximately 66% 
(∆𝑛 = 0.03, ∆∆𝐺0 = −0.4  𝑘𝐽 ∙ 𝑚𝑜𝑙−1, ∆∆𝐻0 = −0.3  𝑘𝐽 ∙ 𝑚𝑜𝑙−1, −𝑇∆∆𝑆0 = −0.1 𝑘𝐽 ∙
𝑚𝑜𝑙−1). 
 
2.5.3 Inorganic Ligand Contaminations Can Also Affect Thermodynamic Profiles of 
Protein-Ligand Binding 
A second TGT inhibitor was included in our studies. Compound 4a shows low purity after 
synthesis without any further purification steps. According to elementary analysis, the 
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powder contains the desired compound 4a to approximately one-third. Contrary to the 
results of 3a, the yield resulting from the ratio found to theoretical percentage of carbon and 
nitrogen, respectively, shows only subtle differences (∆𝑦𝑖𝑒𝑙𝑑 = 0.9%). Therefore, most 
likely an inorganic impurity originating from synthesis is present in the ligand preparation. 
The binding isotherm yielded a binding affinity of 𝐾𝑑 = 38 𝑛𝑀 for the impure sample of 4a 
and 𝐾𝑑 = 41 𝑛𝑀 for the pure one (∆∆𝐺
0 = 0.2 𝑘𝐽 ∙ 𝑚𝑜𝑙−1). Again, the largest changes 
between pure and impure preparations are noticeable in the thermodynamic partitioning: 
The enthalpic term increases remarkably from −27.3 𝑘𝐽 ∙ 𝑚𝑜𝑙−1 to −78.3 𝑘𝐽 ∙ 𝑚𝑜𝑙−1 
(∆∆𝐻0 = −51.0  𝑘𝐽 ∙ 𝑚𝑜𝑙−1), the entropic contribution decreases from −15.1 𝑘𝐽 ∙ 𝑚𝑜𝑙−1 to 
an unfavorable term of 36.1 𝑘𝐽 ∙ 𝑚𝑜𝑙−1 (−𝑇∆∆𝑆0 = 51.2 𝑘𝐽 ∙ 𝑚𝑜𝑙−1). In addition, 
stoichiometry is diminished by a factor of about three from 2.23 to a more reasonable value 
for this inhibitor of 0.68. In the observed case, re-fitting of data could be performed easier 
since the results from elementary analysis indicated a purity level of approximately 33% due 
to an inorganic salt. The obtained values were in good agreement with the values derived 
from the pure ligand preparation, even if close to the significance level. Stoichiometry 
differed by 0.05, ∆𝐻0 by −3.1 𝑘𝐽 ∙ 𝑚𝑜𝑙−1 and −𝑇∆𝑆0 by −0.3 𝑘𝐽 ∙ 𝑚𝑜𝑙−1. Changes in ∆𝐺0 
were slightly higher than for the other described compounds 1 – 3a (∆∆𝐺0 = −3.4 𝑘𝐽 ∙
𝑚𝑜𝑙−1, 𝐾𝑑 = 41 𝑛𝑀  vs. 11 𝑛𝑀). 
It is known that salts can significantly influence the activity and stability of proteins in 
aqueous solution both in favorable and unfavorable means according to the Hofmeister 
series [Kunz et al., 2004]. Indeed, TGT needs high salt conditions to be soluble in the long 
term. To determine possibly occurring protein or ligand aggregation due to an increased salt 
concentration, dynamic light scattering (DLS) measurements were performed additionally. 
While inactive aggregates formed by the protein are not expected to change the 
thermodynamic profile drastically as shown in our studies, aggregates formed by ligands are 
able to bind to the protein unspecifically leading to false positive signals [McGovern et al., 
2002]. Measurements were carried out in the absence and presence of 4a (Figure 4.4) using 
the same conditions as in the ITC experiments. Neither the obtained mean peak size 
(∆𝑑 = 0.9) nor the average peak volume (∆𝑉 = 0.0) deviated significantly. Therefore, the 
difference in enthalpy of  ∆∆𝐻0 = −3.1  𝑘𝐽 ∙ 𝑚𝑜𝑙−1  between re-fitted data originating from 
impure ligand preparation and data from repurified ligand preparation was unexpected. 
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Figure 2.4 Influence of 4a on the size distribution by volume of Z. mobilis TGT. In both cases a 10 µM protein 
solution was analyzed. A) A total of three DLS measurements of TGT in the absence of any ligand show a 
monomodal size distribution with an average diameter of 9.3 nm. The mean peak volume is 99.97%. B) A total 
of three DLS measurements of TGT in presence of 4a with a concentration of 28 µM (equivalent to 20 injections 
of 2 µl of a 200 µM inhibitor solution) show no influence on the monomodal size distribution. The average 
diameter of the protein is 10.2 nm with a mean peak volume of 99.97%. 
 
2.6 Comparative discussion 
In biophysical investigations, one is urged to work with protein and in the field of protein-
ligand interactions also with ligands of high purity [Daviter and Fronzes, 2013]. ITC is a key 
technique to thermodynamically characterize chemical and biochemical binding processes. 
Before analyzing the interaction of interest, particular attention needs to be paid to carefully 
calibrate the microcalorimeter using well-known standard chemical reactions as well as to 
the achievable precision and systematic differences reported for various microcalorimeters 
[Wadsö, 2000; Tellinghuisen, 2007; Baranauskienė et al., 2009] When it comes to analyzing 
the thermodynamics of protein-ligand interactions, ITC is a central method but frequently 
proteins and ligands are difficult to prepare at high purity. Therefore, we investigated the 
effects of errors in protein and ligand concentration and impurities on the obtained 
thermodynamic property values. We found that, for high-affinity interactions with c values 
over 100 [Wiseman et al., 1989], neither considering hydrate water nor further uncertainties 
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in protein concentration resulted in differences of thermodynamic property values 
compared to values obtained with the simple protein weight concentration. Hence, ignoring 
a concentration error of up to 33% and thereby hydrate water and contaminants such as 
salts in the protein preparation did not affect the apparent thermodynamic data of a 
protein-ligand interaction. This finding is in agreement with a study of metal ions binding to 
crown ethers [Turnbull and Daranas, 2003]. Errors in the receptor (crown ether) 
concentration of up to 15% lead neither to changes in the standard free binding energy nor 
the binding enthalpy [Turnbull and Daranas, 2003]. The c value is defined as 𝑐 = 𝑛 ∙
 𝑃𝑟𝑜𝑡 𝑡𝑜𝑡𝑎𝑙 /𝐾𝑑 . Even a more than twice as large error of 33% was found to be acceptable in 
this study. The tolerance can be rationalized by the idea that for high affinity ligands, the 
amount of ligand binding to its receptor for each injection is almost solely dependent on the 
actual amount of ligand injected and therefore not sensitive to changes in receptor 
concentration and errors in its determination are compensated for during modeling by the 
stoichiometry parameter n [Tellinghuisen, 2005; Tellinghuisen and Chodera, 2011]. Changes 
of the latter mainly lead to shifting the binding isotherm to different interaction 
stoichiometries accompanied by small changes in ∆𝐺0. Still it is important for experimental 
accuracy to determine the actual protein concentration as precisely as possible, especially if 
the interaction stoichiometry is unknown. We showed that routine use of a calculated 
extinction coefficient might not accurately reflect the actual absorption property of a protein 
as it is the case for trypsin, hinting at differences in absorption profiles between its native 
and denatured form. In the absence of a known experimental extinction coefficient, the 
micro-biuret assay proved to be a valuable method safeguarding against inaccurately 
quantifying protein concentration. 
Considering the ligand, a larger impact of concentration inaccuracies and impurities 
on thermodynamic properties is to be expected. The fitting process involves normalization of 
observed heat per injection by the amount of ligand added and the normalized heat is then 
plotted against the molar ratio of ligand per receptor. Supporting this reasoning, variability 
in thermodynamic parameters of a benchmarking protein-ligand interaction in an 
interlaboratory study was found to be mainly caused by varying errors in determining the 
ligand concentration [Myszka et al., 2003; Tellinghuisen and Chodera, 2011]. Indeed, impure 
ligand preparations of ligands 1–4a used in this study all showed a reduced apparent binding 
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enthalpy compared to binding enthalpy of the pure ligand. Impurities present in a ligand 
preparation can be thought of as principally belonging to three major classes:  
Firstly, side products of synthesis, which contain fragments of the actual ligand and 
are capable of binding to the same protein, thereby acting as competitive ligand. The 
contaminant of ligand 1 showed a similar HPLC-retention and UV-absorption behavior as the 
ligand itself, pointing toward possible structural similarities to the ligand. Therefore, the 
contaminant itself might also exhibit protein-binding activity. A mixture of ligand and 
protein-binding by-product is difficult to model in ITC data, as quantification of the ligand 
content alone is not sufficient for accurate correction. In those cases, ligand repurification is 
inevitable. Due to the minor impurity content of ligand 1, the deviations in thermodynamic 
parameters ∆𝐺0 and ∆𝐻0 were in the range of 2 𝑘𝐽 ∙ 𝑚𝑜𝑙−1.  
The second class of impurities are organic compounds originating from the synthesis 
itself, such as coupling agent reaction products, or remaining from so called “leaking” 
columns used in purification. These compounds are unlikely to exhibit specific protein 
binding but might otherwise influence the protein-ligand interaction. The contaminants of 
ligands 2 and 3a belong to that class. In both cases, an impurity content of up to 40% led to a 
drastically decreased apparent binding enthalpy whereas ∆𝐺0 was much less affected. 
Thereby, a much more entropically driven ligand binding is suggested. As ligands 1 and 2 
belong to the same congeneric ligand series where the latter contains a more hydrophobic 
substituent in position R, one could have expected a trend toward increased entropic 
contribution. However, characterization using the pure ligand preparation showed a less 
pronounced trend of such an entropic contribution. This case underlines the importance of 
considering the observed binding stoichiometry as a parameter for quality control. An 
interesting question arose after the pure ligand 2 was characterized: Are thermodynamics 
profiles of impure and pure ligand preparations of 2 comparable if corrected for the actual 
ligand concentration by fitting to the same interaction stoichiometry? Identical values 
indicate that solely adjusting ligand concentration during modeling might be sufficient. 
However, a difference in standard binding enthalpy of 3.8 𝑘𝐽 ∙ 𝑚𝑜𝑙−1 remained between re-
fitted data and data of pure ligand, pointing toward the contaminant influencing the protein-
ligand interaction. The underlying mechanism remained unclear. The magnitude of the 
observed difference is close to the threshold of 4 𝑘𝐽 ∙ 𝑚𝑜𝑙−1, above which a difference in 
binding enthalpy is considered to be significant [Holdgate, 2001]. 
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In contrast, comparison of the re-fitted data of the contaminated ligand 3a and its pure form 
showed that it is possible to obtain the actual thermodynamic parameters under 
consideration of elementary analysis results. The data fitted to a purity of 66%, taking into 
account the ratio between the found and theoretical nitrogen value, give the same 
parameters like the pure compound does, within the error limits. However, the fit to a purity 
of 73%, as suggested by the ratio between found and theoretical values for carbon, failed to 
yield the same thermodynamic signature as for the pure ligand. Therefore, a prerequisite for 
the successful re-fitting is the knowledge of the composition of the impurity contained in the 
ligand preparation. Furthermore, even if no structural similarities are present, one has to 
reassure that the contamination does not interact with the protein or influence its stability 
or interaction with a ligand during the measurement period.   
Hence, even when correcting for the actual ligand concentration, one has to be 
aware that the resulting apparent thermodynamics may not accurately reflect the actual 
thermodynamics. This deviation may go undetected if ligand concentration is adjusted 
during the fitting process in order to give a reasonable interaction stoichiometry and no 
revalidation is performed to what extent that adjustment is sufficient. Therefore, this 
manual adjustment is poor practice.  
Thirdly, the ligand preparation may contain a varying proportion of salts resulting 
from synthesis and/or purification, which may change the thermodynamic properties 
similarly like an organic impurity. As described for 2 and 3a, also 4a shows significant 
changes in its enthalpic and entropic properties while  ∆𝐺0 remains largely unaffected. Re-
fitting according to elementary analysis yielded improvements only toward the pure 
compound close to the significance limit. Influences of ions binding to the protein surface 
might be imaginable. Besides that, the solubility of compound and protein at high 
concentrations needed for ITC measurements might be negatively affected. The impact of 
ligand as well as protein aggregation can be easily monitored by Dynamic Light Scattering.  
Within the error range of the method, elementary analysis gave the identical yield of 
4a regarding analyzed values for carbon and nitrogen. As a consequence, it can be assumed 
that an inorganic salt resulting from synthesis as part of the ligand powder. When including 
the actual yield of 4a into the fitting procedure of the binding isotherm, the derived data 
showed a good approximation to the thermodynamic properties obtained with the further 
purified ligand. Despite this and similar to the modeled data of 1 and 2, deviations close to 
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the significance level could be observed (∆∆𝐺0 = 3.4  𝑘𝐽 ∙ 𝑚𝑜𝑙−1, ∆∆𝐻0 = −3.1  𝑘𝐽 ∙
𝑚𝑜𝑙−1). Also DLS measurements did not give any explanations for those deviations. Protein 
and ligand aggregation could be excluded according to the conducted experiments. This 
result was expected since the salt of the ligand powder increases the concentration of the 
salt contained in the experimental buffer by only 0.1% (w/v calculated as NaCl). However, 
also if no measurable protein or ligand aggregation could be observed in dynamic light 
scattering measurements, an influence of increased salt concentrations by other means 
cannot be totally excluded.  
To further verify thermodynamic results, a reverse experimental setup can be 
devised. In such a reverse titration, protein solution is titrated into the ligand containing cell 
and is especially useful to check interaction stoichiometry [Velazquez-Campoy and Freire, 
2006]. For a simple 1:1 interaction, the results should be invariant to the normal 
experimental setup but may change if more complex interaction modes are investigated 
[Liang, 2008; Brown, 2009]. However, protein is required in higher amounts and 
concentrations in such experiments, making additional validation of the absence of possible 
protein aggregation necessary. The herein introduced DLS method is ideally suited for this 
purpose. Unfortunately, this setup is hardly feasible for our model proteins: The self-
digestion of trypsin is increased at higher concentrations. Thus, no reliable results can be 
expected over the period of an ITC experiment. Similarly, TGT’s solubility is drastically 
lowered at low salt concentrations applied during the titration. Therefore, precipitation of 
the protein occurred during a reversed experimental setup at the needed concentrations. 
Additionally to systematic errors discussed above, statistical errors and their correct 
treatment should also be considered [Tellinghuisen, 2003; Tellinghuisen, 2004]. 
 
2.7 Conclusions 
It can be concluded that impurities present in protein preparations used for thermodynamic 
characterization of a protein-ligand interaction by ITC do not necessarily translate into 
deviations from the actual thermodynamic data. Under special circumstances, they can even 
be ignored as it was the case for the protein preparation in the study of high affinity 
interactions. More caution has to be paid to the preparation of high affinity ligands. Even 
contaminants without apparent protein-binding capabilities may distort the thermodynamic 
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properties of a protein-ligand interaction, which goes undetected by sole fitting 
adjustments. Our studies dealing with high c value titrations demonstrated that it is possible 
to derive thermodynamic data from impure ligands, which are in good accordance to data 
obtained with the pure ligand. The basis for successful fitting is the knowledge about the 
composition of the contaminant and its potential influence on the analyzed system, which is 
unfortunately often difficult to estimate. Fitting the binding isotherm of an impure ligand 
following elementary analysis results yielded a good approximation to the actual value in 
one case, proving elementary analysis to be a well-suited complementary analysis to NMR 
and MS methods when it comes to ligand synthesis for ITC purposes. In another case, the 
same data as with a pure compound were obtained. Nonetheless, this procedure is limited 
since only a small data range is accepted before deviations get significant. For ligands 
showing large differences in their thermodynamic profile among each other, this might be 
negligible. However, the practice of sole fitting adjustments may mislead correlation to 
structural data of protein-ligand complexes or interpretation of thermodynamic trends 
observed in a congeneric series of ligands. The latter is especially deleterious as 
thermodynamic characteristics of such stepwise ligand modifications may not show big 
differences between the individual components of the series but are frequently used in 
conjunction with structural data to establish basic mechanisms underlying molecular 
interactions [Snyder et al., 2011; Biela et al., 2013]. In summary, this study pointed out that 
thermodynamic characterization of high affinity protein-ligand interactions by ITC shows 
different robustness against possible experimental errors and highlights the experimental 
parameters which must be rigorously monitored to obtain accurate and reliable 
thermodynamic data. If especially ligand purity cannot be assured, the actual value might be 
at least approximated. However, accurateness of these assumptions and considered values 
may be difficult to assess. Therefore, the efforts should be rather put in reliable purification 
protocols, both for proteins as well as ligands, to provide the basis to obtain accurate data 
by ITC. 
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3.1 Introductory Remarks 
The following chapter was published in the scientific Journal of Medicinal Chemistry.
2
 pKa Calculations were 
carried out by Paul Czodrowski (Merck Discovery Technologies, Darmstadt). TGT compounds were synthesized 
by Luzi Jakob Barandun and Christoph Hohn (ETH Zürich). All crystal structures and ITC measurements were 
performed by the author of this thesis along with drafting the article.  
 
 
 
3.2 Abstract 
A drug molecule will exhibit more desirable properties, if it remains uncharged while it 
travels through the body, is transported across membranes, and adopts a charged state only 
upon protein target binding as usually higher affinity results when charged species interact 
with one another. Such a strategy requires careful design of pKa properties and methods to 
elucidate whether and where protonation state changes occur. We investigated the 
protonation inventory in a series of lin-benzoguanines binding to tRNA-guanine 
transglycosylase, which shows pronounced buffer dependency during ITC measurements. 
Chemical modifications of the parent ligand scaffold along with ITC measurements, pKa 
calculations, and site-directed mutagenesis allow elucidating the site of protonation. The 
                                                          
2 Neeb et al., (2014). Chasing Protons: How Isothermal Titration Calorimetry, Mutagenesis, and pKa Calculations Trace the Locus of Charge 
in Ligand Binding to a tRNA-Binding Enzyme. Journal of Medicinal Chemistry 57, 5554-5565. 
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parent scaffold exhibits two guanidine-type portions and both appear as likely candidates for 
proton uptake. Even mutually compensating effects resulting from proton release of the 
protein and simultaneous trapping by the ligand can be excluded. A cluster of two adjacent 
Asp residues induces a strong pKa shift at the ligand resulting in a transition to the 
protonated state. Furthermore, an array of two parallel H-bonds avoiding secondary 
repulsive effects contributes to the high affinity binding of the lin-benzoguanine scaffold. 
 
3.3 Introduction 
In recent time, isothermal titration calorimetry (ITC) has become a powerful tool in life 
sciences with a broad scope of application, e.g. to obtain insight into the energetics or 
kinetics of binding, permeation through lipids as well as the characterization of low or high 
affinity binding ligands that are not accessible by direct titrations [Zhang and Zhang, 1998; 
Velazquez-Campoy and Freire, 2006; Tsamaloukas et al., 2007; Burnouf et al., 2012]. In 
structure-based drug design, this method is of utmost importance to obtain not only 
information about binding affinities but also to access the entire thermodynamic signature 
of a ligand within one experiment [Ladbury et al., 2010]. In addition, it gives valuable insight 
into changes of protonation states upon protein–ligand binding when the measurements are 
carried out in different buffer systems showing deviating contributions to the heat of 
ionization ∆𝐻𝑖𝑜𝑛  [Baker and Murphy, 1996]. 
Numerous studies have underlined the importance to investigate the protonation 
state of bound ligands to their target enzyme [Dullweber et al., 2001; Raffa et al., 2004; 
Czodrowski et al., 2007; Steuber et al., 2007; Baum et al., 2009; Biela et al., 2012; Biela et al., 
2012]. In fact, the ITC method quantifies the molar amount of protons transferred from or 
released to the buffer environment. Unfortunately, it does not provide any information 
about the exact protonation site. Supporting the ITC measurements by pKa calculations and 
mutational studies can help to detect the residue or ligand functional group responsible for 
the protonation reaction. pKa calculations suggest the likely candidate residues of interest 
and subsequent titrations of the specifically generated mutants can verify the protonation 
sites experimentally [Czodrowski et al., 2007; Steuber et al., 2007]. In an unfortunate 
situation no overall change in protonation can be observed, even though different buffers 
have been used and protons are transferred. Recently, Baum et al. observed the 
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simultaneous superposition of proton uptake and release reaction leading overall to a 
balanced proton inventory during ITC titrations [Baum et al., 2009]. This study underlines the 
importance to investigate congeneric ligand series, which differ only by small gradual 
changes varying the basic or acidic properties, respectively. 
On the one hand, understanding the properties of titratable groups that can change 
their protonation state upon binding, both on the protein and the ligand sites, is an 
important prerequisite to correctly assign and subsequently interpret the thermodynamic 
signature of a compound. For instance, the enthalpic signal recorded in a titration comprises 
the heat contributions of all interactions that are formed between the ligand and the amino 
acids of the target protein as well as those to trapped or released water molecules or ions. 
Depending on the type of interaction ranging from simple hydrogen bonds between 
uncharged species to charge-assisted ones and hydrogen bonds with salt-bridge character, 
their strength and thus their contribution to the enthalpic signal of the binding event can 
vary strongly. Taking continuum electrostatics as a reference, this fact can be easily 
understood. If charge-assisted contacts are formed in an environment of low local dielectric 
conditions, which are usually given in deeply buried binding pockets of significant 
hydrophobic character, they will exhibit large contributions. This results from the fact that 
electrostatic forces, described by Coulomb’s law, show the product of the charges in the 
numerator and, apart for the squared contact distance (if the potential is considered, it is 
inverse-linear in distance), the dielectricity constant ε in the denominator. Thus, high 
dielectricity as given in an aqueous environment (ε ≈ 80) attenuates charge-assisted contacts 
strongly. In hydrophobic environment, where ε is small (ε ≈ 1 – 4), an increasingly 
exothermic signal is experienced as there the involved interacting groups are shielded from 
the solvent environment. The thermodynamic signature of protein–ligand binding can 
become quite complex. For the interpretation of such data, it is therefore of utmost 
importance to know whether and where possible changes in protonation states might create 
charge-assisted contacts. If these contacts are planned and subsequently established in 
buried binding pockets they can contribute significantly to the exothermic binding signature 
and thus enhance affinity in a tailored fashion. 
On the other hand, proper adjustment of protonation states plays an important role 
for the permeation and distribution of the potential drug molecule to obtain access to a 
target cell under consideration. It is well known that permeation depends on multiple 
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factors such as lipophilicity, hydrogen bonding properties, which are important for the 
transfer from the water phase into the lipid bilayer, or the shape of a drug molecule and last 
but not least its charge [Schanker, 1962; Spencer et al., 1979; Conradi et al., 1991; El Tayar et 
al., 1991; Testa et al., 1996]. Drug molecules often contain functional groups of acidic and 
basic character and thus, occur dependent on their pKa values and the local pH conditions of 
the surrounding compartment as charged or neutral species in equilibrium. The uncharged 
form of a drug will permeate to a greater extent through biological membranes than its 
corresponding charged form. Accordingly, it would be highly desirable that a drug molecule 
remains uncharged as long as it is transported via membranes and adopts a charged state 
only upon binding to the target protein as usually higher affinity results when charged 
species interact with one another (see above). 
In the present study we investigated a series of ligands comprising a 6-amino-1,7-
dihydro-8H-imidazo[4,5-g]quinazolin-8-one (lin-benzoguanine) and a 1,7-dihydro-8H-
imidazo[4,5-g]quinazolin-8-one (lin-benzohypoxanthine) scaffold with respect to their 
inhibitory potency of the tRNA modifying enzyme tRNA-guanine transglycosylase (TGT) from 
Zymomonas mobilis [Stengl et al., 2007; Barandun et al., 2012]. TGT has been shown to be a 
putative target to fight the pathogenicity of shigellosis, a severe diarrheal disease [Durand et 
al., 1997; Grädler et al., 2001]. Previous comparisons of the lin-benzoguanines and lin-
benzohypoxanthines already showed surprising differences concerning their binding modes 
and their binding affinities [Barandun et al., 2012], which prompted us to take a closer look 
at the features of the two scaffolds in the TGT-bound state. 
  
3.4 Results and Discussion 
3.4.1 Selected Ligands and Binding Mode of lin-Benzopurines to Z. mobilis TGT 
In order to study putative changes in the protonation states of lin-benzopurines, 4a has been 
selected for our initial measurements (Scheme 3.1).  
This compound exhibits several basic functional groups appropriate to pick-up a 
proton, namely N(5) of the aminopyrimidinone substructure (encircled in orange), N(3) of 
the attached aminoimidazole ring (encircled in green), and the nitrogen of the morpholino 
substituent (encircled in blue). 
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Scheme 3.1 Chemical formulae of the investigated ligands. lin-Benzoguanine 4a changes protonation state 
upon binding and exhibits three potential protonation sites (colored circles). Each of these sites is altered and 
possibly removed by chemical means in the ligands 3a – 3c. 
 
A crystal structure of TGT in complex with 4a was determined to a resolution of 
1.42 Å (Figure 3.1A). The lin-benzoguanine scaffold is well-defined in the  𝐹𝑜  −  𝐹𝑐   
difference electron density and a π-stacking interaction between the side chains of Tyr106 
and Met260 can be observed. Polar interactions of the aminopyrimidinone ring are 
experienced with the side chains of Asp102, Asp156, Gln203, and the backbone NH of 
Gly230 as analogously found for other members of this compound series [Stengl et al., 
2007]. The guanidinium moiety of the aminoimidazole ring forms interactions to the closely 
adjacent backbone carbonyl oxygens of Ala232 and Leu231 and contacts a conserved water 
molecule, which itself is part of a crucial cluster of water molecules [Kohler et al., 2009]. The 
two guanidine-type portions of the parent scaffold are highly buried in the protein and thus 
fully shielded from solvent access (aminopyrimidinone portion: 100%, aminoimidazole 
portion: ≈ 96%, if the conserved water molecule is excluded from the calculation).  
We observed a reasonably well-defined electron density for the entire ligand. 
Although the average B-factor of the morpholino moiety is approximately three-times larger 
than that of the tricyclic scaffold (𝐵𝑚𝑜𝑟𝑝 𝑕𝑜𝑙𝑖𝑛𝑒 = 21.5Å
2  vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 9.1 Å
2), the 
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N+-CH2-CH2-NH linker to the morpholine ring is observed in a gauche-conformation partly 
occupying the flat ribose-33 subpocket and forming a weak charge-assisted hydrogen bond 
(3.3 Å) via its morpholino oxygen to the guanidinium group of Arg286. The morpholine ring 
adopts a chair conformation and was refined in the shown orientation with an occupancy of 
80%. To a minor extent the residual density indicates the fully extended substituent with an 
anti-conformation of the linker.  
Since a broad series of lin-benzoguanines has been synthesized during our studies 
[Hörtner et al., 2007; Stengl et al., 2007; Kohler et al., 2009; Barandun et al., 2012], we 
considered selected ligands in the present work, either avoiding or decreasing the basic 
character of the scaffold and the substituents under consideration (Scheme 3.1).  
 
 
Figure 3.1 Binding modes of TGT∙4a (PDB ID: 4PUJ) and TGT∙3a (PDB ID: 4PUK). The protein is represented as 
cartoon. The ligand and interacting residues are represented as sticks (carbon Protein = gray, carbon Ligand = 
blue/green, nitrogen = blue, oxygen = red). For clarity the π-stacking residues Tyr106 and Met260, which flank 
the tricyclic core, are not shown. The lin-benzoguanine scaffold located in the guanine 34 binding pocket is well 
defined in the  𝐹𝑜 −  𝐹𝑐  difference electron density (green) at a sigma level of 2.5. The ligands form several 
interactions to Asp102, Asp156, Gln203, Gly230, Leu231, and Ala232 (dashed lines). The hydrogen bond to 
Leu231 is enabled by a ligand induced backbone-flip, which is stabilized by Glu235. A) The morpholinoethyl 
substituent shows residual mobility in the bound state indicated by the less well-defined electron density. 
Nevertheless, it was refined to an occupancy of 80%. The linker to the morpholine substituent adopts a gauche-
conformation and forms a weak charge-assisted hydrogen bond of 3.3 Å between the oxygen of the 
morpholine ring and the guanidinium group of Arg286. To minor extent, the residual density indicates the fully 
extended anti-conformer. B) Due to the lack of the extended 2-substituent, the methyl group interacts with the 
solvent (green spheres) showing C∙∙∙O distances of up to 4.1 Å. 
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In ligand 3a the basic morpholinoethyl substituent is replaced by a simple methyl 
group. The binary complex with Z. mobilis TGT was obtained with a maximum resolution of 
1.49 Å (Figure 3.1B). The scaffold adopts exactly the same binding mode forming similar 
interactions to 4a. Due to the lack of the extended 2-substituent, the methyl group is in 
direct contact with five water molecules showing C∙∙∙O distances up to 4.1 Å. 
In addition to the changes found in lin-benzoguanine 3a, the exocyclic amino function 
at the pyrimidinone ring has been removed in lin-benzohypoxanthine 3b. Barandun et al. 
recently reported on the binding mode of this class of lin-benzopurines [Barandun et al., 
2012]. In contrast to binary complexes observed with the lin-benzoguanines, Asp102 adopts 
a downwards-rotated orientation pointing away from the ligand and the binding pocket. The 
observed rotamer undergoes hydrogen bonds to the side chain of Asn70 and the backbone 
NH of Thr71. A similar geometry is found in apo TGT [Brenk et al., 2003]. The created empty 
space between ligand and protein is filled by a cluster of six water molecules. All other 
interactions are established similarly as in the TGT complexes with lin-benzoguanines. 
The strongly basic character of the aminoimidazole moiety in 2-amino-lin-
benzopurines 3a, 3b, and 4a has been changed to a less basic amidinium portion in 3c. 
Except for the hydrogen bond to the backbone oxygen of Ala232, this compound is able to 
undergo the same hydrogen bonding pattern as described for the above-mentioned crystal 
structure (PDB ID: 3C2Y) [Ritschel et al., 2009]. 
 
3.4.2 Protonation States of lin-Benzopurine∙TGT Complexes 
To obtain insights into the potentially superimposed protonation effects that occur upon 
ligand binding, ITC measurements were performed using Hepes, Tris, and Tricine buffer at 
pH 7.8. The three buffers differ in their enthalpy of ionization [Christensen, 1976; Fukada 
and Takahashi, 1998]. The observed enthalpies for the complexation of the studied ligands 
were plotted against the heat of ionization of the buffers (Figure 3.2), and the recorded 
thermodynamic profiles are listed in Table 3.1. Ligand 4a picks up 0.95 protons per mole 
formed complex, which either protonate the protein or the bound ligand (Figure 3.2, blue).  
Apart from the basic functionalities of 4a, there are several amino acid residues that 
could also be involved in the proton uptake. Within a 12 Å radius centered at Cγ of Tyr106 
(Figure 3.3) around the binding pocket, Asp102, Asp156, Glu157, Glu235, and Asp280 are 
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putative proton acceptor groups. According to Poisson-Boltzmann calculations these 
residues can be assumed as fully deprotonated at the applied pH conditions between 5.5 
and 8.5 [Ritschel et al., 2009]. Asp102 and Asp156 are directly involved in ligand binding 
(Figure 3.1).   
 
 
Figure 3.2 ∆𝐻𝑜𝑏𝑠  is plotted against ∆𝐻𝑖𝑜𝑛  for ligands 3a – 4a binding to TGT. The icons indicate the mean of the 
measured enthalpy values for each buffer system in kJ/mol. A linear fit was applied to the data points 
illustrated as solid lines. The positive slope shows a buffer dependency of 3a, 3c, and 4a suggesting an uptake 
of approximately one proton per mole by the complex. Only binding of 3b does not experience any changes in 
protonation state. The corrected value for ∆𝐻𝑏𝑖𝑛𝑑  can be extracted from the intercept, the number of captured 
protons results from the slope, which was calculated separately taking the standard deviations of each data 
point into account. 
 
We decided to first investigate the ligand series exhibiting different basic characters. 
The lin-Benzoguanines 3a (0.96 protons per mole; Figure 3.2, red) and 3c (0.95 protons per 
mole; Figure 3.2, green) also suggest the uptake of approximately one proton. Only lin-
benzohypoxanthine 3b (0.02 protons per mole; Figure 3.2, purple) is obviously not capable 
to share these properties. 
Our findings agree with the experimentally determined pKa values reported for the 
lin-benzohypoxanthines and lin-benzoguanines in aqueous solution (Table 3.2) [Hörtner et 
al., 2007; Barandun et al., 2012]. 
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Table 3.1 Thermodynamic profiles of the investigated ligands in the applied buffer systems. 
Ligand TGT variant 𝑲𝒅 𝒏𝑴  
∆𝑮𝟎 𝒌𝑱
∙ 𝒎𝒐𝒍−𝟏  
buffer 
∆𝑯𝒐𝒃𝒔 𝒌𝑱 ∙
𝒎𝒐𝒍−𝟏 [a] 
−𝑻∆𝑺𝟎 𝒌𝑱 ∙
𝒎𝒐𝒍−𝟏 [b] 
3a Wild type 52.4 ± 6.9 -41.6 ± 0.3 Hepes -74.8 ± 1.8 33.2 ± 1.9 
    Tricine -66.7 ± 0.1 25.1 ± 0.3 
    Tris -50.9 ± 0.9   9.3 ± 0.9 
     -97.4 ± 2.2 55.8 ± 2.2 
3a D102N 146.1 ± 25.6 -39.0 ± 0.4 Hepes -33.5 ± 0.4  -6.1 ± 0.5 
    Tricine -35.0 ± 0.4  -4.0 ± 0.5 
    Tris -33.9 ± 0.3  -4.8 ± 0.4 
     -33.9 ± 2.1 -4.9 ± 2.1 
3a D156N 188.1 ± 59.1 -38.5 ± 0.8 Hepes -51.4 ± 0.2 13.0 ± 0.4 
    Tricine -52.6 ± 2.5 13.4 ± 2.5 
    Tris -49.2 ± 0.4 11.4 ± 0.6 
     -53.2 ± 0.4  12.6 ± 0.9 
3b Wild type 411.0 ± 63.8 -36.5 ± 0.4 Hepes -48.0 ± 0.2 11.5 ± 0.4 
    Tricine -47.7 ± 0.2 11.2 ± 0.5 
    Tris -47.6 ± 0.3 11.1 ± 0.5 
     -48.4 ± 0.3 11.9 ± 0.5 
3c Wild type 287.5 ± 52.9 -37.4 ± 0.5 Hepes -69.3 ± 0.8 31.9 ± 0.9 
    Tricine -57.1 ± 1.6 19.7 ± 1.6 
    Tris -43.4 ± 0.1   6.0 ± 0.5 
     -89.2 ± 1.4 51.8 ± 1.5 
4a Wild type    35.0 ± 6.9    -42.6 ± 0.5[c] Hepes -78.3 ± 1.2     35.7 ± 1.3[c] 
    Tricine -65.8 ± 0.3  23.2 ± 0.6 
    Tris -51.9 ± 1.1    9.3 ± 1.2 
        -96.4 ± 4.0[d]    53.8 ± 4.0[d] 
4a E235Q 1275.6 ± 297.3 -33.8 ± 0.6 Hepes -51.0 ± 0.7 17.9 ± 0.7 
    Tricine -39.9 ± 0.5   6.0 ± 0.5 
    Tris -28.6 ± 0.3  -5.7 ± 0.5 
     -66.2 ± 3.2 32.4 ± 3.3 
a
The corresponding plot to obtain net ∆𝐻𝑏𝑖𝑛𝑑  of wild type TGT corrected for ionization effects is shown in 
Figure 2. 
b−𝑇∆𝑆0 was calculated according to the Gibbs-Helmholtz equation. cErrors were estimated by means 
of standard deviation for 𝐾𝑑  and ∆𝐺
0 comprising at least six measurements and for ∆𝐻𝑜𝑏𝑠  at least two. The 
error for −𝑇∆𝑆0 was calculated according to error propagation. dBuffer corrected data are displayed in bold. 
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Unfortunately, no values are available for the morpholinoethyl substituent in 4a; we 
therefore assume a value similar to that of parent morpholinoethyl. The value for the latter 
has been reported to be pKa = 7.7 [Hall, 1957]. We suppose that this assumption is justified 
as the morpholino portion is attached via an aliphatic ethyl linker which largely avoids 
transmission of electronic effects across molecular portions. For 2-amino-lin-benzoguanines 
a value of 4.4 has been assigned to N(5)H+ and 5.7 to N(3)H+ in lin-benzoguanine 3a 
[Barandun et al., 2012]. Remarkably, the acidity of N(5)H+ is shifted by about two logarithmic 
units to pKa = 1.8 in lin-benzohypoxanthine 3b. 
 
Table 3.2 Measured pKa values for the scaffolds of lin-benzoguanines 3a, 3c, 4a, and lin-benzohypoxanthine 3b. 
  pKa measurements 
  N(7)H N(3)H+ N(5)H+ 
3a 
            
7
5
1
3  
> 10 
5.7 
  6.2[b] 
4.4 
3b 
         
> 10 5.6 1.8 
3c 
                               
n.d.[a] 5.4 n.d.[a] 
4a 
                        
n.d.[a] n.d.[a] n.d.[a] 
a
n.d.: not determined.
 b
Data of Barandun et al., 2012 supersede Hörtner et al.,2007.  
 
In order to confirm the experimentally derived evidence, Poisson-Boltzmann 
calculations were consulted to analyze shifts of pKa values of the active site residues and the 
ligand functional groups upon binding [Czodrowski et al., 2006]. Within the 12 Å sphere 
centered around Cγ of Tyr106 all titratable residues were selected and the corresponding 
pKa values were calculated prior and after complex formation. The calculations reveal only 
significant shifts in basic or acidic properties for Asp102, Asp156, and N(3) or N(5) of ligand 
4a (Table 3.3). Accordingly as a first working hypothesis, either N(3), embedded into an 
aminoimidazole substructure, or N(5), being part of an aminopyrimidinone moiety, could be 
likely candidates for the proton uptake. The shift suggested for N(5) appeared larger 
 
58 
3. Chasing Protons: How Isothermal Titration Calorimetry, Mutagenesis and pKa Calculations 
Trace the Locus of Charge in Ligand Binding to a tRNA-Binding Enzyme 
(∆pKa = 2.6) compared to N(3) (∆pKa = 1.0), however, as N(3) shows the more basic character 
in aqueous solution, both sites appear appropriate to pick up a charge. 
 
Table 3.3. Calculated pKa values of the crucial amino-acid residues within the binding pocket and ligand 3a 
before and after complex formation. 
Residue[a] pKa prior to complexation
[b] pKa in complexed state 
  N3 N5 
Asp102 1.63 1.64 -2.12 
Asp156 5.44 4.40  3.02 
3a[c]  6.65  7.00 
a
All other side chains exhibited only marginal changes in their pKa values and are hence not listed. 
b
For the 
Poisson-Boltzmann calculations a dielectric constant of ε = 20 at a pH of 7.8 was applied.  
c
pKa values in 
aqueous solution according to Barandun et al., 2012. 
  
A previous study on the pKa properties of TGT∙2-amino-lin-benzoguanine inhibitor 
complexes was based on the hypothesis that the ligands bind with N(3) in protonated state 
[Hörtner et al., 2007; Ritschel et al., 2009]. Accordingly, the 2-aminoimidazole moiety of the 
ligand scaffold would be positively charged and form charge-assisted hydrogen bonds to the 
backbone carbonyl oxygens of Leu231 and Ala232. This interaction would induce a backbone 
flip, which is stabilized by a further charge-assisted hydrogen bond formed between Glu235 
and the backbone NH of Leu231 [Hörtner et al., 2007; Ritschel et al., 2009]. The nearly 30-
fold increase in binding affinity suggested by a biochemical assay between 3a and 3c was 
considered as clear indication of this protonation event at the imidazole moiety of 3a. 
However, recent results also support the hypothesis that N(5) is the likely candidate to pick-
up a proton. A newly published crystal structure of Z. mobilis TGT in complex with 2-amino-
lin-benzohypoxanthine-type inhibitors shows that Asp102 adopts a significantly different 
orientation in the complexes compared to the corresponding lin-benzoguanine complexes 
[Barandun et al., 2012]. This residue is rotated away from the ligand towards the ribose 34 
subpocket as similarly found in the apo-enzyme [Brenk et al., 2003; Barandun et al., 2012]. In 
the new position, Asp102 forms an interaction with the carboxamide group of Asn70 and the 
backbone NH of Thr71 [Barandun et al., 2012]. By capturing a proton, the lin-benzoguanine 
moiety obviously shifts its pKa properties and induces an alternative conformation of Asp102 
to interact with the ligand’s guanidinium group.  
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In order to assess whether N(3) or N(5) becomes protonated upon protein binding or 
whether an even more complex situation with several superimposed and mutually 
compensating effects is given, we embarked onto a systematic mutational study combined 
with subsequent ITC experiments and pKa calculations.   
 
3.4.3 Mutational Studies 
According to our pKa calculations, Asp102 and Asp156 form charge-assisted interactions with 
the aminopyrimidinone portion of the lin-benzoguanine-type inhibitors and might be 
involved in the protonation of N(5). Therefore, we decided to replace Asp by Asn at both 
sites to investigate the impact of these residues on ligand binding. 
The replacement by Asn avoids the negative charge in this region and introduces a 
permanently uncharged contact. While the Asp156Asn mutant still exhibits some, however 
by a factor of three significantly reduced catalytic activity compared to the wild type, the 
Asp102Asn mutant shows no activity at all [Romier et al., 1996]. For both mutants, the 
crystal structures with 3a were determined and ITC measurements carried out in the three 
buffer systems.  
Structural data were recorded to a resolution of 1.65 Å and 1.85 Å. Ligand 3a adopts 
in the Asp156Asn mutant a similar binding mode to the wild type (Figure 3.3A and 3.3B). The 
aminopyrimidinone ring interacts with the side chains of Asp102, Asn156, Gln203, and the 
backbone NH of Gly230. The orientation of the replaced Asn156 residue is slightly shifted 
compared to the wild type moving the terminal carboxamide group approximately 16° out of 
the plane through the lin-benzoguanine scaffold. The interaction between the terminal 
carboxamide oxygen of Asn156 and the ligand’s exocyclic amino function remains 
unchanged compared to the wild type (∆d = 0.1 Å). However, the adjacent contact via the 
NH2 of the carboxamide group of Asn156 and N(7) of 3a is extended from 2.7 Å to 2.9 Å. This 
expansion both results from the larger radius of the nitrogen atom and the replacement of a 
charge-assisted hydrogen bond by a neutral one. Additionally, the side chain oxygen of 
residue Gln203 tilts about 13° to the front elongating the distance between its amino 
function and the same group in Asn156 from 2.8 Å to 3.2 Å. The strength of the interaction 
formed to the carbonyl oxygen of the complexed ligand and Gln203 remains unaffected as 
the uncharged contact distance suggests. Also the interactions formed between the ligand 
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and the side chain of Asp102 do not differ from the wild type. To establish this interaction 
pattern, the proton at N(7) must be transferred to N(5) to produce the other tautomer. In 
summary, neutral hydrogen bonds are formed to Asn156 and charge-assisted ones to 
Asp102 (Scheme 3.2). 
 
 
Figure 3.3 The protein is displayed as cartoon with its interacting residues shown in line representation. The 
mutated side chains and 3a are highlighted by sticks (nitrogen = blue, oxygen = red). Dashed lines represent 
hydrogen bonds. Distances are given in Å. A) Superimposition of 3a as bound to wild type TGT (cyan; PDB ID: 
4PUK), mutant Asp102Asn (yellow; PDB ID: 4PUL) and mutant Asp156Asn (orange; PDB ID: 4PUM). The ligands 
adopt overall the same orientation in all displayed complexes. The side chain of Asn102 adopts a conformation 
rotated away from the binding site compared to Asp102 in the wild type enzyme. Contrary, Asn156 remains in 
a similar position as observed for Asp156. B) Close-up of the interactions of the mutated residue Asn156 
(orange) compared to those of wild type enzyme (cyan). Asn156 is slightly rotated by 16° extending the 
interaction to the amino group of Gln203 and N(7) of the ligand. All other connections remain unaffected. C) 
Close-up of the interactions of the mutated residue Asn102 (yellow) compared to those of wild type enzyme 
(cyan). Asn102 shows the rotated orientation adopting a similar conformation as found for the lin-
benzohypoxanthine complexes. Instead of interacting similarly with the ligand as Asp102 in the wild type, 
Asn102 forms contacts to the backbone NH of Asn70 and a nearby water molecule.  
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In the complex structure of the Asp102Asn mutant with 3a, the ligand adopts a 
position similar to the one in the wild type. It is slightly shifted off from the position of 
Asp156 (Figure 3.3A). The mutated residue Asn102 does not form hydrogen bonds to the 
aminopyrimidinone moiety of the ligand but adopts an orientation similar to those of wild 
type enzymes with the lin-benzohypoxanthine-type inhibitors. A hydrogen bond is formed to 
a nearby water molecule (2.8 Å) and the backbone NH of Thr71 (2.7 Å) [Barandun et al., 
2012].   
As expected, the binding affinity of 3a determined by ITC measurements drops for 
both mutant variants as favorable interactions are lost in both cases. For the Asp156Asn 
mutant a reduction by a factor of nearly four (wild type: 49 ± 5 nM, mutant: 188 ± 59 nM) is 
found, whereas a threefold loss is recorded for the Asp102Asn mutant (146 ± 26 nM). 
Surprisingly, 3a does not show any significant buffer dependency upon binding to the 
two mutants (Table 3.1). Also, Poisson-Boltzmann calculations performed on these mutant 
complexes support this hypothesis (Table 3.4). The close contacts to the two negatively 
charged aspartates in the wild type reinforce protonation of the ligand and cause the strong 
pKa shift.  
Remarkably, in the Asp102Asn mutant, the presence of Asp156 as charged residue 
and the neutral Asn102, which is rotated away from the binding site is not sufficient to 
induce an equally strong pKa shift and thus, a protonation of the ligand as experienced in the 
wild type. This finding also correlates with the expanded interactions of Asn156 and the 
ligand’s aminopyrimidinone moiety in the Asp156Asn mutant where no positive charge is 
located on this part of the ligand. 
 
Table 3.4 Calculated pKa values of the crucial amino-acid residues within the binding pocket of Asp102Asn and 
Asp156Asn, respectively, and N(5) of ligand 3a before and after complex formation. 
Mutant Residue pKa prior to complexation
[a] pKa in complexed state 
Asp102Asn Asp156 2.80  2.57 
-1.14  3a  
Asp156Asn Asp102 1.29 -2.31 
 5.32  3a  
a
For the Poisson-Boltzmann calculations the same conditions were applied as noted in Table 3. 
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Scheme 3.2 Interactions formed between 3a and amino acids 102 and 156 of wild type TGT (cyan), the D156N 
mutant (orange) and the Asp102Asn mutant (yellow). In the TGT∙3a complex N(5) of the parent scaffold 
becomes protonated upon binding and forms salt bridges to Asp102 and Asp156. To bind to the Asp156Asn-
mutant in a similar way, the proton at N(7) must be transferred to N(5), then forming hydrogen bonds to 
Asn156 and charge-assisted ones to Asp102. In the Asp102Asn∙3a complex Asn102 is rotated off the binding 
pocket. Therefore, N(7) carries the proton to form charge-assisted hydrogen bonds to Asp156.  
 
3. Chasing Protons: How Isothermal Titration Calorimetry, Mutagenesis and pKa Calculations 
Trace the Locus of Charge in Ligand Binding to a tRNA-Binding Enzyme 
63 
Up to this point all experimental findings indicate a protonation of N(5) in the 
aminopyrimidinone moiety. Does this, however, rule out the former hypothesis that N(3) in 
the aminoimidazole portion changes protonation and that the picked-up charge contributes 
significantly to the enhanced binding affinity? Also, a more complex situation with respect to 
changes of protonation states might be given in this part of the structure. In this area, 
Glu235 takes an important role on ligand-binding and protein function. It has been shown 
that Glu235 adapts its protonation state depending on the orientation of the peptide bond 
between Leu231 and Ala232 (Scheme 3.3A, B) [Brenk et al., 2003]. This peptide bond is 
exposed to the binding pocket and experiences a backbone flip upon ligand binding or upon 
changes in the environmental pH value. If a lin-benzopurine binds to the active site, the 
peptide bond’s carbonyl oxygen of Ala232 is oriented into the binding pocket and accepts a 
hydrogen bond from N(1)H of the ligand (Scheme 3.3C). In consequence, Glu235 becomes 
deprotonated in order to accept a hydrogen bond of the flipped backbone NH group [Tidten 
et al., 2007]. Glu235 is the only proximal amino acid involved in ligand binding, which could 
be able to release a proton.  
Based on these considerations, we mutated Glu235 to Gln to experimentally assess 
the remaining overall protonation inventory. ITC experiments were carried out with the 
Gln235 variant in the three mentioned buffer systems indicating an overall proton uptake of 
0.79 protons per mole. This nearly identical protonation inventory speaks for N(5) in the 
aminopyrimidinone moiety as sole proton acceptor of the lin-benzoguanine scaffold. 
Nonetheless, these experiments do not completely rule out a possibly more complex 
situation. Glu235 has to release a proton in consequence of the peptide bond flip. This only 
makes this bond able to recognize the lin-benzopurine scaffold.  
It could be imagined that the proton release of Glu235 is combined with the 
simultaneous protonation of N(3) in the aminoimidazole portion. In this case both effects 
would mutually compensate and nullify in the inventory. The following experiment makes 
this consideration unlikely. Previously, we were able to determine the apo structures of TGT 
wild type at pH 5.5 and 8.5 [Romier et al., 1996; Brenk et al., 2003]. At pH 5.5, the NH group 
of the Leu231/Ala232 peptide bond is oriented towards the binding pocket and Glu235 must 
adopt a protonated state to stabilize the peptide bond (Scheme 3.3A). At pH 8.5, the flipped 
peptide bond orientation is given and Glu235 has to adopt a deprotonated state 
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(Scheme 3.3B). We therefore took crystals grown at pH 5.5 and transferred them in a 
gradual stepwise fashion to higher pH finally reaching a value of 7.8. 
 
 
Scheme 3.3 Dependence of the peptide bond between Leu231 and Ala232 on the pH value and ligand binding. 
TGT apo structures of crystal grown at different pH values clearly indicate that a backbone flip between Leu231 
and Ala232 occurs dependent on the environmental pH value and the ligand bound. A) Scheme of the 
backbone orientation at pH 5.5. The backbone NH group of Leu231 is facing the binding pocket. The carboxyl 
group of Glu235 is present in its protonated state interacting with the carbonyl function of Leu231 and the 
backbone NH group of Val233. B) Scheme of the backbone orientation at pH 8.5. The backbone carbonyl 
function of Leu231 is exposed to the binding pocket. Hence, the side chain of Glu235 accepts two hydrogen 
bonds from the backbone NH groups of Ala232 and Val233 and must occur in its deprotonated form. The 
crystal structure determined at pH 7.8 and obtained by a gentle pH transition from pH 5.5 shows the same 
backbone orientation as at pH 8.5. This clearly indicates that Glu235 is already deprotonated in the apo 
structure at pH 7.8. C) Scheme of the ligand bound backbone orientation. Taking the orientation of the peptide 
bond between Leu231 and Ala232 in the apo structure at pH 7.8 into account, Glu235 accommodates a bound 
ligand without release of a proton at this pH value. D) Overlay of TGT apo structures at pH 5.5 (PDB ID: 1P0D), 
7.8 (PDB ID: 4PUN) and 8.5 (PDB ID: 1PUD). Amino acid residues are shown in stick representation (nitrogen = 
blue, oxygen = red). For clarity the side chain of Val233 is not shown. 
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Subsequently, we subjected the thus treated crystal to a structure determination and 
observed the geometry of the peptide bond with the backbone carbonyl group oriented 
towards the binding pocket (Scheme 3.3B). This geometry is only compatible with Glu235 
present in the deprotonated state. We thus conclude that the backbone flip must occur 
already at lower pH and ligand binding studied by our ITC titrations occurs to the enzyme 
with the peptide bond in the orientation for binding the ligand and with Glu235 in the 
deprotonated state. Therefore, a simultaneous compensating protonation change of N(3) 
and Glu235 can be excluded. 
Finally, there remains the question why the addition of the exocyclic C(2)–NH group 
at the imidazole moiety of the lin-benzopurines (3a compared to 3c) results in a significant 
affinity enhancement, which made Ritschel et al. to believe that this part of the ligand would 
bear a charge improving the affinity contribution of the formed additional hydrogen bonds 
[Ritschel et al., 2009]. The biochemical assay exaggerated this improvement (factor 30) as 
the ITC experiments suggest a smaller value (factor 5.5). Nonetheless, the enhancement is 
still remarkable. It has to be regarded that both NH functionalities of the 2-aminoimidazole 
portion forming the hydrogen bonds to the neighboring carbonyl groups of Leu231 and 
Ala232 are mutually adjacent (Scheme 3.3C). This dual hydrogen bonding array involves a 
pattern of two donor and acceptor groups with parallel orientation. Such an arrangement 
avoids secondary repulsive interactions that, for example, are given in the above-discussed 
contact of the aminopyrimidinone moiety and Asn156 (Scheme 3.2, center). The separation 
distance of the hydrogen atoms in the directly adjacent hydrogen bonds is rather short and 
thus substantial electrostatic interactions will occur [Jorgensen and Pranata, 1990]. Partial 
positive charges are given on the hydrogen atoms whereas partial negative charges are 
experienced on the nitrogen and oxygen atoms in the NH∙∙∙O hydrogen bonds. A favorable 
situation is given, as in the present case, where one of the binding partners bears all the 
hydrogen donor groups, the other all acceptor groups. The situation is worse, if donor and 
acceptor sites alternate between both partners, since then secondary repulsive interactions 
results from complexation. This incident is given in the contact to Asn156 and clearly 
responded by the structure with expanded and distorted geometry (Figure 3.3B). The 
enhancement of adjacent hydrogen bonding contacts following the DD/AA pattern has 
already been described in host–guest complexes many years ago [Murray and Zimmerman, 
1992]. 
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3.5 Conclusion 
In the present study, changes of the protonation states of ligands binding to the active site 
of the enzyme TGT were investigated. ITC measurements supported by pKa calculations 
confirmed the uptake of one proton in case of the lin-benzoguanine-type ligands. The 
structurally related lin-benzohypoxanthines do not show such a pick-up of a proton. 
Considering the adopted binding modes, the lin-benzohypoxanthines do not induce a 
relocation of the side chain of Asp102, which binds in case of the lin-benzoguanines directly 
to the ligand via two short hydrogen bonds. This relocation of Asp102 and the presence of 
Asp156 in short distance to the aminopyrimidinone moiety of the ligand creates a negatively 
charged environment. This provokes a significant pKa shift of the ligand’s heterocyclic 
moiety, which therefore becomes protonated and thus positively charged. Mutational 
exchanges of both Asp residues by Asn underline that the cluster of negative charges is 
responsible for this induced pKa shift.  
However, the intrinsic pKa values of the uncomplexed ligand under consideration 
must fall into a crucial window to achieve such a change in protonation upon binding. Both, 
the lin-benzoguanines and the lin-benzohypoxanthines exhibit a second guanidinium type 
motif in the five-membered imidazole portion. Our investigations reveal, however, that N(3) 
of the aminoimidazole moiety does not change its protonation state upon binding but the 
moiety experiences favorable hydrogen bond contacts to the protein avoiding secondary 
repulsive interactions. In summary, the lin-benzoguanines bear no charge in aqueous 
solution at pH 7.8 but become positively charged at the binding site. The charge is mainly 
distributed over the guanidine motif of the aminopyrimidinone and only minor effects might 
influence the aminoimidazole portion. 
This observation explains the high potency of the lin-benzoguanines showing binding 
affinities down to the one-digit nanomolar range. Their binding is characterized by a strong 
enthalpic binding signature resulting from the salt bridges formed between the 
aminopyrimidinone moiety and the deprotonated side chains of Asp102 and Asp156 
(Table 1). The contacts to both acidic residues are established in a deeply buried binding 
pocket that shields the formed charge-assisted interactions from solvent access. In this 
environment of low local dielectricity the formed charged contacts experience an enhanced 
affinity contribution [Bogan and Thorn, 1998]. In addition, the hydrogen bonds formed 
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between the aminoimidazole ring and the backbone carbonyl oxygens of Leu231 and Ala232 
are expected to be energetically favorable avoiding repulsive effects. 
The dramatic loss in binding affinity in case of the lin-benzohypoxanthines results 
from a loss of the interaction to Asp102, which rotates away from the ligand recognition site 
towards the ribose-34 binding pocket. As a consequence, the pyrimidinone ring remains 
uncharged, as found in aqueous solution prior to binding. Obviously, Asp156 alone does not 
take sufficient impact on the adjacent pyrimidinone moiety of the lin-benzohypoxanthines to 
induce a sufficiently large pKa shift to result in protonation and consequently charge-assisted 
interactions.  
With respect to bioavailability, the aminopyrimidinone portion in the lin-
benzoguanines exhibits the desirable feature of getting protonated upon protein binding 
only. Despite this advantage, overall the molecular properties of the ligands are not yet ideal 
regarding membrane transportation due to a large polar character of the molecules. Both 
the lin-benzoguanines and the lin-benzohypoxanthines show unsatisfactory membrane 
permeation in PAMPA measurements [Barandun et al., 2012]. 
This study demonstrates the importance to analyze the protonation properties of 
structurally closely related ligands. ITC titrations, performed in different buffer conditions, 
allow elucidating the net protonation inventory and stoichiometry. These studies, however, 
have to be complemented by site-directed mutagenesis and pKa calculations to trace where 
the protons go and accordingly the charges reside on the formed complex. They also help to 
avoid false conclusions resulting from mutually compensating effects and allow to localize 
the hot spots of binding and to tailor ligand properties so that transformation to the charged 
state only occurs upon target binding.  
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Complexity of a Flat Structure–Activity Relationship for 
Inhibition of a tRNA-Modifying Enzyme 
 
4.1 Introductory Remarks 
The following chapter was published in the scientific Journal of Medicinal Chemistry.
3
 Water cluster analyses 
were carried out by Michael Betz (Philipps-Universität Marburg). TGT compounds were synthesized by Luzi 
Jakob Barandun and Christoph Hohn (ETH Zürich). All crystallographic and microcalorimetric studies have been 
performed by the author of this thesis along with the drafting and discussion of the paper. 
 
 
 
4.2 Abstract 
Lead optimization focuses on binding affinity improvement. If a flat structure–activity 
relationship (SAR) is detected, usually the optimization strategy will be abolished as 
unattractive. Nonetheless, as affinity is composed of an enthalpic and entropic contribution, 
factorization of both can unravel the complexity of a flat, on first sight tedious SAR. In such 
cases, the binding free energy of different ligands can be rather similar, its factorization into 
enthalpy and entropy can be distinct. We investigated the thermodynamic signature of two 
classes of lin-benzopurines binding to tRNA–guanine transglycosylase. While the differences 
                                                          
3 Neeb et al. (2014). Beyond Affinity: Enthalpy-Entropy Factorization Unravels Complexity of a Flat Structure-Activity Relationship for 
Inhibition of a tRNA-Modifying Enzyme. Journal of Medicinal Chemistry 57, 5566-5578. 
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between the two series are hardly visible in the free energy term, they involve striking 
enthalpic and entropic changes. Analyzing thermodynamics along with structural features 
revealed that one ligand set binds to the protein without inducing significant changes 
compared to the apo structure, however, the second series provokes complex adaptation 
leading to a conformation closely similar to the substrate-bound state. In the latter state, a 
cross-talk between two pockets is suggested based on these observations. 
 
4.3 Introduction 
In a medicinal chemistry program, the optimization of a given lead structure seeks for an 
improvement of binding affinity. This goal is usually achieved by systematic replacement and 
expansion of functional groups and building blocks at the parent scaffold of the lead 
structure. Nowadays, the optimization process is supported by structure-based 
considerations, particularly if the 3D structure of the target protein is available. The value of 
such modeling attempts is highly appreciated, however, the experts also know that modeling 
might predict correct affinity correlations and structure–activity relationships based on false 
assumptions, which remain undiscovered as long as only affinity data are available. Without 
performing crystal structure determinations of every optimization candidate with the target 
protein, such putative misconceptions about binding modes or interaction patterns could 
easily remain undetected. Complex and difficult structure–activity relationships can even be 
reflected by featureless and flat correlations due to compensating effects. In such cases, it 
might be important to validate whether additional parameters beyond affinity can help to 
obtain more relevant insights into the properties of the studied system.  
The binding affinity is a Gibbs free energy value that decomposes into an enthalpic 
and entropic contribution. Both properties can provide additional information about the 
binding event, however, as their changes are also related to the entire protein–ligand 
binding process, any modification of the whole system will be compressed into the 
measured overall ∆𝐺0, ∆𝐻0, and 𝑇∆𝑆0. It is therefore extremely difficult to factorize the 
changes of these properties into individual contributions that can be assigned to single 
interactions or particular binding steps. Only within congeneric series of ligands and 
considering the binding to proteins classified as rigid, such decompositions have been 
successful [Dullweber et al., 2001; Baum et al., 2010; Snyder et al., 2011; Biela et al., 2012; 
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Biela et al., 2012; Biela et al., 2013; Martin and Clements, 2013]. In these analyses, it should 
not be forgotten that changes in the individual solvation pattern resulting from differences 
of one single water molecule can strongly perturb and shift the thermodynamic signature 
between ligands. Nonetheless, differences in the thermodynamic profiles of chemically 
closely related ligands usually indicate deviating binding features and help to validate 
structure–activity relationships.  
In the current study, we investigated the binding of two ligand series modified at two 
positions of the parent lin-benzopurine scaffold (Scheme 4.1) [Barandun et al., 2012]. The 
first modification involves attachment of an exocyclic amino group to a pyrimidinone 
headgroup, which makes the considered ligands competent to establish enhanced charge-
assisted or even salt-bridge type hydrogen bonds [Neeb et al., 2014]. The second 
modification concerns attachment of a series of substituted amino groups at the remote end 
of the parent scaffold [Ritschel et al., 2009]. The binding affinity determined via the 
dissociation constant (𝐾𝑑  value) measured by isothermal titration calorimetry varies only 
slightly among individual derivatives of the two series and differs among corresponding 
members of both series by about one order of magnitude depending whether the amino 
group is present or absent at the pyrimidinone moiety [Barandun et al., 2012]. It is 
exceptional is, however, that the attachment of the remote amino substituents of chemically 
rather different nature does not have much influence on the affinity. This at first glance 
rather unspectacular flat structure–activity relationship turns out to be very substantial if 
thermodynamic profiles and detailed binding modes are correlated.  
The addressed structure–activity relationship is presented for the binding of ligands 
to the tRNA-modifying enzyme tRNA–guanine transglycosylase (TGT). This enzyme catalyzes 
a complete exchange of a nucleobase at the wobble position of some tRNAs [Xie et al., 
2003]. Inhibition of this protein in bacteria is a promising therapeutic perspective as its 
function has been linked to the pathogenicity of Shigella, the causative agent of bacterial 
dysentery [Durand et al., 2000; Sansonetti, 2001]. Shigellosis occurs predominantly in 
developing countries and is responsible for more than 100’000 lethal cases every year 
[Kotloff et al., 1999]. 
In the present study, we show that two ligand series based on two slightly different 
parent scaffolds show quite distinct thermodynamic signatures even though the same 
substituents are attached. The recorded differences find an explanation in the features of 
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the protein conformer to which the ligands bind. Whereas one series binds to a protein 
conformer similar to that of the apo protein, the other series binds to the enzyme in a 
conformation related to the one adopted with the bound substrate. Due to considerable 
rearrangements of the protein, a crosstalk between binding subpockets is established, which 
gives rise to differences in the thermodynamic signatures. These significant differences in 
the binding properties would have never been detected if solely affinity data across the two 
ligand series would have been evaluated. Only by taking the thermodynamic profiles and the 
partitioning in enthalpy and entropy into account these differences do become apparent. 
 
4.4 Results and Discussion 
4.4.1 Binding Affinities and Thermodynamic Profiles of the 2-Amino-lin-benzopurines 
 
Scheme 4.1 Chemical formulas of the investigated ligands 3a – 6a and 3b – 6b. 
 
To establish a structure–activity relationship for the two compound series 3a – 6a and 3b –
6b (Scheme 4.1), we determined their inhibitory potency (𝐾𝑖  values). In previous studies, we 
characterized this property by a functional biochemical assay, which records by how much 
the incorporation of radioactively labeled guanine into the tRNA is suppressed when the 
catalytical properties of the target enzyme TGT are blocked [Meyer et al., 2006]. This assay is 
a rather indirect measure, as guanine itself exhibits some inhibitory potency and a size-
dependent inhibition model has to be considered for the bound ligands. Inhibitors decorated 
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by large substituents are competitive with tRNA binding whereas inhibitors of the size of the 
natural nucleobase substrates can block the enzyme, even if the tRNA is intermediately 
covalently attached to the protein. They compete for the binding site of the exchanged 
nucleobase. In the latter situation, the protein must be present in the substrate-bound 
conformation. As this binding assay superimposes multiple steps to the actual binding event 
and characterizes the inhibitory potential of the ligands rather indirectly, we used isothermal 
titration calorimetry (ITC) in the present study instead. This method directly reveals the 
dissociation constant 𝐾𝑑  for the binary protein–ligand binding event. From this, the Gibbs 
free energy of binding can be accessed using the equation ∆𝐺 = 𝑅 ∙ 𝑇 ∙ 𝑙𝑛 𝐾𝑑 . The measured 
data are listed in Figure 4.1. Remarkably, the ITC binding data of 3a – 6a match quite well 
with those determined by the biochemical assay, whereas for the series 3b – 6b deviations 
up to a factor of 16 (for 3b) are found [Ritschel et al., 2009; Barandun et al., 2012]. Apart 
from differences in the applied assay buffer conditions and the temperature used to run the 
experiments (ITC: 25°C, biochemical assay: 37°C), conformational differences given for the 
protein and discussed later in this contribution might give rise to these deviations. 
The Gibbs free energy of binding shows rather similar values across the lin-
benzoguanine 3a – 6a (mean: −41.6 ± 1.4 kJ ∙ mol−1) and lin-benzohypoxanthine 3b – 6b 
series (mean: −35.7 ± 1.8 kJ ∙ mol−1) indicating a flat and at first sight rather unspectacular 
structure–activity relationship. Without consulting the additional thermodynamic properties, 
this finding could have been the end of the current drug development study. The more it is 
surprising that the thermodynamic signature factorizes in both series very differently in 
enthalpy and entropy. All inhibitors exhibit strong exothermic binding and, as expected, this 
strong negative enthalpic contribution is larger for the lin-benzoguanine series. Remarkably, 
the enthalpic signature scatters for the lin-benzohypoxanthines series across a rather small 
window of ∆∆𝐻0 = 8.5 kJ ∙ mol−1 whereas the lin-benzoguanines spread over a nearly four 
times larger range of ∆∆𝐻0 = 31.1 kJ ∙ mol−1. Among the latter compound series, 6a 
exhibits with −66.3 kJ ∙ mol−1 the smallest exothermic signal followed by 5a with 
−78.9 kJ ∙ mol−1. Inhibitors 3a and 4a show the largest negative enthalpy, −97.4 kJ ∙ mol−1 
and −96.4 kJ ∙ mol−1. The entropic contribution is unfavorable for all ligands of both series. 
Remarkably, the methyl derivative 3a and the morpholinoethyl derivative 4a exhibit nearly 
identical entropic signatures. Overall, the entropic contribution is detrimental to the free 
energy of binding, resulting in pronounced enthalpy/entropy compensation in both series.  
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Figure 4.1 Chemical formulas and thermodynamic profiles of the investigated ligands. The compounds 3 – 6 
differ in their substitution pattern in 2-position. Additionally, their scaffolds vary among each other from lin-
benzoguanines (X = NH2) to lin-benzohypoxanthines (X = H). Values for the Gibbs free enthalpy are shown as 
blue bars, buffer corrected enthalpy values as green bars, and entropy values as red bars, each in units of 
kJ ∙ mol−1. Measurements to obtain ∆𝐺0comprise at least six measurements. Compounds 3a, 4a, 5a, and 6a 
show a buffer dependency. On average, approximately one proton is picked up by the ligand upon binding. 
Thus, ∆𝐻𝑜𝑏𝑠  was measured at least in duplicate in three different buffer systems (Hepes, Tris, Tricine). 
Subsequently, enthalpy values of lin-benzoguanines were corrected for buffer contribution. ∆𝐺0  and ∆𝐻𝑏𝑖𝑛𝑑  
values for lin-benzohypoxanthines represent the mean of at least three independent measurements. −𝑇∆𝑆0 
was calculated according to the Gibbs-Helmholtz equation.  
 
The observed trends in the thermodynamic signatures indicate that the attached 
substituents in the ribose-33 pocket are not the sole determinant for the observed profiles, 
as the relative differences in the thermodynamic properties among ligands with the same 2-
substituents do not match across the two series a and b. Also the differences between ligand 
pairs within the two series do not correspond to one another. Focusing on a mutual 
comparison of ligands from both series with identical 2-substitution reveals differences in 
∆∆𝐻0 of 24.2 kJ ∙ mol−1 to 49.7 kJ ∙ mol−1. At first glance, they should map the energy 
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difference resulting from the exocyclic NH2 group at the pyrimidinone moiety. Nonetheless, 
the deviating factorization of the thermodynamic data of the two compound series indicates 
a more complex structure–activity relationship than initially anticipated. Thus, to obtain a 
more detailed insight into the binding properties of the two ligand series, we resolved the 
crystal structures of the studied inhibitors bound to the enzyme. 
 
4.4.2 Crystal Structures and Binding Modes of 2-Amino-lin-benzopurines in Z. mobilis TGT 
The 2-amino-lin-benzoguanines 3a – 6a were determined at pH 5.5 with a resolution of 
1.25 – 1.49 Å, the corresponding lin-benzohypoxanthines 3b – 6b provided crystals that 
diffracted to 1.33 – 1.65 Å (Figure 4.2). The structures of 3a [Neeb et al., 2014], 3b 
[Barandun et al., 2012], and 4a [Neeb et al., 2014] had been previously determined. 
In all structure determinations, the tricyclic lin-benzoguanine scaffold is well-defined 
in the electron density. It adopts a binding pose with favorable π-stacking interactions to the 
adjacent Tyr106 and Met260. As reported previously, ligands based on the lin-benzoguanine 
scaffold form hydrogen bonds to the side chain functional groups of Asp102, Asp156, 
Gln203, and the backbone NH group of Gly230 (Figures 4.2A, C, E, G) [Hörtner et al., 2007; 
Stengl et al., 2007; Kohler et al., 2009]. In addition, the backbone carbonyl groups of Leu231 
and Ala232 are hydrogen-bonded to the aminoimidazole portion of the ligand. Exposure of 
the two backbone C=O groups to the binding pocket in parallel fashion requires a peptide-
backbone flip compared to the apo protein determined at a pH value of 5.5. The adjacent 
Glu235 carboxylate group is deprotonated and accepts two hydrogen bonds from the 
neighboring backbone NH groups of Ala232 and Val233. The interaction pattern stabilizes 
the backbone flip and makes a dual ladder of parallel hydrogen bonds to the bound ligand 
possible avoiding unfavorable secondary repulsive interactions among the closely 
approaching hydrogens in the hydrogen-bonding arrays [Immekus; Brenk et al., 2003; Neeb 
et al., 2014].  
Detailed analyses of the protonation inventory overlaid to the binding event showed 
that N(5) of the lin-benzoguanine scaffold becomes protonated whereas N(3) remains in the 
neutral uncharged state [Neeb et al., 2014]. 
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Figure 4.2 Binding modes of the investigated ligands to TGT (PDB IDs: 3a, 4PUK; 3b, 3S1G; 4a, 4PUJ; 4b, 4Q4R; 
5a, 4Q4O; 5b, 4Q4P; 6a, 4Q4S; 6b, 4Q4Q). The protein is represented as cartoon; similar protein states with 
respect to helix αA are colored identically (cp. Figure 7). The ligand and interacting residues are represented as 
sticks (nitrogen = blue, oxygen = red, sulfur = yellow). Chloride ions are shown as green spheres. For clarity, the 
π-stacking residues Tyr106 and Met260 are not shown, except when involved into the binding of the 2-
substituent. Water molecules are also not displayed in the representation. The lin-benzopurine scaffold located 
in the guanine 34 binding pocket is well defined in the  𝐹𝑜  −  𝐹𝑐  difference electron density (green) at a sigma 
level between 2.5 and 3.0. The scaffold forms several interactions with Asp102, Asp156, Gln203, Gly230, 
Leu231, and Ala232 (dashed lines). The hydrogen bond to Leu231 is enabled by a ligand induced backbone-flip, 
which is stabilized by Glu235. The substituents are not equally well defined as the scaffolds suggesting residual 
mobility to some extent. Occupancies for the different substituents are given using the corresponding color of 
the ligand.  
 
The lin-benzohypoxanthine scaffold adopts a very similar binding mode, and the 
interaction pattern to Asp156, Gln203, Gly230, Leu231, and Ala232 is analogously 
established [Barandun et al., 2012]. The lin-benzohypoxanthines lack the exocyclic NH2 
group at the pyrimidinone moiety. This results in different contacts with the adjacent 
Asp102. The latter residue orients its carboxylate group off from the binding site and 
remains in a geometry very similar to that found in the apo structure of the enzyme [Brenk 
et al., 2003]. Instead of forming a direct contact to the bound ligand, Asp102 experiences 
hydrogen bonds to the carboxamide NH2 of Asn70 and the backbone NH group of Thr71 
(Figures 4.2B, D, F, H). As a consequence of this outwards rotated pose of the Asp102 
carboxylate group, a network formed by up to six adjacent water molecules is established 
involving the carboxylate groups of Asp102 and Asp156 [Barandun et al., 2012]. As the 
parent ligand scaffold is no longer involved in a direct contact to Asp102, a small 
displacement of the ligand is observed resulting in slightly reduced distances to the 
remaining residues in contact with the lin-benzohypoxanthines. ITC measurements revealed 
that the lin-benzohypoxanthines bind to the protein without entrapping a proton at N(5) 
[Neeb et al., 2014]. As a result, the lin-benzohypoxanthines bind significantly weaker than 
the lin-benzoguanines. The salt-bridge type hydrogen bonds to Asp156 formed by the lin-
benzoguanines are replaced by more weakly charge-assisted contacts in the lin-
benzohypoxanthines [Neeb et al., 2014]. 
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In previous studies [Ritschel et al., 2009], it has been assumed that the substituents 
attached in 2-position to the lin-benzopurine scaffold of both parent structures exhibits large 
residual mobility in the bound state as no properly defined electron density was detected for 
this part of the ligands. Screening for modified crystallization conditions performed in the 
current study revealed for most of the studied ligands difference electron density in the 
crystals, which allows assignment of the 2-substituent in ordered geometry. Nonetheless, 
reduced population and elevated B-factors found for this part of the ligands suggest also in 
the recent structure determinations some residual mobility or scatter over multiple 
orientations. 
The difference electron density  𝐹𝑜  −  𝐹𝑐   fully defines the binding mode of 3a and 
3b (Figure 4.2A, B). The 2-methyl group at both parent scaffolds points towards Val282 in 
the ribose-33 pocket (cp. Figure 4.3). The remaining part of the ribose-33 pocket is virtually 
unoccupied by the ligand due to the small size of the methyl group, instead several water 
molecules are found in the pocket. 
The morpholinoethyl substituent of 4a has been refined in the displayed gauche 
conformation to a population of 80%. The remaining tricycle converges to an occupancy of 
100% (Figure 4.2C). A similarly reduced population (73%) is found for the 2-substituent in 4b, 
even though the substituent adopts an all-trans conformation in this case (Figure 4.2D). In 
both examples, elevated B-factors are assigned to the morpholinoethyl substituents in 
comparison to the parent scaffolds (4a: 𝐵𝑚𝑜𝑟𝑝 𝑕𝑜𝑙𝑖𝑛𝑒 = 21.5 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 9.1 Å
2; 4b: 
𝐵𝑚𝑜𝑟𝑝 𝑕𝑜𝑙𝑖𝑛𝑒 = 26.4 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 18.4 Å
2), suggesting enhanced residual mobility of this 
part of the ligand. Although different conformers with slightly different placements in the 
ribose-33 pocket are experienced, the terminal ether oxygen of the morpholine ring forms 
expanded hydrogen bond contacts to Arg286 (4a: 3.2 Å; 4b: 3.1 and 3.1 Å). In the latter case, 
refinement indicates the presence of two disordered conformers of the arginine side chain 
exhibiting equal population. The six-membered heterocycle exhibits a favorable chair 
conformation in 4a and 4b. 
The nearly isostructural piperidinoethyl substituents of 5a and 5b are both well 
visible in the difference electron density with virtually identical poses matching that of the 
all-trans conformer in 4b (Figure 4.2E, F). Whereas the substituent at the lin-benzoguanine 
scaffold refines to 64% occupancy, the one attached to the lin-benzohypoxanthine moiety is 
fully populated. Also for these ligands, the B-factors suggest enhanced residual mobility   
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(5a: 𝐵𝑝𝑖𝑝𝑒𝑟𝑖𝑑𝑖𝑛𝑒 = 19.8 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 13.1 Å
2; 5b: 𝐵𝑝𝑖𝑝𝑒𝑟𝑖𝑑𝑖𝑛𝑒 = 22.8 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 =
17.2 Å2). In both structures, the piperidine ring adopts the energetically favored chair 
conformation. As a special feature, both ligands entrap a chloride ion at a position occupied 
in the other structures by a water molecule. Assignment of a chloride ion to this density peak 
was confirmed by evaluating the density maps for anomalous scattering using the program 
ANODE [Thorn and Sheldrick, 2011]. In the structure of 5b, the anomalous density signal of 
𝜎 = 5.73 appears close to the signal of the structural zinc atom and the sulfur atoms of 
some methionines. In the complex TGT∙5a, an anomalous signal of 𝜎 = 4.23 is found. Most 
likely, the entrapping of the chloride ion correlates with the occupancy of the piperidine side 
chain, thus a reduced value for the chloride signal is reasonable in the latter structure. 
Refinement with Phenix [Adams et al., 2010] converged to 69% chloride occupancy, well in 
agreement with the substituent population in 5a. Crystal growth of TGT is performed under 
1 M NaCl concentration; accordingly, the uptake of a chloride ion appears likely. This 
assumption is supported by the fact that the most likely protonated piperidine nitrogen (pKa 
value ≈ 11.2 [Berrien et al., 2007]) forms a hydrogen bond to the chloride ion. This ion is 
further stabilized through contacts to the backbone NH group of Val282 and an adjacent 
water molecule (Figure 4.3). 
 
 
Figure 4.3 Position of the captured chloride ion. The protein is represented as cartoon, the ligand and 
interacting residues as sticks (nitrogen = blue, oxygen = red, sulfur = yellow). Chloride ions are shown as green 
spheres. The anomalous signal calculated with the program ANODE is shown at a sigma level of 3.0. The 
chloride ion is clearly defined by the anomalous electron density interacting with the most likely protonated 
nitrogen of the ligand’s piperidinoethyl substituent and the backbone NH of Val282. Occupancy refinement 
results in a similar value as found for the compound’s substituent. In TGT∙5a (PDB ID: 4Q4O), it is occupied to 
100%, in TGT∙5b (PDB ID: 4Q4P) to 69%. Peak intensities for the anomalous signal are given as green numbers. 
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In the complexes of 4a, 4b, and 5a the substituent refines to reduced occupancy. The 
analysis of the difference electron density on a reduced sigma level suggests the presence of 
a minor populated gauche or anti conformer, respectively. Consulting the geometries found 
in small molecule crystal structures deposited in the CSD [Allen, 2002] reveals preferred 
angular distributions around ±60° and 180° for an N+-CH2-CH2-NH torsion fragment (Figure 
4.4). The distribution suggests only minor preference for the gauche conformation. 
Accordingly, we also assume in the TGT complexes studied here that two arrangements are 
adopted. 
 
 
Figure 4.4 Rose plot of the CSD search results for the torsion angles of a N
+
-CH2-CH2-NH linker as found in the 
substituents of 4 and 5. The circles represent the frequency [%] of the matched torsion angle in steps of 
20 percent. The position on the circumference gives the value of the torsion angle. The data set comprised 414 
structures (updated CSD version 5.34; filters: not disordered, no errors, not polymeric, only organics). The 
carbon atoms were defined to be acyclic. Overall, gauche conformations are present in 39% of all analyzed 
structures, and the anti conformation is adopted in 61% of all cases.  
 
Interestingly enough, the difference electron density does not disclose any 
orientation of the thiophenomethyl substituent in 6a even though the better diffracting 
sulfur atom should be easier to detect. The electron density allows placement of the methyl 
group, however, the terminal thiophene moiety appears to be scattered over multiple 
orientations (Figure 4.2G). In contrast, the analogous lin-benzohypoxanthine derivative 6b 
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discloses the thiophenomethyl substituent in two equally populated orientations (Figure 
4.2H). The first conformer A orients the thiophene moiety into the ribose-33 pocket and 
experiences weak hydrophobic interactions with the side chain of Ala232. In the second 
conformation B, the thiophene ring rotates out of the ribose-33 pocket and approaches 
Tyr106. A weak hydrogen bond between the thiophene sulfur atom and the Tyr106 OH is 
established (3.1 Å). Also in this structure, the B-factors of the thiophene substituent refine to 
a value significantly larger as those of the parent scaffold (𝐵𝑡𝑕𝑖𝑜𝑝𝑕𝑒𝑛𝑒  𝐴 = 27.5 Å
2, 
𝐵𝑡𝑕𝑖𝑜𝑝𝑕𝑒𝑛𝑒  𝐵 = 21.7 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 11.2 Å
2). 
 
4.4.3 Correlation of Thermodynamic Signatures and Binding Modes 
As described above, the lin-benzoguanines 3a – 6a form, upon protonation at N(5), two 
bidentate salt bridges to Asp102 and Asp156. In contrast, the lin-benzohypoxanthines 3b – 
6b do not induce a similar reorientation of Asp102 and the carboxylate group of this residue 
remains in its orientation pointing away from the binding pocket. In consequence, the pKa 
shift at N(5) of the lin-benzohypoxanthine moiety is not provoked and one of the salt bridges 
assigned in case of the lin-benzoguanines to the guanidinium portion is lost. The second one 
transforms into two most likely attenuated charge-assisted hydrogen bonds to Asp156 
[Neeb et al., 2014]. As they lack secondary repulsive interactions [Jorgensen and Pranata, 
1990; Murray and Zimmerman, 1992], they can still contribute significantly. The 
thermodynamic and structural data recorded for thrombin-ligand binding have shown that 
the loss of a bidentate salt-bridge is equivalent to about −25 kJ ∙ mol−1 in ∆∆𝐻0 [Baum et 
al., 2009]. This value is approximately matched by the congeneric pairs 5a/5b and 6a/6b 
whereas 3a/3b and 4a/4b show significantly larger enthalpy differences. This finding 
indicates that the thermodynamic signatures in the current compound series are determined 
by additional effects superimposed on the sole loss of a salt bridge.  
Comparing the structural data of the apo protein with those of the lin-
benzohypoxanthine complexes, it becomes evident that Asp102 virtually remains in its 
original conformation upon ligand binding (Figure 4.5B) [Brenk et al., 2003; Barandun et al., 
2012]. Also the network of water molecules found in the apo structure is maintained and 
contributes contacts between the protein and the accommodated ligands. Accordingly, the 
lin-benzohypoxanthines 3b – 6b bind to the enzyme without inducing major changes 
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compared to the apo structure, which might require a strong enthalpic price to be paid. 
Notwithstanding, overall, a significant enthalpy-driven binding is observed for the lin-
benzohypoxanthine series. 
The structural situation is different for the lin-benzoguanines. Their binding triggers 
the rearrangements of Asp102 towards the binding pocket. This movement narrows the 
binding pocket, and the network of water molecules is displaced from the binding site in 
contrast to the binding of the lin-benzohypoxanthines. Subsequent to the reorientation of 
Asp102 and as a consequence of the loss of interactions with the adjacent residues such as 
Asn70, a cascade of structural rearrangements is induced, which results in a collapse of the 
interaction patterns among Asp102, Asn70, Thr47, and Gln107 previously seen in the apo 
protein (Figure 4.5) [Brenk et al., 2003; Stengl et al., 2007].  
 
 
Figure 4.5 Cascade of residue rotation initiated by the movement of Asp102. The same representation was 
applied as noted for Figure 4.2. For crystal structure analysis, all complexes containing lin-benzoguanines (A) 
and lin-benzohypoxanthines (B) were aligned, respectively. A) The side chains of Thr47, Asn70, His73, Gln107, 
and Asp102 are involved in the domino effect. All complex structures with lin-benzoguanine-based ligands 
show a high flexibility of the involved amino acid residues. Due to the missing interaction to Asp102, Asn70 is 
not fixed in an ordered conformation interacting either with Thr47 or Gln107. Gln107 can be found in multiple 
conformations, indicated by a partly missing electron density for its side chain. The previously found interaction 
to His73 cannot be detected in any of the complex structures under investigation. B) In binary complexes with 
lin-benzohypoxanthine-type inhibitors, residue Asp102 serves as an anchor point fixing the side chain of Asn70 
in a position competent to build hydrogen bonds to Thr47 similar to the apo enzyme. The side chain of Gln107 
shows different conformations capable to interact either with His73 or Asp102. 
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Even some movements of secondary structural elements are observed compared to 
the apo protein and the lin-benzohypoxanthine complexes (Figure 4.6). Accordingly, the 
binding of the lin-benzoguanines involves a fair number of adaptation processes, which all 
will be linked to significant changes of the thermodynamic properties. The formation of the 
salt bridges was already mentioned as an enthalpically driven step. The displacement of 
ordered water molecules from a protein binding site usually results in an entropically 
favorable binding signal [Baum et al., 2009; Biela et al., 2012].  
 
 
Figure 4.6 Influence of Asp102 on secondary structure elements of TGT. An overlay of all investigated 
structures of the TGT-bound lin-benzohypoxanthines (white) and lin-benzoguanines (dark gray and blue) shows 
substantial differences in the position of the β3-αA-loop, β-strand 2, helix α2A, and the β1-α1-loop. The binding 
of members of the lin-benzohypoxanthine series has only a slight effect on the global protein structure, which 
stays closely to the state of the apo enzyme. Contrary, due to the up-rotation of Asp102 towards the ligand, 
members of the lin-benzoguanine series trigger a kind of domino effect by which the β3-αA-loop, β-strand 2, 
helix α2A, and the β1-α1-loop move closer to the guanine 34 binding pocket. 
 
In 4a, 4b, 5a, 6a, and 6b, a residual mobility of the 2-substituent is observed that 
might suggest an entropically favorable contribution to binding. Most likely, these effects are 
beneficial for ligand binding but they will be partly compensated by the rearrangements 
crystallographically observed in the protein. They will cost a price in either enthalpy or 
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entropy. Nonetheless, overall a net improvement in the Gibbs free energy of binding of 
about −6 kJ ∙ mol−1 is observed for the lin-benzoguanines over the lin-benzohypoxanthines. 
Detailed factorization appears difficult in the present case, also as the price for the 
desolvation will be distinct for the lin-benzoguanine and lin-benzohypoxanthine series. 
The detailed comparison of the thermodynamic profiles of the lin-benzoguanines 
3a – 6a and lin-benzohypoxanthines 3b – 6b unravels another striking feature (Figure 4.1). 
Whereas the lin-benzohypoxanthines factorize quite similarly in enthalpy and entropy, the 
members of the lin-benzoguanine series exhibit large differences in their profiles. This 
observation suggests that the lin-benzohypoxanthines do not experience large differences in 
their thermodynamic properties. Thus, hardly any dependence on the actual size and 
chemical properties of the substituents attached at the 2-position is observed. This picture 
appears different for the lin-benzoguanines as here the thermodynamic profile is 
significantly modulated by the properties of the attached 2-substituent. Obviously, in the 
latter compound series a crosstalk between the rearrangement of Asp102 and the binding to 
the ribose-33 pocket is given, whereas across the lin-benzohypoxanthine series this 
interdependence can hardly be recognized. 
To find some explanations for these differences in the pocket crosstalk, we have 
analyzed the crystal structures of the various complexes. Interestingly enough, binding of the 
lin-benzoguanines, which recruits Asp102 for ligand recognition translates into a significant 
shift of helix αA (Figure 4.7). This helix adopts virtually the same geometry in the apo protein 
and the lin-benzohypoxanthine-bound complexes. It is placed nearly perpendicular to the 
guanine-34 recognition site and extends from Tyr106 to Leu110. Once the lin-benzoguanines 
are bound to the enzyme, this helix is significantly shifted towards the ligand-binding site. 
This movement is triggered by the rearrangement of Asp102. A comparison of the enzyme 
structure with the bound substrate tRNA and the discussed lin-benzoguanine inhibitor 
complexes is quite conclusive. Obviously, also the binding of the tRNA induces this shift of 
helix αA very similar to that observed in the lin-benzoguanine complexes but clearly distinct 
from the geometry found for the apo protein and the lin-benzohypoxanthine complexes. A 
predominant role can be assigned to Tyr106, which resides on this helix. Upon the shift of 
the helix, the Tyr106 side chain penetrates by 2.5 Å deeper into the ribose-33 pocket. This 
replacement allows Tyr106 to experience whether any ligand portion is bound to the ribose-
33 pocket. In the apo protein and the structurally very similar lin-benzohypoxanthine 
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complexes, Tyr106 remains in a remote position, but for the lin-benzoguanine complexes, 
Tyr106 is pushed to varying extend (1.3 – 1.9 Å) into a proximate position bordering the 
ribose-33 pocket (Figure 4.8). 
 
 
Figure 4.7 Influence of the various ligands on helix αA. The protein is represented as cartoon. The ligands are 
shown as sticks and colored according to Figure 4.2. A) All binary TGT complexes with lin-benzohypoxanthine- 
based inhibitors exhibit one fixed helix conformation (white). lin-Benzoguanine·TGT complexes show different 
conformations of the helical part: TGT∙3a (green), TGT∙4a (blue), and TGT∙5a (orange) show a similar position 
among each other, which deviate from that in the lin-benzohypoxanthine∙TGT complexes (gray). An even larger 
perturbation results from the binding of 6a which leads to strong repositioning of Gln107, Val108, and Met109 
concomitant with an up-rotation of the helix (blue). Additionally, TGT∙4a shows a second populated binding 
mode with an up-rotated helix conformation as similarly found in complex TGT∙6a (blue). B) Modulations of the 
backbone trace of the β3-αA loop upon formation of the different complexes. lin-Benzohypoxanthine 
complexes are displayed in white, TGT∙3a, TGT∙5a in gray, and TGT∙4a, TGT∙6a in blue. All white structures show 
a conserved orientation of helix αA. It is noticeable that the backbone of the β3-αA loop adopts a conformation 
distal to the tricyclic ligand core. In lin-benzoguanine∙TGT complex structures, the whole loop region is 
positioned closer to the ligand’s scaffold. Thereby, the closest position can be found, if helix αA is rotated 
upwards (TGT∙4a, TGT∙6a). TGT∙5a adopts an intermediate orientation since Tyr106 indicates that an up-
rotated helix conformation could be possible, although not observed in electron density. 
 
Obviously, the lin-benzohypoxanthines bind to TGT in a conformation that closely 
resembles that of the apo protein whereas the lin-benzoguanines provoke an arrangement 
that approximates the architecture of the enzyme in the substrate-bound state as observed 
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in the covalent tRNA intermediate (PDB ID: 1Q2R) trapped by crystallization with the 
substrate mimetic 9-deazaguanine (Figure 4.9). This finding explains why the thermodynamic 
binding signature of the latter inhibitors is more sensitive to the properties of the attached 
2-substituent as the presence of such a substituent is recognized and thus transmitted via 
Tyr106 and the shifted helix αA. With respect to the enzymatic function, such a behavior 
appears very reasonable as the enzyme must distinguish what is bound to the ribose-33 
recognition pocket. Discrimination between correct and false substrates relies on the 
recognition of the nucleobase in this pocket. Accordingly, the binding properties of this part 
of the substrate must be transmitted and have to result in a varying thermodynamic binding 
profile. Exactly this feature we also observe between the lin-benzohypoxanthine and lin-
benzoguanine-type inhibitor series, which gives rise to the rather complex structure–activity 
relationship between both series. 
 
 
Figure 4.8 Overlay of the TGT structure binding the natural substrate tRNA (PDB ID: 1Q2R) as well as the 
analyzed lin-benzoguanine and lin-benzohypoxanthine-bound structures. Helix αA as well as the tRNA are 
visualized in cartoon representation (lin-benzohypoxanthines = white, lin-benzoguanines = gray/blue, 1Q2R = 
green). The ligands, nucleic acid bases, and Tyr106 are highlighted as sticks (nitrogen = blue, oxygen =red). The 
α-helix A of the TGT∙tRNA complex adopts an orientation similar to the lin-benzoguanine-bound protein. In the 
same way, Tyr106 of the latter complexes reaches deeper into the ribose-33 subpocket. Obviously, these 
positional changes induce a cooperativity between the guanine-34 recognition site and the ribose-33 
subpocket leading to the observed diverse thermodynamic profiles. 
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Figure 4.9 Influence of substrate recognition on the guanine-34 recognition site. As representatives, the 
complexes TGT∙3b (A), TGT∙3a (B), the apo enzyme at pH 7.8 (C), and the ternary complex TGT∙9-
deazaguanine∙tRNA (D) are illustrated. The latter complexes mimic an intermediate situation during the 
nucleobase exchange reaction when tRNA is covalently attached and guanine is cleaved off. This situation is 
captured in the cocrystallized ternary complex using the geometrically identical but chemically unreactive 
9-deazaguanine. The protein is shown in surface representation (white = apo state, gray = substrate bound 
state). The ligands are displayed as sticks, the tRNA stem loop as cartoon (nitrogen = blue, oxygen = red, 
sulphur = yellow, phosphorus = orange). In complex TGT∙3b (PDB ID: 3S1G, A), the lin-benzohypoxanthine is not 
recognized as substrate-like by Asp102 as the exocyclic NH2 group is missing. Asp102 adopts a conformation 
remaining within the protein similar to apo TGT (PDB: 4PUN, C). Therefore, they share a similar protein surface 
(white) exhibiting two entries to the active site indicated by arrows. In complexes TGT∙3a (PDB ID: 4PUK, B) and 
TGT∙9-deazaguanine∙tRNA (PDB ID: 1Q2R, D), the lin-benzoguanine and the substrate mimetic 9-deazaguanine, 
respectively, are recognized as substrate surrogates by the enzyme. Asp102 rotates towards the guanine-34 
recognition site and forms hydrogen bonds to the aminopyrimidinone moiety of the ligand. Provoked by the 
structural changes due to the up-rotation of Asp102, the second entrance to the guanine-34 recognition site is 
closed (gray). 
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We mentioned above the deviating potency profiles obtained by the biochemical 
assay and the ITC data, particularly for the lin-benzohypoxanthine series (differences in 𝐾𝑖  
values up to a factor of 16 for 3b). ITC measures directly the binding to the protein 
conformer competent to accommodate a ligand, yielding 𝐾𝑑  values. The biochemical assay 
requires the protein to be in the state able to recognize the tRNA substrate, thus with 
Asp102 oriented towards the binding pocket. Only the lin-benzoguanines will bind to this 
conformation, not the lin-benzohypoxanthines. Thus, a conformational change would be 
required to accommodate the latter ones. However, as a size-dependent inhibition model 
has to be assumed for the ligands binding to the enzyme, small inhibitors can show a 
significant inhibitory component even if the intermediately bound tRNA is attached to the 
protein. Supposedly, this inhibitory component can only be realized by the lin-
benzoguanines and not by the lin-benzohypoxanthines. Possibly, this effect also has 
influence on the inhibitory properties determined by the biochemical assay or ITC and 
underestimates the intrinsic binding potency of the lin-benzohypoxanthines in the 
biochemical assay.   
 
4.5 Conclusions 
The two congeneric series of inhibitors, varied at the pyrimidinone moiety and the 2-amino 
substituents of a lin-benzopurine scaffold, show a rather flat and unattractive SAR with 
nearly unchanged binding affinities within the series and an offset of about one order of 
magnitude between both series. The loss in affinity between the lin-benzoguanine and the 
lin-benzohypoxanthine series can be related at first glance to the loss of a salt bridge formed 
to the pyrimidinone moiety with and without an attached amino group. The unmodulated 
affinity recorded for the attachment of a 2-amino substituent at the remote end of the 
parent lin-benzopurine scaffold can hardly be explained on the affinity level. The 
thermodynamic signature accessible by ITC measurements provides some surprises as in the 
lin-benzohypoxanthine series all ligands factorize similarly in enthalpy and entropy whereas 
the lin-benzoguanines show strong and complex changes in the enthalpy/entropy signature. 
Interestingly enough, the crystallographic analysis shows that the lin-benzohypoxanthines 
bind to the protein without inducing major conformational changes of the enzyme 
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compared to the apo structure. With respect to the thermodynamic properties, small or 
large 2-substituents of deviating chemical nature experience the same hardly discriminating 
profile. The lin-benzoguanines bind to a protein conformation approximating the enzyme in 
the substrate-bound geometry. Major conformational changes are all triggered by the 
reorientation of Asp102. This residue is important for substrate recognition. Simultaneously, 
the protein architecture varies in a way that a crosstalk between the binding signature 
resulting from the ligand portion accommodating the guanine-34 and the ribose-33 pocket is 
established. In consequence, quite surprisingly, the attached 2-substituents at the lin-
benzoguanine scaffold receive an individually modulated thermodynamic signature across 
the compound series. 
The example shows, even though a detailed partitioning in individual thermodynamic 
contributions is impossible due to the given complexity of the system, that a combination of 
thermodynamic signature analysis and structural information provides an insight into 
structure–activity relationships beyond sole affinity considerations. They are important for a 
rational and predictive design of novel inhibitors. 
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5. Creating a Resistance Model for TGT: the Effect of Mutations on 
Flexible lin-Benzoguanine Substituents 
 
5.1 Introduction 
After the successful design of high-affinity inhibitors for a distinct target, which exhibit 
favorable bioavailability features, the development of drug resistance due to active-site as 
well as non-active-site mutations often constitutes a painful backlash [Erickson and Burt, 
1996]. Such mutations can either result in a decreased binding affinity of the ligand or an 
enhanced activity of the enzyme overcoming the inhibitory effect [Luque et al., 1998].   
In order to tackle this problem investigations were directed towards the analysis of 
the enthalpic and entropic properties of various inhibitors and how their binding is 
influenced by the appearance of resistance mutations [Velazquez-Campoy et al., 2000; 
Velazquez-Campoy et al., 2001; King et al., 2012]. Data collected for HIV-protease inhibition 
suggested that ligands binding with a mainly entropic contribution to the target enzyme are 
more susceptible to variations in the amino acid sequence. It could be shown in case of HIV-
protease that favorable entropy could mainly be achieved by rigidifying the inhibitor in a 
way that it optimally fits the active site of the enzyme. As a consequence, the ligand looses 
less conformational degrees of freedom upon binding. Simultaneously, however, its ability to 
escape mutational variations within the binding site is significantly reduced. Contrary to rigid 
molecules, flexible compounds were found to respond to mutational perturbations at critical 
positions of the target protein with a less pronounced decrease in binding affinity. As a 
strategy to overcome the loss in conformational entropy upon binding of a previously 
flexible ligand, an enthalpic compensation was conceived. To achieve this goal, polar groups 
were introduced to the molecules, which were assumed to form strong hydrogen bonds or 
salt bridges, respectively. As a result not only enthalpy-entropy compensation was partly 
avoided but also the binding specificity to the target enzyme could be increased.  
As a model system to investigate the behaviour of different ligands towards 
mutations, we selected the tRNA modifying enzyme tRNA-guanine transglycosylase, which 
plays a key role in the pathogenicity of Shigella bacteria, the causative agent of Shigellosis 
[Sansonetti, 2001]. Disappointingly, the treatment of the disease becomes more and more 
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challenging due to the increasing resistance development of Shigella to current antibiotics 
[Ashkenazi et al., 2003]. Therefore, the design of new selective antibiotics inhibiting TGT is of 
utmost importance. In the present study, we chose 2-amino-lin-benzoguanine type TGT 
inhibitors as model compounds to test their resistance tolerance in TGT binding [Hörtner et 
al., 2007]. 
As reported in chapter 3 and 4 these ligands exhibit pronounced enthalpic binding 
due to various favorable van der Waals interactions, hydrogen bonds and salt bridges 
formed between the protein and the ligand [Neeb et al., 2014]. Crystal structure analysis 
revealed that the substituents attached in 2-position of the parent lin-benzoguanine scaffold 
exhibit enhanced residual mobility indicated by increased B-factors compared to the parent 
scaffold and by the presence of multiple conformations of the 2-substituents [Neeb et al., 
2014]. This flexibility of the 2-substituents might be advantageous as ligand portions capable 
to bind with multiple orientations might be better suited to cope and tolerate resistance 
mutations of the target protein. We hypothesized that such ligands or ligand portions are 
potentially more appropriate for targeting mutated TGT variants since no specific 
interactions with any protein side chains are required and the ligand can still find an 
acceptable binding pose.  
Overall, this study was intended to show whether a ligand exhibiting high residual 
mobility is better able to avoid a loss in binding affinity upon a target protein mutation than 
a ligand adopting only one ordered binding mode.  
 
5.2 Results 
5.2.1 Mutations of Wild Type TGT 
The simulation of resistance development requires the selection of amino acids appropriate 
for mutagenesis. Since resistance mutations usually do not affect residues, which are directly 
involved in catalysis, we focused on amino acids present in the uridine-33 subpocket. The 
number of exposed side chains in this pocket is limited due to the fact that the area of this 
pocket, which is located next to the ligand’s substituent, mainly contains backbone atoms 
and glycine residues (Figure 5.1A). Accordingly, Val262 was chosen for mutational analysis, 
and replaced by threonine, aspartate and cysteine, respectively. The presence of each 
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mutated codon was confirmed by sequencing and mass spectrometry (see appendix). 
Subsequently, the putative influence of the respective mutations on the binding mode of the 
ligand were analyzed by MD simulations (not shown), and the steric and electronic 
consequences of the newly introduced side chains were investigated by X-ray 
crystallography.  
The apo structure of TGT(Val262Thr) was determined at a resolution of 1.24 Å (Figure 5.1B, 
green). The mutated threonine residue adopts a conformation similar to that of Val262 in 
the wild type enzyme. In addition, a second orientation is indicated by the difference 
electron density, which could, however, not satisfyingly be resolved during refinement. Yet, 
in this alternative position Thr262 seems to be slightly shifted into the ribose-33 subpocket 
and most likely forms, via its side chain hydroxyl, a hydrogen bond to the side chain 
carboxylate of the adjacent Asp267. The solvation pattern within the pocket is similar to the 
one observed in the apo structure of the wild type. 
The apo structure of TGT(Val262Asp) shows a nominal resolution of 1.33 Å (Figure 
5.1C, yellow). The mutated aspartate is well-defined by the electron density. Compared to 
the apo structure of the wild type, the peptide bond between Gly261 and Asp262 is flipped. 
As a consequence, the backbone of Asp262 reaches into the ribose-33 subpocket with its 
side chain interacting with the backbone NH groups of Val282 (3.08 Å) and Leu283 (2.79 Å) 
as well as three close-by water molecules (2.79 – 3.05 Å). To avoid unfavorable contacts to 
the side chain of Asp262 the positions of Asp280, Cys281, Val282 and Leu283 are slightly 
altered compared to the wild type. 
The nominal resolution of the TGT(Val262Cys) structure amounts to 1.44 Å (Figure 
5.1D, cyan). Surprisingly, the crystal structure shows a disulfide bridge, which is partially 
formed between Cys262 and Cys281 despite of the presence of DTT as reducing agent during 
crystallization. Similar to TGT(Val262Asp) the peptide bond between Gly261 and Cys262 is 
flipped. The formation of the disulfide bridge is concomitant with the rearrangement of 
several amino acids resulting in the dislocation of residues Leu283 to Arg289.  
Kinetic characterization of the mutated variants revealed both for TGT(Val262Thr) 
and TGT(Val262Asp) a turn-over number which was, compared to the wild type enzyme, only 
slightly reduced (see Appendix 10.6). Therefore, and as the Val262Thr and the Val262Asp 
mutations each led to different alterations of the uridine-33 subpocket, they provide a good 
platform to investigate various resistance scenarios. 
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Figure 5.1 Apo structures of the analysed mutated variants of TGT. The protein is shown in cartoon 
representation. The mutated residues as well as adjacent amino acids possibly affected by the respective 
mutation are depicted as sticks (nitrogen = blue, oxygen = red, sulphur = yellow). For clarity, water molecules, 
which are not in contact with the mutated residues are not shown. Interactions formed by the mutated residue 
with its local environment are visualized as dashes. For comparison, the structure of the wild type enzyme 
(transparent) is superimposed in images B – D. A) Apo structure of wild type TGT (PDB ID: 1PUD [Romier et al., 
1996]). The uridine-33 subpocket is mainly bordered by backbone atoms restricting possible sites appropriate 
for site-directed mutagenesis. B) TGT(Val262Thr). This variant shows a similar structure as the wild type 
enzyme. Accordingly, Thr262 adopts an orientation similar to that of the wild type, although a second 
conformation interacting via its hydroxyl group with the side chain of Asp267 is weakly indicated by the 
difference electron density. C) TGT(Val262Asp). Asp262 interacts with the backbone NH groups of Val282 (3.08 
Å) and Leu283 (2.79 Å) resulting in the positional deviations of residues Gly261 and Asp262 as well as Asp280 
to Leu283 from the wild type. D) TGT(Val262Cys). Cys262 forms a disulfide bond with Cys281 leading to a 
similar backbone orientation of Gly261 and Cys262 as observed in TGT(Val262Asp). Additionally, the formation 
of the disulfide bridge results in the dislocation of residues Leu283 to Arg289 (dotted cyan line). 
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Unfortunately, the Val262Cys mutant did not yield kinetics that could be evaluated 
conclusively in a Michealis-Menten plot despite of its present activity. Presumably, the 
partially formed disulfide bridge between Cys262 and Cys281 caused the inconsistent data. 
Nonetheless, the mutated variant still exhibits reasonable kinetic activity. In order to 
produce reliable kinetic results for this variant, TGT(Val262Cys) has to be expressed, purified 
and crystallographically analyzed in the absence of oxygen and under inert gas conditions 
that guarantee Cys262 and Cys281 to be present in their reduced state. 
 
5.2.2 Binding Affinities 
To address the question whether a ligand showing residual mobility constitutes a more 
resistance tolerant antibiotic, the 𝐾𝑑  values of different 2-amino-lin-benzoguanines were 
measured against the three generated mutants using isothermal titration calorimetry. The 
obtained values were compared to the data obtained for the wild type protein (Table 5.1). 
 
Table 5.1 Binding affinities of lin-benzoguanine type inhibitors to mutated TGT variants as determined by 
isothermal titration calorimetry at least in triplicates.   
Ligand Chemical formulae 
𝑲𝒅[nM] 
WT Val262Thr Val262Asp Val262Cys 
3a 
 
49 ±   5 44 ±   5 158 ±   5 16 ± 1 
4a 
 
32 ±   7 27 ±   7 181 ± 17 18 ± 4 
5a 
 
34 ±   7 34 ±   4 152 ±   9 ---[a] 
6a 
 
81 ±   8 63 ± 15 557 ± 20 27 ± 2 
7 
 
57 ± 14 36 ±   5 359 ± 18 19 ± 2 
a𝐾𝑑  for the Val262Cys variant was measured against the oxidized protein and is thus not listed. 
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Thereby, 3a served as a reference as, due to the small size of its 2-substituent, it 
hardly occupies the ribose-33 subpocket. 
Interestingly, all ligands respond to the introduced mutations in a similar way, 
independently of the respective 2-substituent. As expected, the binding affinities for the 
TGT(Val262Thr) resemble, within the range of experimental accurancy, those obtained for 
the wild type enzyme. In this variant only minor changes in the binding pocket were 
introduced. In contrast, the binding affinities to TGT(Val262Asp) are consistently decreased 
by a factor of three to seven. Remarkably, all 2-amino-lin-benzoguanines show a two- to 
threefold increase in potency towards TGT(Val262Cys). 
  
5.2.3 Exploring the Adaptations of 4a Targeting the Mutated TGT Variants 
As a representative for the 2-amino-lin-benzoguanine type ligands, 4a was chosen and its 
binding mode with the mutated TGT variants was investigated by crystal structure analysis. 
We focused on the response of ligand binding on the modified protein environment as well 
as on the orientation of the 2-substituent within the altered uridine-33 subpocket.  
The structure of TGT(Val262Thr) in complex with 4a shows a maximum resolution of 
1.89 Å. The parent lin-benzoguanine scaffold adopts the previously described binding mode 
involving the π-stacking residues Tyr106 and Met260 as well as hydrogen bonds to Asp102, 
Asp156, Gln203, Gly230, Leu231 and Ala232 (Figure 5.2A). As similarly observed in the 
corresponding complex structures of the wild type enzyme, the 2-substituent is positioned 
within the ribose-34 subpocket adopting a gauche-conformation. The morpholine ring is 
weakly defined most likely showing the favorable chair conformation. Its occupancy 
amounts to 82%. Via its morpholino oxygen the substituent interacts with the side chain of 
Arg286. Contrary to the apo structure of TGT(Val262Thr), no difference electron density 
indicating a second conformation of Thr262 is observed. The side chain of Thr262 is solely 
present in an orientation similarly found for the valine side chain in wild type TGT.   
The binary complex of TGT(Val262Asp) with 4a was determined at a resolution of 
1.38 Å. As expected, the lin-benzoguanine scaffold as well as its 2-substituent show the same 
interaction pattern as observed in previous structures (Figure 5.2B). The morpholine ring is 
weakly defined by the electron density. It is refined in its chair conformation to an 
occupancy of 69%.  
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Figure 5.2 Binding mode of 4a as bound to the different mutated TGT variants. The protein is displayed in 
cartoon representation. The ligand as well as interacting protein residues are highlighted as sticks (nitrogen = 
blue, oxygen = red, sulphur = yellow). Hydrogen bonds are visualized as dashes. Delocalized protein residues 
are indicated by dotted lines. The 2  𝐹𝑜 −  𝐹𝑐   density is shown at a sigma level of 1.0 in blue. For clarity, water 
molecules are not shown. A) Binding mode of 4a to TGT(Val262Thr). The same interaction patterns are 
experienced by the lin-benzoguanine scaffold as in the wild type. The 2-substituent shows a gauche 
conformation forming a hydrogen bond to Arg286 at a distance of 3.0 Å. Its occupancy amounts to 82%. Thr262 
adopts a conformation similar to that of Val262 in the wild type protein. B) Binding mode of 4a to 
TGT(Val262Asp). The lin-benzoguanine scaffold forms the same interactions as previously described. Its 2-
substituent binds in a gauche conformation and is refined to an occupancy of 69%. The side chain of Arg286, 
usually interacting with the terminal ether oxygen of the morpholine ring, is not resolved in the electron 
density. Upon binding of the lin-benzoguanine scaffold Ser287 and Gly288 get completely disordered (dotted 
orange line). The hydrogen bonds experienced by the mutated aspartate to Val282 and Leu283 in the apo 
protein are broken and its side chain faces the most likely protonated morpholine ring. C) In the complex of 4a 
bound to TGT(Val262Cys) only the tricyclic core of the ligand is clearly defined. Contrary to the other crystal 
structures, the 2-substituent could not be assigned to the difference electron density. Similarly as in the apo 
state, Cys262 and Cys281 form a disulfide bridge. Due to minor rearrangements next to the site of mutation, 
helix αB is completely disordered (dotted blue line). 
 
The difference electron density for the mutated aspartate is not as properly defined 
as in the apo structure. The hydrogen bonds to Val282 and Leu283 are broken and the side 
chain of Asp262 is rotated towards 4a being in van der Waals contact with the ligand’s 
morpholino moiety. Furthermore, the difference electron density for the region comprising 
Asp280 to Arg286 indicates higher residual mobility than observed in the apo form. An 
increased mobility is also observed for the neighboured amino acids Ser287 and Gly288 
whereby no electron density can be detected for the latter one. 
A data set with a maximum resolution of 1.72 Å was collected for the 
TGT(Val262Cys)∙4a complex. Also in the complex structure, the disulfide bridge between 
Cys262 and Cys281 is clearly visible. Contrary to the above-described inhibitor complexes, 
the present crystal structure shows well-defined electron density only for the parent scaffold 
while no defined density is observed for the 2-substituent (Figure 5.2C) indicating enhanced 
flexibility of this part of the ligand. Also no defined electron density can be assigned to helix 
αB comprising the amino acids Leu283 to Asn290. 
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5.3 Discussion 
To investigate the effects of the introduced mutations on the binding affinity to the 2-amino-
lin-benzoguanine scaffold, the 𝐾𝑑  values of 3a, which is 2-substituted with only a methyl 
group, and the mutated variants were determined first. In a second step, the influences of 
the 2-substituents were evaluated by comparing the affinities and crystallographically 
determined binding modes of the remaining ligands to that of the reference ligand 3a. 
Within the range of experimental accuracy all ligands exhibit the same affinity 
towards TGT(Val262Thr) as towards the wild type. This result is well consistent with the 
crystal structures obtained from this variant: Firstly, the binding of the lin-benzoguanine 
scaffold does not take any influence on the order of the protein’s secondary structure 
elements as shown by the comparison of the TGT(Val262Thr) apo structure and its complex 
structure with 4a. Secondly, the morpholinoethyl substituent of the ligand adopts a similar 
gauche-conformation in TGT(Val262Thr) as described for the wild type. Also the enthalpies 
recorded for the binding of the different ligands to this mutated variant are similar to those 
observed for the wild type (Figure 5.3, green bars). Therefore, it is highly probable that the 
substituents of 5a, 6a and 7 behave upon binding to TGT(Val262Thr) similarly as described 
for wild type TGT in chapter 4.  
The 𝐾𝑑  values of the different 2-amino-lin-benzoguanines measured for 
TGT(Val262Asp) show, compared to the wild type TGT, a significant loss in binding affinity. 
Taking a closer look at the crystal structure of the TGT(Val262Asp)∙4a complex, the position 
and orientation of the morpholinoethyl substituent exhibits no major difference to the WT 
TGT∙4a complex. However, it can be clearly noticed that the β8αB-loop as well as helix αB 
show a signficantly increased flexibility upon ligand binding, which leads to the complete 
dislocation of two amino acids. In contrast to the structure in complex with 4a, this part of 
TGT(Val262Asp) adopts a more rigid geometry in the apo structure. Possibly, the observed 
increase in flexibility is responsible for the drop in binding affinity. Moreover, this loss is 
more pronounced for 6a and 7, which are endowed with hydrophobic substituents, while 4a 
and 5a, endowed with polar most likely charged substituents, experience no changes in their 
𝐾𝑑𝑠 compared to the reference ligand 3a. Additionally, a significant loss in binding enthalpy 
and simultaneous gain in entropy is experienced by the ligands 3a, 4a 6a and 7 upon 
mutation of Val262 to aspartate (Figure 5.3, orange bars). An exception represents 5a. 
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Certainly, electrostatic interactions either attractive (4a and 5a) or repulsive (6a and 7) will 
influence the resulting binding constants and thermodynamic profiles.  
 
 
Figure 5.3 Enthalpy differences of the investigated ligands 3a – 7 compared to wild type TGT. The ∆∆𝐻 values 
are shown as bars in units of kJ ∙ mol−1. ∆𝐻𝑜𝑏𝑠  was measured in triplicates. The errors were calculated 
according to error propagation. The light gray box represent the ± 4 kJ ∙ mol−1 area, within that data are 
considered not significantly different. 
 
The binding potency of the investigated ligands towards the protein slightly increases 
upon mutation of Val262 to cysteine. Although parts of helix αB are delocalized in the 
structure of this variant in complex with 4a no impact on the 𝐾𝑑  value is noticeable in 
comparison to Val262Asp∙4a. Inspecting the crystal structure, however, shows already a high 
flexibility of this part of the protein in the apo state of the mutant variant. The observed 
affinity gain and enthalpy differences (Figure 5.3, blue bars) can hardly be explained by 
means of the crystal structures since the disulfide bridge is presumably not present in 
solution and only formed during crystallization in consequence of an exposure of the sample 
to oxygen over several days. Also the fact that stored and subsequently thawed protein 
shows a drastically decreased affinity in ITC measurements supports the assumption that the 
freshly expressed protein is initially present in its reduced state. 
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5.4 Conclusions 
The present chapter describes how various lin-benzoguanine type inhibitors with different 
flexible 2-substituents respond, with respect to their binding affinities, to mutations 
changing the properties of the flat, solvent-exposed uridine-33 subpocket of the target 
protein TGT.  
The 2-amino-lin-benzoguanines included in this study exhibit varying behaviours of 
their 2-substituents: While 3a serves as a reference ligand lacking any substituent to be 
deeply placed into the ribose-33 subpocket, 4a and 5a are endowed with flexible 
substituents attached to the tricyclic parent scaffold. Conformationally, the attached 
substituents might swap between gauche- and anti-conformation giving rise to enhanced 
residual mobility. For 6a this flexibility is particularly pronounced, which is why no properly 
defined difference electron density for the thiophenomethyl substituent was detected in 
multiply recorded data sets. In contrast, 7 binds to TGT with its phenylethyl substituent in 
one single fully occupied orientation.  
Our studies confirmed that gaining reliable information concerning the development 
of potential resistances requires the presence of an appropriate resistance model. As a 
prerequisite for the reasonable interpretation of crystal structures, these have to reflect the 
behaviour of the protein in solution best possible, which, in the present study, only applied 
to TGT(Val262Thr) and TGT(Val262Asp). Considering the potency of a compound we were 
able to show that not only the substituent, which binds into the pocket of interest, has to be 
taken into account but also the binding of the parent scaffold. In case of TGT(Val262Asp) the 
mere binding of the tricyclic core provoked disorder within the protein structure next to the 
site of mutation, which drastically decreased the binding affinity of the investigated 
inhibitors. Moreover, our studies indicate that the various 2-substituents do not show a 
large difference in their potency compared to the reference ligand 3a. If at all, the 
investigated 2-amino-lin-benzoguanines only show any significant variance with respect to 
the 2-substituent when binding to TGT(Val262Asp) (factor three to seven). However, these 
could rather be explained by their chemical properties than by differences in their 
occupancies. Obviously, those ligands, which are endowed with a positively charged 
substituent, are able to attract the Asp262 side chain carboxylate, which leads, compared to 
the uncharged hydrophobic derivatives, to a less pronounced loss of affinity. The more 
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electron-rich aromatic substituents, in contrast, experience a distinct loss in potency most 
likely due to unfavourable electrostatic interactions. 
In summary, the responses of the tested ligands upon mutations in the uridine-33 
binding pocket of TGT proved diverse results. Although the crystal structures determined in 
this study suggest closely related binding modes of the ligands to the mutated variants, no 
clear correlation with respect to their 2-substituents was found. This leads to the conclusion 
that their potency predominantly results from the binding of their tricyclic scaffold. 
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6. Addressing a New Subpocket of TGT by Elongated 2-Amino-lin-
benzoguanines 
 
6.1 Introduction 
The rational design and synthesis of potent ligands which do not only occupy the tunnel-
shaped guanine-34 recognition site but also target the neighboring subpockets has been one 
of the major goals in the development of new TGT inhibitors. To this end various 
substituents were attached to the parent tricyclic scaffold of lin-benzoguanine. As 
appropriate substitution sites the 2-position and/or the 4-position were used resulting in 
potent ligands binding in the low nanomolar range [Stengl et al., 2007; Kohler et al., 2009; 
Ritschel et al., 2009; Ritschel et al., 2009; Barandun et al., 2013]. While in the crystal 
structures of these compounds in complex with TGT the position of the 4-substituent could 
be clearly assigned to the difference electron density in nearly all cases, in no case any 
reasonable difference electron density could be spotted for the 2-substituent [Kohler et al., 
2009; Ritschel et al., 2009]. This observation led to the assumption that the attached 2-
substituents may be highly flexible even in the enzyme bound state. 
Thus, further substituents were synthesized with the goal to fix this ligand portion 
within the uracil-33 subpocket by implementing basic ring systems that were meant to 
interact with backbone groups within the pocket. Similarly, polar terminal functions were 
attached to the ring systems that were meant to experience hydrogen bonds to Asp267 and 
Lys264 located at the far end of the uracil-33 subpocket. Furthermore, combined ring 
systems were added to mimic the uracil portion of the natural substrate and to achieve high 
shape-complementary. Finally, for crystallographic reasons, various substituents containing 
the stronger diffracting sulphur were synthesized [Ritschel, 2009].    
Unfortunately, none of the chemical modifications resulted in an ordered binding 
mode of the 2-substituent visible in the crystal structure and, consequently, all previous 
studies had to consider binding geometries suggested by docking. However, also docking 
yielded multiple orientations of the attached 2-substituents, which made it impossible to 
detect the actual binding mode reliably [Ritschel, 2009; Ritschel et al., 2009]. 
 
102 6. Addressing a New Subpocket of TGT by Elongated 2-Amino-lin-benzoguanines 
In the present study we performed an excessive screening for modified crystallization 
conditions, which ultimately enabled us to trace the positions of the various 2-substituents 
[Neeb et al., 2014]. Although new interactions between the substituents and the protein 
could be identified within the ribose-34 subpocket, the originally addressed uracil-33 
subpocket remained unoccupied. Therefore, we decided to extend the substitution pattern 
of the ligand in order to occupy additional chemical space and gain affinity. Thus, we 
designed modified ligands based on a successfully crystallized ligand exhibiting a phenylethyl 
substituent in 2-position.  
Since docking results had not been able to indicate the binding poses of the 2-
substituent in previous studies, we used MD simulations as an alternative computational 
method to predict binding poses, particularly of ligands exhibiting residual mobility. 
Subsequently, we determined the crystal structures of the designed ligands in complex with 
TGT to check for the actual binding modes, and quantified their binding affinities via a 
biochemical assay. 
 
6.2 Results and Discussion 
6.2.1 Ligand Design 
As a starting point for ligand design we selected the 2-amino-lin-benzoguanine 7 decorated 
with a phenylethyl substituent (Table 6.1).  
The first criterion for this choice had been bioavailability since the class of lin-
benzoguanine-based inhibitors shows only poor permeability in PAMPA measurements 
[Barandun et al., 2012]. From a bioavialability-point-of-view the phenylethyl substitution 
bears no additional protonation site that potentially lowers the permeability through cell 
membranes at a physiological pH value as it is the case, e.g., for the basic morpholinoethyl or 
piperidinoethyl substituent.  
Secondly, we had focused on the binding affinity (𝐾𝑖) of the ligands. Remarkably, 
attachment of the phenylethyl substituent increases the potency of the parent inhibitor 
scaffold by a factor of about ten in the biochemical assay although, compared to the parent 
scaffold, no further polar interactions are provided [Ritschel et al., 2009].  
Finally, we had selected this substitution pattern from crystallographic 
considerations. Solely the phenylethyl substitution had resulted in a ligand that could be 
 
103 6. Addressing a New Subpocket of TGT by Elongated 2-Amino-lin-benzoguanines 
refined to an occupancy of 100% while all other members of the 2-amino-lin-benzoguanine 
compound class under investigation had exhibited a reduced occupancy due to scatter over 
multiple conformations.  
In the present study, we designed and synthesized, based on the parent scaffold 7, 
four different elongation motifs exhibiting diverse chemical properties (Table 6.1). 
 
Table 6.1 Chemical formulae and binding affinities of the extended 2-amino-lin-benzoguanines. 
Compound 
 
𝑲𝒊 [nM] 
7    10 ± 3
[a] 
7a 
    
  2 ± 2 
7b 
 
  7 ± 3 
7c 
     
21 ± 8 
7d 
       
30 ± 7 
  a𝐾𝑖  value according to Ritschel et al., 2009.  
 
6.2.2 MD Simulations 
MD simulations were performed using the program AMBER under NTP conditions 
(𝑝 = 1𝑏𝑎𝑟,𝑇 = 300𝐾). 7a and 7d were simulated over 10 ns. 7b and 7c were trapped in a 
local minimum over a 10 ns period. Thus, for these ligands simulation time was extended to 
100 ns. Subsequently, the ligand conformations taken up along the trajectory were 
hierarchically clustered into families with maximal RMSDs of 2 Å using the program ptraj and 
representative arche types were visually inspected. The results are listed in Table 6.2.
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Table 6.2 Results of the hierarchical clustering after the performed MD simulations. Given is the total 
simulation time, the number of observed clusters, the most populated binding poses, their percental 
occurrence, and the RMSD compared to the binding mode observed in the subsequently determined crystal 
structure. 
 time # clusters Binding poses[a] Occurrence RMSD[b] 
7a 10 ns 3 
 
63.6% 
 
63.6% 
0.4 Å 
 
0.4 Å 
7b 100 ns 8 
 
46.8% 
 
  4.3% 
4.9 Å 
 
0.4 Å 
7c 100 ns 6 
 
76.1% 
 
  2.5% 
3.5 Å 
 
1.6 Å 
7d 10 ns 8 
 
34.2% 
   
8.8% 
1.3 Å 
 
1.1 Å 
a
Color code: green = most represented, blue = most similar to crystal structure, yellow = crystal structure. 
b
RMSD values were calculated using fconv after alignment on the tricyclic scaffold without hydrogens [Neudert 
and Klebe, 2011]. 
 
All simulations were able to find a binding pose of the 2-substituent similar to the 
one observed in the crystal structure within an RMSD between 0.4 Å and 1.6 Å. Thereby, the 
pose of 7a matched particularly well (RMSD = 0.4 Å) and, moreover, was the most 
representative in terms of percental occurrence, closely similar to the occupancy found by 
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X-ray crystallography (63.6% vs. 74%). For the remaining ligands 7b, 7c and 7d different 
binding poses were suggested as the most populated orientations deviating between 1.3 Å 
to 4.9 Å compared to those found in the subsequently determined crystal structures. 
 
6.2.3 Affinity Data 
Binding affinities were obtained via a radioactive enzyme assay. Thereby, the incorporation 
of [8-3H]guanine into tRNATyr (ECY2) at position G34 at pH 7.3 and 37°C was measured by 
liquid scintillation counting. Inhibition constants were calculated by the comparison of the 
initial velocities of the base-exchange reaction in absence and presence of the ligand. 
All analyzed ligands show a binding affinity in the low one- to two-digit nanomolar 
range (Table 6.1). Reference ligand 7 exhibits a binding affinity of about 10 nM [Ritschel et 
al., 2009]. Interestingly, the attachment of the methylester in 7a is able to achieve a 
significant enhancement in binding affinity by a factor of five. For 7b further decoration of 
the phenyl moiety does not yield a significant change in the 𝐾𝑖  value, although its ligand 
efficiency is decreased by the attachment of the hydroxyethyl group. In contrast, 7c and 7d 
show a slightly decreased potency. Compared to the unsubstituted phenylethyl lead 
structure the value for the derivative 7c with an attached nitrile group is reduced about 
twofold, while the decoration with a carboxylate group in 7d results in a loss by a factor of 
three. Obviously, the desolvation costs especially of the attached polar functional group of 
7d are larger than the actual gain in affinity due to newly formed interactions. 
 
6.2.4 Crystal Structure Analysis 
For the investigated ligands crystal structures were determined with a resolution of 1.14 – 
1.40 Å. In all structures the fully occupied lin-benzoguanine scaffold is well-defined in the 
difference electron density (Figure 6.1). It is placed into the guanine-34 recognition pocket 
forming a π-stacking between the side chains of Tyr106 and Met260 and establishing the 
same interactions to neighboured amino acids as previously described [Stengl et al., 2007; 
Kohler et al., 2009; Ritschel et al., 2009; Ritschel et al., 2009; Barandun et al., 2013]. 
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Figure 6.1 Binding modes of the analyzed lin-benzoguanines 7 (A), 7a (B), 7b (C), 7c (D) and 7d (E) as well as a 
tRNA analogue (F). The protein surface is shown in white. The ligands and interacting residues are displayed as 
sticks (nitrogen = blue, oxygen = red, phosphorus = orange). Hydrogen bonds are visualized as dashes. The 
 𝐹𝑜  −  𝐹𝑐   difference electron density is illustrated at a sigma-level of σ = 2.5 as green meshes. For clarity the 
π-stacking residues Tyr106 and Met260 as well as water molecules are not shown. A – E) The tricyclic parent 
scaffold is well defined in the difference electron density experiencing hydrogen bonds to residues Asp102, 
Asp156, Gln203, Gly230, Leu231 and Ala232 within the guanine-34 recognition site. Depending on its 
substitution pattern, the phenylethyl substituent in 2-position adopts either an orientation within the ribose-33 
subpocket or is rotated out of it facing the backbone of Val233 and Gly234. Only 7d (E) forms additional polar 
interactions to the guanidinium head group of Arg286. While in the complex structures TGT∙7, TGT∙7a and 
TGT∙7d the side chain of Arg286 closes the ribose-32 subpocket, 7b and 7c are able to bind to that site turning 
the side chain of Arg286 apart. F) Binding of tRNA induces the same conformation of Arg286 as found in the 
complexes TGT∙7b and TGT∙7c opening the ribose-32 subpocket (blue). Ribose-32 interacts with the side chain 
of Arg286 via two charge-assisted hydrogen bonds. 
 
The  𝐹𝑜  −  𝐹𝑐    difference electron density fully defines the binding mode of 7 (Figure 
6.1A). Yet, increased B factors of the 2-substituent compared to the tricyclic parent scaffold 
are observed (𝐵𝑝𝑕𝑒𝑛𝑦𝑙 = 31.5 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 17.2 Å
2). The phenylethyl substituent 
occupies the ribose-33 subpocket adopting an all-trans conformation. Weak hydrophobic 
interactions are experienced between the side chains of Ala232, Cys281, Val282, Leu283 and 
the 2-substituent, which covers in lid-like fashion the hydrophobic residues in this pocket. 
The 2-substitutent of 7a refines to a reduced occupancy of 75% indicating higher 
flexibility of this moiety compared to that observed for 7 (𝐵𝑝𝑕𝑒𝑛𝑦𝑙 = 28.9 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 =
14.6 Å2). The C-CH2-CH2-NH linker adopts a gauche conformation with a torsion angle of -
61.3°, which, most likely, is energetically less favourable (Figure 6.1B). Contrary to the 
gauche-isomer of the substituent in 4a (Chapter 4), the one in 7a is oriented out of the 
ribose-33 subpocket facing the backbone of Val233 and Gly234. Obviously, an extended all-
trans conformation of this substituent would lead to a clash with Arg286 and, therefore, is 
not adopted. Instead, the substituent is forced to fold back into the described conformation 
moving the ligand out of the ribose-33 pocket. Weak van-der-Waals interactions are formed 
to the side chain of Ala232. Additionally, an expanded hydrogen-bond contact between the 
backbone NH group of Gly234 and the carbonyl oxygen of the ester group in 7a is formed 
(3.51 Å). Remarkably, such a folded conformation is observed for an attached 2-substituent 
for the first time.  
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For 7b two data sets showing different results with respect to the substituent’s 
binding mode were obtained (Figure 6.1C). The first structure displays the 2-substituent in 
two conformations with a summed overall occupancy of 100%. In both conformations the 
substituent is not sufficiently resolved in the difference electron density due to the residual 
mobility of that part of the molecule resulting in an ill-defined difference electron density for 
the hydroxyethly moiety. In the first conformer, the C-CH2-CH2-NH linker adopts an all-trans 
conformation with an occupancy of 56% and enhanced residual mobility (𝐵𝑝𝑕𝑒𝑛𝑦𝑙 = 20.3 Å
2 
vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 11.9 Å
2). The adopted orientation is similar to that observed for 7. In the 
second conformer, the linker exhibits gauche conformation resulting in an analogous binding 
mode as observed for 7a (𝐵𝑝𝑕𝑒𝑛𝑦𝑙 = 19.8 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 11.9 Å
2). In this orientation the 
substituent refines to 44%. In a second independently collected data set using another 
crystal the whole ligand is visible in the difference electron density in the all-trans 
conformation only, although a slightly reduced occupancy for the 2-substituent of 87% is 
refined. With increasing distance from the parent scaffold the difference electron density 
becomes more smeared out and, accordingly, the assigned temperature factors increase 
(𝐵𝑠𝑢𝑏𝑠𝑡𝑖𝑡𝑢𝑒𝑛𝑡 = 26.4 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 12.4 Å
2). The position of the hydroxyethly portion can 
hardly be assigned to the density. Interestingly, the side chain of Arg286 is shifted out of the 
ribose-33 subpocket presumably to create sufficient space to accommodate the 
hydroxyethyl moiety of the ligand now extending its binding towards the ribose-32 
subpocket. This region of the protein has never been occupied by synthetic ligands so far. 
Comparably, also the 2-substituent of 7c adopts an all-trans conformation 
penetrating into the ribose-32 subpocket (Figure 6.1D). The whole ligand is fully occupied, 
although its 2-substituent shows increased temperature factors compared to the parent 
scaffold (𝐵𝑠𝑢𝑏𝑠𝑡𝑖𝑡𝑢𝑒𝑛𝑡 = 17.4 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 9.8 Å
2). The terminal nitrile group does not 
experience specific interactions with any of the amino acid residues found in the ribose-32 
subpocket. Only a single water molecule is located in close distance (3.0 Å) to the nitrile 
functional group. The side chain of Arg286 has to change its orientation and is shifted out of 
the ribose-33 subpocket adopting the previously found conformation.  
The binding mode of 7d is fully defined in the  𝐹𝑜  −  𝐹𝑐   difference electron density  
(Figure 6.1E). The C-CH2-CH2-NH linker adopts an all-trans conformation reaching into the 
ribose-33 subpocket. Under the applied pH conditions the terminal carboxylate group is 
most likely deprotonated. In this state, it forms a bidentate salt-bridge to the guanidinium 
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moiety of Arg286. In order to do so, the polar group of Arg286 bends towards the ribose-32 
subpocket. Despite of the strong electrostatic interaction between the carboxylate group of 
the ligand and the side chain of Arg286, the 2-substituent exhibits B factors, which are 
similarly increased as those of the remaining derivatives investigated in this study 
(𝐵𝑠𝑢𝑏𝑠𝑡𝑖𝑡𝑢𝑒𝑛𝑡 = 21.1 Å
2 vs. 𝐵𝑡𝑟𝑖𝑐𝑦𝑐𝑙𝑒 = 11.1 Å
2).  
 
6.3 Conclusions 
In the present chapter the binding modes of five extended 2-amino-lin-benzoguanines were 
predicted using MD simulations as in silico design technique. Subsequent to synthesis their 
binding modes were determined experimentally by crystal structure analyses whereby 
modified crystallisation conditions were developed. Previous studies based on docking 
predictions and crystal structure analyses using soaking protocols had failed to actually 
characterize the binding poses of the attached 2-substituents [Ritschel, 2009; Ritschel et al., 
2009]. In all cases enhanced disorder and scatter over multiple orientations of the 
substituent was suggested. Therefore, we applied molecular dynamic simulations as this 
method is better suited to explore the accessible configuration space of the 2-substituent. In 
one example the MD simulations predict the binding mode, which was subsequently found 
via X-ray crystallography, well. Also in the other three cases binding modes, which are similar 
to those found in the crystal structures, are predicted by MD. However, the attributed 
populations of the different configurations do not match with the refined occupancies in the 
respective crystal structures.  
The subsequently determined crystal structures of the four TGT-ligand complexes, 
which were based on a co-crystallization protocol, provide a more detailed insight into the 
binding mode of the extended 2-substituents. While in previous studies our design 
hypotheses were based on in silico docking performed to interpret the ill-defined difference 
electron density in the area where the 2-substituent would be expected, reasonable 
 𝐹𝑜  −  𝐹𝑐   density is observed for nearly all ligands in the analyses presented in this 
contribution. The crystal structures indicate different conformations of the attached 2-
substituents, which will either reach into the ribose-33 subpocket, if the C-CH2-CH2-NH linker 
adopts an all-trans conformation, or out of the ribose-33 pocket facing the backbone of 
Val233 and Gly234, if the linker folds into a gauche orientation. Surprisingly, the terminal 
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groups of 7b and 7c are able to force Arg286 into a conformation pointing off the ribose-34 
subpocket. The latter residue acts as a kind of flexible gatekeeper, which controls access to 
the ribose-32 subpocket. In a conformation oriented out of the ribose-33 pocket, it adopts a 
position similarly found in the structure with the natural RNA substrate (Figure 6.1F). In this 
geometry the pocket is opened towards the uridine/cytosine-32 recognition site, a pocket, 
which previously had never been addressed by any of our synthetic ligands. Remarkably, the 
displacement of the flexible side chain of Arg286 does not result in a significant affinity loss.  
The deduced information concerning the binding modes of the extended 2-
substituent opens the perspective for a new strategy to design more potent ligands forming 
new interactions within the nucleoside-32 subpocket. This region offers polar side chains to 
be addressed similarly as by the ribose-32 portion of the natural substrate tRNA. 
Two messages can be learnt from this contribution. First of all, the visibility of 
substituents in the difference electron density may depend on the applied crystallization 
protocol. In consequence, not every ill-defined electron density inevitably indicates the 
residual mobility or the scatter of a substituent in the protein-bound state. It may instead 
result from the particular protein conformation preformed during crystallization. This 
preformed conformation may prevent the mutual conformational adaptation of the protein 
and the ligand and thus, prevent the ligand from adopting a defined and, from an enthalpic 
point of view, favorable conformation when bound to the crystallized protein. Accordingly, it 
is of utmost importance to distinguish if soaking or co-crystallization protocols were applied 
when discussing the results of structural studies including protein-bound ligands. As a 
consequence, the direct comparison of protein-ligand complex structures must be deemed 
problematic, if the considered crystals were not produced via the same crystallization 
protocol. 
The second message concerns the attachment of polar groups at the terminal end of 
ligands. In the present compound series no dramatic change in binding affinity was 
experienced in comparison to the original phenylethyl reference substituent, although in the 
case of 7d even a novel salt bridge contact to Arg286 is established. Nonetheless, this ligand, 
which is endowed with a carboxylate group, looses affinity. This may, at least in part, be due 
to the high desolvation costs for such a charged functional group. Definitely, this example 
underlines that a solvent-exposed salt-bridge as the one formed to Arg286 at the rim of the 
ribose-33 pocket has hardly any enhancing effect on binding affinity. Such an interaction will 
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only improve binding affinity strongly, if it is formed in a deeply buried environment well-
shielded from the surrounding water. Only there a charge-assisted contact is strongly 
enhanced by the local environment of low dielectricity. This has to be well regarded if 
putative interaction sites in flat solvent-exposed binding pockets are thought of as potential 
hot-spots to be addressed in a drug design study. 
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7.1 Introduction  
Fragment-based lead discovery (FBLD) has been well established as an alternative to high-
throughput screening (HTS) in the field of lead finding to develop novel drug-like candidates. 
Prerequisite for the success of such approaches was the introduction of sensitive biophysical 
methods such as surface plasmon resonance (SPR) [Perspicace et al., 2009; Navratilova and 
Hopkins, 2010] or NMR [Fejzo et al., 1999; Dalvit et al., 2002], which are able to detect weak 
ligand-protein binding. FBLD comprises several steps starting with the design of an 
appropriate fragment library, followed by in-vitro testing of fragments detected in 
biophysical prescreening by X-ray crystallography and reliable affinity measurements. In a 
subsequent phase promising fragments have to be evolved to putative lead structures either 
by fragment growing, linking or merging. This strategy is accompanied by multiple steps of 
optimization consisting of modelling, structure determination and assay measurements.   
Although HTS focuses on the testing of a large magnitude of compounds in the range 
of 106, this method faces a number of problems with respect to subsequent optimization, 
such as too high lipophilicity or poor solubility of the initial hits leading to false positives in 
the primary HTS assays [Scott et al., 2012]. Also discovered hits do not necessarily fill binding 
pockets of the target protein in an optimal manner as the initial test compounds are rather 
large with respect to their molecular weights ranging from 300 to 500 Da [Lipinski et al., 
2001]. Even though discovered hits might show low-micromolar binding, their suitability as 
starting point for the optimization is difficult to estimate since the contribution of individual 
interactions to binding affinity remains virtually undefined. 
Optimal compound selection for FBLD was suggested to follow the Astex Rule of 
Three, which means that the molecular weight should be below 300 Da, not more than three 
hydrogen bond acceptor or donor functionalities should be present and the calculated logP 
value has to be lower than three [Congreve et al., 2003]. Attributed to the smaller size of 
fragments, test libraries usually comprise only 103 members and still are assumed to cover 
the chemical space sufficiently well, much better than HTS collections can actually achieve 
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[Makara, 2007]. Moreover, the quality of the formed interactions between the small and 
often optimally fitting fragments and the target’s amino acids is better and more efficient 
than with HTS compounds since a weak binding fragment has to establish binding via fewer 
interactions.   
To better relate the potency of a compound to its actual size ligand efficiency (LE) 
measures have been suggested, which determine the ratio between Gibbs free energy of 
binding (−Δ𝐺 (𝑘𝑐𝑎𝑙 𝑚𝑜𝑙−1)) and the number of non-hydrogen atoms of the compound 
[Kuntz et al., 1999]. Thus, efficient ligands will only be attributed to high affinity binding, if 
they simultaneously exhibit low molecular weight. More recently, the concept of group 
efficiency (GE) has been proposed to estimate the contribution of an added functional group 
to the free energy during optimization [Verdonk and Rees, 2008]. Group efficiency defines 
the gain in affinity (𝑘𝑐𝑎𝑙 𝑚𝑜𝑙−1) compared to the molecule lacking the functional group 
under investigation related to the number of added non-hydrogen atoms.   
The optimization of fragment and HTS hits is illustrated in Figure 7.1. The goal to hit 
by putative drug candidates is an area of high LE with a molecular weight not exceeding 
500 Da. HTS hits start at lower LE than fragments as they exhibit already a molecular weight 
approaching the 500 Da limit. Therefore, LE of HTS hits has to be increased while there is 
only little room to simultaneously introduce new functional groups, which augment 
molecular weight. Thus, interactions experienced by the HTS hits have to be replaced by 
alternative ones leading to stronger interactions whereby even a reduction in ligand size 
might be necessary. In contrast, fragment hits exhibit low LE but they offer multiple options 
to attach additional groups to achieve more contacts with the protein and improve LE. 
Recently, the 6-amino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-ones (lin-benzo-
guanines) and 1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-ones (lin-benzohypoxanthines) 
were introduced as potent scaffolds inhibiting the tRNA-modifying enzyme tRNA-guanine 
transglycosylase (TGT) from Zymomonas mobilis [Stengl et al., 2007; Barandun et al., 2012]. 
Substituents attached at position 2 and 4 of the parent scaffolds lead to binding affinities in 
the nanomolar range [Hörtner et al., 2007; Kohler et al., 2009]. Despite their high potency, 
lin-benzopurines do not exhibit ideal properties for good in vivo activity as parallel artificial 
membrane permeability assay (PAMPA) measurements suggest that they may hardly be 
transported over biomembranes [Barandun et al., 2012]. Unfortunately, the most promising 
compounds only accumulate within the membrane but do not succeed in transportation.  
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Figure 7.1 Comparison of fragment based lead discovery (FBLD) and high throughput screening (HTS) 
approaches modified according to Scott et al., 2012. The molecular weight of putative hits is plotted against 
their potency. The right corner represents the low LE area, the left corner the high LE area. Fragment hits 
(orange) exhibit low molecular weight as well as low binding affinity. Upon optimization fragments are 
iteratively grown, linked or merged to a putative drug candidate (blue) of higher molecular weight settled in 
the Lipinski area between 300 and 500 Da. By this procedure potency is gained by attaching additional 
functional groups and high LE is reached. Contrary, HTS hits (red) show already a high molecular weight, which 
makes the introduction of new functional groups difficult. Therefore, existing functionalities have to be 
replaced by ones of higher quality. Even a reduction of the molecule’s size might be necessary.  
 
Therefore, the search for novel scaffolds with improved bioavailability is of utmost 
importance. In the present study we embarked onto a fragment-based approach aimed at 
the reduction of the tricyclic ring system of the lin-benzopurines. Starting point for the 
design was a fragment suggested by modelling, which consists of a 5-azacytosine core. In its 
structural and physicochemical properties it exhibits similarity with the natural substrate 
guanine and bears a directly linked phenyl ring. We focused on the optimization of this initial 
fragment by attaching additional groups in order to improve its LE. 
 
7.2 Results and Discussion 
7.2.1 Ligand Design 
Z. mobilis TGT exerts a nucleobase exchange of guanine by a modified base in the wobble 
position G34 of the tRNA-anticodon loop. Thereby, the molecular recognition of the 
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1
5
3
substrate is established by the amino acid side chains of Asp102, Asp156, Gln203 and the 
backbone NH of Gly230. Additionally, the nucleobase is sandwiched in π-stacking fashion 
between Tyr106 and Met260 located above and below the binding site [Xie et al., 2003; 
Tidten et al., 2007].  
 
Table 7.1 Chemical formulae, calculated cLog P values, corresponding 𝐾𝑖  values to Z. mobilis TGT determined 
by the radioactive enzyme assay and ligand efficiencies of the 5-azacytosine analogues.  
  cLog P[a] 𝑲𝒊 [µM] LE 
 
8 0.40 465 ± 139 0.32 
 
9 0.25 346 ± 210 0.30 
 
10 -0.74 107 ± 231 0.34 
 
11 1.39 4 ± 222 0.41 
 
12 0.24 1476 ± 648 0.24 
a
cLog P values were calculated using the Properties Viewer online software on chemicalize.org. 
 
The 5-azacytosine core is deduced from the natural substrate guanine. During design 
it was assumed to establish similar interactions to Asp102, Asp156, Gln203 and Gly230. The 
attached phenyl ring is meant to enhance binding affinity by π-stacking interactions to 
Tyr106 and Met260. In addition, it serves as an anchor point to decorate the novel scaffold 
by easily accessible chemistry with substituents in 2- and 4-position. These substituents were 
planned to reach into the hydrophobic ribose-34 subpocket flanked by Val45, Leu68, Leu100 
and Val282 and the solvent-exposed uridine-33 cavity made up of various backbone atoms 
and sealed at the far end by residues Lys264 and Asp267.  
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In addition to the described scaffold, also ligands exhibiting small decorations at the 
phenyl moiety were synthesized in order to search for promising substituents as starting 
points for fragment growing. These included a nitrile, an aminomethyl and a methoxy group 
in meta position of the phenyl ring as well as an additional fused aromatic ring leading to a 
naphthyl substituent. Details concerning the physicochemical properties of ligands 8 – 12 are 
listed in Table 7.1.   
 
7.2.2 Inhibition Mode and Affinity Data 
The blocking of the function of the target protein TGT can follow, depending on the size of 
the active-site ligand, an inhibition mechanism which is competitive or non-competitive with 
simultaneous binding of the tRNA. Therefore, prior to affinity measurements the inhibition 
mode was determined by a trapping experiment [Xie et al., 2003]. The results are visualized 
in Figure 7.2A. All investigated ligands show only one band attributed to the mass of TGT 
with the bound ligand at approximately 43 kDa. This clearly indicates that a competitive 
binding mode is given not allowing the tRNA molecule to bind to the protein-inhibitor-
complex. Obviously, the tRNA is sterically blocked from simultaneous binding to the protein 
likely due to the attached phenyl ring at the basic scaffold (Figure 7.2B).  
Binding affinities were determined via a radioactive enzyme assay. Thereby, the 
incorporation of [8-3H]guanine into tRNATyr (ECY2) at position G34 at pH 7.3 and 37°C is 
measured by liquid scintillation counting [Stengl et al., 2005]. Inhibition constants were 
calculated by the comparison of the initial velocities of the base-exchange reaction in the 
absence and presence of the inhibitor. 
The phenyl derivative 8 shows an inhibitory constant of 465 µM. Compared to the lin-
benzoguanine scaffold affinity drops by a factor of approximately 100 [Hörtner et al., 2007]. 
The substitution of the phenyl ring in meta position by a nitrile group in 9 does not result in a 
noticeable change of the 𝐾𝑖  value within the range of error, yielding a value of 346 µM. By 
introducing an aminomethyl group (10) an approximately 4.3-fold increase in binding 
strength could be measured, resulting in a 𝐾𝑖  value of 107 µM.  
Unexpectedly, the naphthyl substituent of 11 improves affinity significantly to the 
one-digit micromolar range to 4 µM, which corresponds to a more than 100-fold affinity 
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increase. In case of GABAA antagonists a similar affinity gain has been observed by increasing 
the hydrophobicity of the ligand from a phenyl to a naphthyl moiety [Frølund et al., 2002].  
Contrary to the other ligands, compound 12 changes the potency to the worse by a 
factor of 3.2 compared to the parent scaffold 8. Its 𝐾𝑖  amounts to 1476 µM.   
 
 
Figure 7.2 Inhibition mode of 5-azacytosine type ligands. A) Trapping experiment performed by SDS-PAGE using 
a mixture of TGT, tRNA and the different 5-azacytosines. M, size marker; DAQ, 2,6-diamino-3H-quinazolin-4-
one. The reference band 1 as well as the samples 2 – 6 containing 5-azacytosine based ligands show only one 
band indicating a competitive inhibition mode. The reference sample  containing DAQ as an uncompetitve 
inhibitor, which stabilizes the covalently linked TGT∙tRNA complex, exhibits an additional retarded band (lane 
7). B) Superimposition of the proposed binding mode of 8 (cyan) and the tRNA stem loop (green, PDB ID: 
1Q2R). The ligands are shown in stick representation. Oxygen atoms are colored in red, nitrogen atoms in blue 
and phosphate atoms in orange. The surface of the protein is represented in gray. For clarity, the surface of 
Tyr106 and Cys158 is not shown. The inhibition mode is confirmed by the proposed binding mode of 8. The 
phenyl ring in 6-position and ribose-34 of the tRNA are in too close proximity (2 Å) to allow the binding of 8 to 
the guanine-34 recognition site of the enzyme-tRNA intermediate.  
 
7.2.3 Putative Agglomeration Behaviour of the Naphthyl Derivative 11 
Hydrophobic ligands tend to agglomerate above a critical agglomeration concentration 
(CAC), which is typically found in the micromolar range [McGovern and Shoichet, 2003; Coan 
and Shoichet, 2008; Doak et al., 2010]. The agglomerate binds to the protein surface in 
unspecific manner and suggests false positive signals [Feng and Shoichet, 2006; Feng et al., 
2007; Thorne et al., 2010]. According to Table 7.1 11 exhibits the lowest solubility in aqueous 
solution in agreement with the cLog P value of 1.39. Therefore, the question arises, whether 
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the high potency of 11 is due to an unspecific binding event. To rule out this eventuality the 
following experiments were performed:  
Dynamic light scattering (DLS) measurements were carried out to identify potential 
aggregate formation [Feng et al., 2005]. A ligand solution was analyzed under the same 
conditions as applied in the assay measurements (200 mM Hepes pH 7.3, 20 mM MgCl2 and 
0.037% (v/v) Tween 20 at 37°C).  
 
 
Figure 7.3 DLS measurements. A) Boxplot showing the count rates of the analyzed samples in kHz. The gray box 
represents the interquartile range (IQR) with its borders giving the first (Q1) and third quartile (Q3) of the 
measurements. The median is represented by a gray bar within the box. The average count rate is visualized by 
a circle; the red color indicates that the signal exceeds the 10-fold of the blank value. The borders of the 
dashed lines give Q1 – 1.5 IQR and Q3 – 1.5 IQR, respectively. While 11 shows a count rate in the range of the 
blank measurement (24 kHz vs. 27 kHz), clotrimazole exhibits an over 100-fold increased count rate of 3020 
kHz. B) Autocorrelation functions of the samples plotted against time. 11 shows a similar autocorrelation 
function as the measurement of the sole buffer. Clotrimazole exhibits a sigmoidal autocorrelation function 
indicating its behaviour as strong aggregate former.  
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The ligand concentration was adjusted to 20 µM corresponding to the highest 
concentration of the dilution series in the assay. Samples were measured iteratively every 
ten minutes over a period of one hour and compared to the data observed by the strong 
aggregate former clotrimazole [Seidler et al., 2003].  
According to theory, the autocorrelation function of a DLS measurement shows a 
sigmoidal curve in case of an agglomeration event accompanied by the significant exceeding 
of the count rate compared to blank measurements, which displays the number of photons 
detected per second and therefore, serves as an indicator for signal strength and sample 
quality.  
Figure 7.3 summarizes the results of the analyzed compounds. The average count 
rates are shown in Figure 7.3A. While 11 exhibits an average count rate in the range of the 
blank measurement (24 kHz vs. 27 kHz), clotrimazole exhibits a signal height which is 
drastically increased by a factor about 100 (3020 kHz). Furthermore, only the autocorrelation 
function of clotrimazole exhibits a sigmoidal shape (Figure 7.3B). Therefore, DLS experiments 
suggest that 11 does not form aggregates in solution over the period of an assay 
measurement at the chosen concentration.    
Furthermore, the binding of 11 to an alternative protein was tested in ITC 
measurements according to an application note suggested by the manufacturer (28-9815-
96). Thereby, the ligand was titrated either to the target protein TGT or bovine serum 
albumin (BSA), respectively.  
BSA is commonly used in biochemical assays to reduce the tendency for 
agglomeration [McGovern et al., 2002]. The mechanism of this interference is not yet fully 
understood. Titration of 11 to BSA should only yield a binding isotherm if the ligand 
agglomerates in solution and thus, unspecifically mounts to the BSA surface. 
The obtained thermograms are shown in Figure 7.4. As already indicated by DLS also 
the ITC measurements support the assumption that no aggregate formation has warped the 
assay results: Only in case of the titration of 11 to TGT a binding isotherm is observed (Figure 
7.4A), while the addition to BSA yields only heat signals of dilution (Figure 7.4B). The 𝐾𝑑  
value of 11 determined by ITC averages to 7 µM, which is in good accordance with the 
results of the [8-3H]guanine assay. 
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Figure 7.4 Thermograms for the binding of 11 to TGT (A) and BSA (B). Titrating 11 to its target protein TGT 
yields an endothermic binding isotherm. Due to the low affinity of the ligand it does not exhibit a sigmoidal 
shape. The resulting 𝐾𝑑  value is comparable to that observed in the enzyme assay. However, the reaction 
shows an unreasonable binding stoichiometry. Therefore, a second experiment revealing potentially unspecific 
binding to the protein surfaces was performed by titrating 11 in a BSA solution. Contrary to A only small peaks 
of dilution could be observed during this titration. Details concerning the setup of the measurements are listed 
in the experimental section. 
 
7.2.4 Crystal Structure Analysis 
A crystal structure of TGT in complex with 8 was determined at a resolution of 1.62 Å. The 6-
phenyl-5-azacytosine scaffold is well defined in the  𝐹𝑜  −  𝐹𝑐   difference electron density 
(Figure 7.5). Most likely, due to its low solubility, the ligand is not fully populated in the 
guanine recognition site (84% occupancy). The ligand skeleton intercalates similar to the 
natural substrate guanine between Tyr106 and Met260 (Figure 7.6). Additionally, it forms 
hydrogen bonds to the side chains of Asp102, Asp156, Gln203 and the backbone NH of 
Gly230. A further interaction is mediated via a water molecule between N1 of the 5-
azacytosine moiety and the backbone NH of Ala232. As a donor function is missing in this 
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area no backbone flip is induced as in case of preQ1 or lin-benzopurines [Stengl et al., 2007; 
Barandun et al., 2012].  
 
 
Figure 7.5 Binding mode of 8 within the guanine-34 recognition site (PDB ID: 4Q4M). The protein is shown as a 
cartoon, interacting residues as well as 8 in stick representation (carbon = cyan, oxygen = red, nitrogen = blue). 
Water molecules are represented as spheres. Hydrogen bonds are visualized as dashed lines with their 
distances given in Å. The 6-phenyl-5-azacytosine scaffold is contoured at 3σ in the  𝐹𝑜 −  𝐹𝑐   density map 
(green) of the structural model refined after removing the ligand. Compound 8 adopts a similar binding mode 
as the natural substrate guanine with an occupancy of 84%. Several hydrogen bonds are formed to the side 
chains of Asp102, Asp156, Gln203 and the backbone NH group of Gly230. In addition, the ligand interacts with 
the backbone of Gly230, Leu231 and Ala232 via a close-by water molecule. Contrary to guanine, 8 does not 
show a fully planar binding geometry and the phenyl moiety exhibits a torsion angle Φ of about 35° with 
respect to a plane through the heterocycle. Furthermore, the side chain of Asp102 adopts two different 
positions: In its ligand-facing orientation it is able to interact with the exocyclic amino function of the 5-
azacytosine ring via one hydrogen bond (cyan, 42%). The second orientation is similar to that in TGT apo 
structures forming hydrogen bonds to the side chain of Asn70 and the backbone of Thr71 (teal, 58%). The 
water molecule encircled in red will only be present, if Asp102 is rotated out of the pocket. 
 
Unlike previously known substrates and ligands, the ring system of 8 does not adopt 
a planar geometry at the binding site. The phenyl ring is rotated approximately 35° out of 
plane of the heterocycle (Figure 7.5). Furthermore, the hydrogen bond formed to Asp102 
suggests suboptimal interaction geometry. In the binary complex of TGT and guanine (PDB 
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ID: 2PWU) the substrate shows an occupancy of 75% [Tidten et al., 2007]. Asp102 is present 
in two conformations, one facing the ligand by establishing two parallel hydrogen bonds to 
N3 and the exocyclic amino function of guanine (75%). The second conformer (25%) is 
rotated out of the pocket interacting with the side chain of Asn70 and the backbone NH of 
Thr71, an orientation also found in the apo enzyme [Brenk et al., 2003]. The structure 
indicates that the rotation of Asp102 into the binding pocket is ligand-induced and correlates 
with the observed occupancy of the compound.  
 
 
Figure 7.6 2D ligand interaction diagram of 8 and guanine generated with MOE. The two ligands exhibit similar 
interaction patterns within the guanine-34 recognition site forming hydrogen bonds to the side chains of 
Asp102, Asp156, Gln203 and the backbone NH group of Gly230. The water mediated interaction between the 
backbone NH group of Ala232 and N1 of the 5-azacytosine 8 is performed by N7 in case of guanine as the 
binding partner. 
 
Although 8 is occupied to 84%, the higher populated conformation A of Asp102 is 
rotated out of the guanine recognition site (58%). In that case, a close-by water molecule is 
observed adjacent to the aspartate side chain (Figure 7.5). The other conformer (42%) of 
Asp102 orients towards the ligand and the above-mentioned water molecule is displaced. 
However, the side chain of Asp102 adopts a conformation orthogonal to a best plane 
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through 8. Only one H-bond is formed to the carboxylate oxygens via the exocyclic amino 
group of the 5-azacytosine. Due to the one-sided fixation of the its scaffold, 8 exhibits a 
rather loose binding with an average B-factor of 26.4 Å2 showing its highest flexibility at the 
phenyl portion.  
For complex TGT∙9 a maximum resolution of 1.79 Å was achieved. The binding mode 
observed for 8 is also found for 9 (Figure 7.7A). The occupancy of the common 6-phenyl-5-
azacytosine core amounts to 84%. Unfortunately, sufficient difference electron density for 
the nitrile substituent in meta position is lacking. A small bulge next to the phenyl ring 
suggests that the nitrile moiety points towards the ribose-33 subpocket (Figure 7.7B).  
 
 
Figure 7.7 Binding mode of 9. The same options for visualization have been applied as in Figure 7.5. A) The 
binding mode of the 6-phenyl-5-azacytosine scaffold of 8 is confirmed by 9. The heterocycle is clearly defined 
by the  𝐹𝑜 −  𝐹𝑐   density map (green) showing an occupancy of 84%. However, adequate difference electron 
density is missing for the attached nitrile substituent at the phenyl ring. B) Close-up of the phenyl moiety and 
its nitrile substituent in meta position. A small bulge of the difference electron density suggests the nitrile 
functionality to point towards the adjacent ribose-33 subpocket. 
 
Again, Asp102 adopts the previously described conformations. The occupancy of the 
side chain conformer facing the ligand amounts to 46%. Thus, the orientation of Asp102 
resembling the one, which is found in the apo enzyme, also represents the predominant 
conformation in this complex. Similarly, the ligand shows elevated B-factors of 36.3 Å2. 
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The binary complex of TGT∙10 shows a resolution of 1.76 Å. The 6-phenyl-5-
azacytosine core refines to 88% occupancy. The position of the aminomethyl substitution 
cannot be clearly assigned to the  𝐹𝑜  −  𝐹𝑐  electron density due to an enhanced residual 
flexibility of this ligand portion with an average B-factor of 48.3 Å2. The conformer of Asp102 
oriented by a monodentate H-bond towards the 5-azacytosine moiety represents 46% 
population. 
Data sets for TGT∙11 and TGT∙12 were collected with a resolution of 1.35 Å and 
1.74 Å, respectively, including crystals grown under varying co-crystallization conditions. 
Unexpectedly, difference electron density neither for the 5-azaytosine core nor for the 
substituted phenyl ring could be observed, probably due to low solubility (compound 11) or 
rather reduced potency (compound 12). 
 
7.2.5 MD Simulation 
To investigate the properties of the 6-phenyl-5-azacytosine scaffold within the guanine 
recognition site and to get an idea about its flexibility considering the meta substituent, a 
short molecular dynamic (MD) simulation of 10 ns was carried out for the complex TGT∙9.  
 
 
Figure 7.8 Results of the MD simulation performed for 9. A) Dialplot tracing the movement of the phenyl 
moiety in 6-position along the trajectory. The radius of the plot represents the time scale of the simulation, the 
circumference the value for the calculated dihedral. The plotted dihedral ranges between -154.9° and 144.9°. 
B) Visualisation of the distance, which is covered by the nitrogen of the nitrile group due to the variance in the 
torsion angle marked in red. ∆𝑑 is calculated as segment along the circular arc.  
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The trajectory was analyzed by means of the torsion angle formed between N3 and 
C6 of the 5-azacytosine moiety and C1 and C2 of the attached phenyl ring (Figure 7.8B, red). 
The results are visualized in terms of a dialplot in Figure 7.8A.  
The torsion angle oscillates by about 60° between extrema of 144.9° and -154.9° with 
an average value of 171.2°. This torsion oscillation translates into a wiggling motion of the 
nitrile group swinging along a circular arc (Figure 7.8B). Overall, a maximum scatter of 3.8 Å 
is covered by the carbon and 4.9 Å by the nitrogen atom of the nitrile group explaining why 
no properly defined density is visible for this part of the molecule.       
 
7.2.6 Docking Solutions 
The crystal structures of the various TGT-ligand complexes do not provide a satisfactory 
explanation for the affinity differences of the inhibitors 8 – 12. To obtain additional insight 
into possible binding modes, 9 – 12 were docked into the guanine recognition site. The 
suggested binding modes are summarized in Figure 7.9.  
 
 
Figure 7.9 Docking solutions of ligands 9 – 12 generated by GOLD. The protein surface is shown in gray except 
for Tyr106 and Cys158, which are omitted from the plot for clarity. The ligands are visualized in stick 
representation (oxygen = red, nitrogen = blue).  
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The scaffold intercalates between Tyr106 and Met260 and hydrogen bonds are 
formed to the side chains of Asp102, Asp156, Gln203 as well as the backbone NH of Gly230.  
As expected, the docked binding mode of 9 suggests the nitrile substitution to be oriented 
towards the uracil-33-subpocket without forming any directional interaction. The torsion 
angle between the 5-azacytosine and the phenyl ring averages to 50°. However, also the 
alternative orientation of the nitrile group towards the ribose-34 pocket is observed on the 
less well ranked docking solutions. 
In contrast to 9, docking suggests one consistent binding mode for 10 placing the 
aminomethyl substituent into the ribose-34 subpocket next to the side chains of Asp102 and 
Asp280. Thereby, the substituent displaces a water molecule and participates in interactions 
with a water cluster placed between the two aspartates (Figure 7.10).  
 
 
Figure 7.10 Five-membered water cluster located between Asp102 and Asp280 in TGT∙8. The protein surface is 
shown in gray. Water molecules are represented as blue spheres and contoured at 1σ in the 2  𝐹𝑜 −  𝐹𝑐   
density map (dark blue). Compound 8 and residues forming hydrogen bond contacts to the water cluster are 
visualized in stick representation (carbon, gray/cyan; oxygen, red; nitrogen, blue). Hydrogen bonds are 
indicated by blue dashes up to a maximum distance of 3.6 Å. 
 
In these docking solutions the torsion angle between the 5-azacytosine and the 
phenyl ring amounts to 10° to 25°. The enhanced binding affinity of 10 is in agreement with 
this binding mode and mirrors the properties of similarly substituted lin-benzoguanine 
inhibitors. In this series, an attached terminal amino group also replaces a water molecule 
and participates in a cluster of water molecules located between Asp102 and Asp280 
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without a loss in affinity compared to the unsubstituted parent structure (Figure 7.11) 
[Ritschel et al., 2009]. In case of 10 even a gain in affinity by a factor of 4.3 is noticed. 
The loss in binding affinity of 12 by a factor of 3.2 can be explained by similar 
considerations. The meta methoxy substituent at the phenyl ring is placed into the ribose-
34-subpocket upon docking. Thereby, it disturbs the mentioned water cluster and 
experiences unfavorable contacts to the most likely charged side chains of Asp102 and 
Asp280, which explains its loss in binding affinity. 
 
 
Figure 7.11 Influence of various substituents placed into the ribose-34 subpocket on the binding affinity to Z. 
mobilis TGT. On the left hand side, ligands 8, 10 and 12 representing 5-azacytosine type inhibitors are displayed 
while the right hand side shows members of the lin-benzoguanines with similar substituents at the 4-position 
of the scaffold. In each case the compound in the center of the scheme serves as a reference lacking a 
substitution, which binds to the ribose-34 subpocket. In both ligand series a substituent exhibiting a primary 
amino function is related to affinity gain. This functionality displaces a water molecule of the network located 
between Asp102 and Asp280 and is able to actively interfere with this network.  
 
For the placement of the naphthyl substituent 11 docking suggests two different 
binding modes. For the better ranked docking solutions a coplanar orientation of the 
naphthyl ring with the heterocycle is found with deviations from a common plane of 25° and 
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40°. The less well ranked solutions show the naphthyl substituent in perpendicular 
orientation to the cytosine moiety. This orientation of the naphthyl ring appears less 
favourable as it penetrates between Asp102 and Asp280 and disturbs the five-membered 
water cluster resulting in a loss of binding affinity.  
 
7.3 Conclusions 
In the present chapter a new class of fragment-like TGT inhibitors with potentially increased 
bioavailability has been studied. The 5-azacytosine scaffold was selected as it should exhibit 
similar features as the closely related natural substrate guanine. Considering the key 
interactions to Asp102 and Asp156, which are prerequisite to induce a protonation change 
of the ligand and therefore provoke the potent binding of a charged ligand was assumed to 
be transferable to the 5-azacytosines. Another advantage of the compound class is its easy 
synthetic accessibility allowing for the production of multiple derivatives. 
Unfortunately, the newly introduced unsubstituted 6-phenyl-5-azacytosine scaffold 
showed only binding affinity in the three-digit micromolar range. Further decorations in 
meta position did not yield a satisfactory increase in potency. Successfully accomplished 
crystal structures of 8, 9, and 10 indicate that the interaction to Asp102 is not optimally 
formed to the 5-azacytosine scaffold. The latter amino acid has been shown to exhibit a key 
role in substrate recognition, ligand protonation and pocket crosstalk (Chapter 4). Especially 
the protonation provoked by a strong pKa shift at N(5) in case of the lin-benzoguanines 
resulted in a substantial increase in potency due to the formation of two bidentate salt 
bridges between Asp102, Asp156 and the ligand [Neeb et al., 2014]. Additionally, the pKa 
value assigned to the change in protonation at N(5) is essential for the protonation 
behaviour of the ligand and the generation of a charged species. In contrast to the lin-
benzoguanines, the pKa value of the 5-azacytosine moiety is lowered by almost one 
logarithmic unit from approximately 4.4 to 3.5 [Tyagi et al., 2003; Barandun et al., 2012]. 
This difference makes a pKa shift induced by the two adjacent aspartate residues 
rather unlikely. In consequence of the absent protonation of the 5-azacytosine moiety no 
charged species seems to be created and the salt bridges to the protein are supposedly not 
formed.  
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In summary, as shown by crystal structure analyses and assay measurements, the low 
pKa value of the novel parent scaffold paralleled by the deviation from planarity of the 
attached phenyl ring most likely results in a perturbation of the key interaction to Asp102. In 
consequence, only unsatisfying LEs are observed for this scaffold. Obviously, the formation 
of salt bridges to Asp102 and Asp156 are essential for potent binding. 
Surprisingly, the naphthyl derivative 11 shows significantly improved binding with a 
remarkable LE of 0.41 𝑘𝑐𝑎𝑙 𝑚𝑜𝑙−1 similar to those of lin-benzoguanine type inhibitors. 
Unfortunately, a crystal structure of TGT in complex with this ligand could not be 
determined. Accordingly, it remains purely speculative to assume that this ligand exhibits 
properties to induce a sufficient pKa shift to bind in protonated state. At least such behavior 
could explain the substantial increase in binding affinity. Despite good LE of 11, the 
compound appears less suited for further optimization due to its low solubility and the 
danger of aggregation at higher concentrations even though at lower concentrations this 
behaviour could be ruled out by DLS experiments. As general strategy, polar groups are 
introduced to a fragment to allow for the formation of hydrogen bonds to the protein and to 
achieve sufficient solubility. In later design cycles hydrophobic groups can be attached to the 
lead fragment. In order to follow this basic rule, the design of alternative fragment-like TGT 
inhibitors should focus on an ammeline scaffold, which exhibits an elevated pKa of 4.5 
[Schmitt et al., 1997], and an attached second amino group suitable to avoid unfavourable 
contacts to Asp102. 
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8. Summary and Outlook 
 
The present thesis deals with structure-based design, in particular the characterization and 
improvement of selective antibiotics targeting the enzyme tRNA–guanine transglycosylase. 
TGT plays a key role in the pathogenicity of Shigella, the causative agent of Shigellosis, 
performing a base exchange reaction that yields modified tRNA. This modification is 
essential for Shigella to invade the epithelial cells of the colon. The worldwide increasing 
resistance of Shigella species against currently administered antibiotics requires the urgent 
development of novel drugs for the treatment of Shigellosis especially to cure patients in 
developing countries. 
Recently, the lin-benzopurine scaffold was introduced as promising starting point for the 
structure-based design of TGT inhibitors. Two classes, namely the lin-benzoguanines and lin-
benzohypoxanthines varying in an exocyclic amino functionality, were found to inhibit the 
target enzyme in the nanomolar range. However, the analyzed molecules did not yet show 
ideal drug metabolism and pharmacokinetic features since firstly they showed poor 
permeation through cell membranes in PAMPA measurements and secondly their attached 
2-substituents binding to the ribose/uracil-33 subpocket were poorly defined in the 
difference electron density in crystal structures complicating the establishment of a 
structure–activity relationship. 
In a comprehensive study the first issue was addressed by focusing on the protonation 
inventory of lin-benzopurines prior to and after complex formation. Different in vitro and in 
silico methods comprising isothermal titration calorimetry, site-directed mutagenesis and 
Poisson-Boltzmann calculations were applied to identify and verify the site of protonation. 
Prerequisite for this assignment is the set-up of ITC measurements appropriate to 
analyze the buffer dependency of the lin-benzopurines, which in return allows concluding 
the proton uptake or release by the system under investigation (Chapter 2). Subsequently, 
the robustness of the settings was tested by investigating the influence of protein and ligand 
impurities on the derived thermodynamic profiles. The latter comprised organic and 
inorganic impurities. Due to the low solubility of lin-benzopurines combined with 
unfavorable polar properties such impurities are complicating the preparation of pure 
compounds. Accompanied by measurements including the second model system trypsin, our 
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investigations showed that protein impurities are not necessarily influencing the 
thermodynamic properties of high affinity ligands binding to the target protein. Their 
presence is rather reflected in the binding stoichiometry. However, caution has to be paid 
especially in case of analyzing unknown binding reactions since incorrect binding 
stoichiometry of the interacting species can be suggested. Contrary to protein impurities, 
impure ligand preparations were found to influence the partitioning of the enthalpic and 
entropic term significantly while the binding free energy remains largely uneffected. In case 
of an impurity exhibiting similar binding properties to the intended ligand the actual 
thermodynamic profile cannot be deduced from ITC measurements and further purification 
is inevitable. Even organic and inorganic impurities that are not able to interact with the 
target protein can influence the thermodynamic properties drastically. In the fortune case of 
knowledge about the exact composition of the impurity, elementary analysis provides a 
helpful tool to support re-fitting the derived thermodynamic data yielding a good 
approximation to the actual enthalpic and entropic terms. This procedure, however, should 
be applied with caution since only a small deviation is accepted until changes in the 
thermodynamic signature are considered as significant. Especially in congeneric series, 
which might show only marginal differences in their binding enthalpy and entropy, sole re-
fitting may lead to a misinterpretation of data. Instead, more effort should be spent into the 
purification protocol of the ligands. If pure ligands cannot be obtained at all, reverse 
titrations might be consulted. However, this set-up also bears several problems like the 
requirement of large amounts of pure protein, which must be stable in the applied buffer 
system over the period of titration. For this purpose, dynamic light scattering has been 
shown to provide valuable insights to access whether protein or ligand aggregation 
influences the experiments. 
The established ITC technique has then been used to analyze the protonation 
inventory of the complex formation between lin-benzopurines and TGT (Chapter 3). Initial 
ITC measurements performed with lin-benzoguanine-type ligands suggested the uptake of 
one proton by either the protein or the ligand. Focusing on the ligand side, subsequent pKa 
calculations identified two basic nitrogens within the guanidine moiety of either the 
aminoimidazole or the aminopyrimidinone portion of the parent scaffold exhibiting 
significant changes in their pKa properties upon complexation. Even though being the less 
basic group, the protonation of the aminopyrimidinone moiety was suggested to be more 
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likely; however, the results obtained for the aminoimidazole did not allow to fully exclude 
protonation at this site. Thus, we analyzed different ligands in further ITC experiments, each 
of them excluding one of the basic sites by chemical modifications. Surprisingly, the lin-
benzoguanines exhibited a distinct buffer dependency while the lin-benzohypoxanthines did 
not show this behavior. To explain these results crystal structures of both inhibitor classes 
were consulted. A major difference in their binding modes was observed for the 
aminopyrimidinone portion: While the lin-benzohypoxanthines bind to a TGT conformation 
closely similar to the apo enzyme interacting with only one aspartate within the guanine-34 
recognition site, addition of the exocyclic amino functional group in case of the lin-
benzoguanines induces the rotation of a second aspartate towards the binding pocket. 
Obviously, the negatively charged environment of both aspartates in short distance 
provokes a pKa shift in case of the lin-benzoguanines strong enough to induce the uptake of 
a proton. If only one aspartate residue is oriented towards the binding pocket this shift is not 
sufficient for protonation as shown for the lin-benzohypoxanthines. This hypothesis could be 
confirmed by generating mutants with the aspartates replaced by asparagines, respectively. 
Performing similar ITC experiments titrating the lin-benzoguanines to the Asn-mutants did 
not show the previously observed buffer dependency anylonger. Previous in silico studies 
concerning the same issue proposed that the aminoimidazole portion of the parent scaffold 
would also change protonation state in the protein-bound state. According to our ITC 
measurements, this moiety would only become protonated upon binding if a protein residue 
simultaneously released a proton. The sole candidate to feature this property is a proximal 
glutamate residue, which is known to change its protonation state depending on the bound 
ligand or the applied environmental pH value. pH-Soaking experiments unravelled that this 
residue is already deprotonated at the applied pH value and thus, the aminoimidazole 
portion must remain in uncharged state. The gain in binding affinity previously ascribed to 
the protonation event could be attributed to an array of two parallel H-bonds directly 
formed with two adjacent C=O groups of the protein backbone avoiding secondary repulsive 
interactions. 
PAMPA measurements unravelled that the parent scaffold of the lin-benzoguanines 
exhibits a too polar character to permeate through the membrane of cells. Taking the 
present studies into account, it does not come as a surprise that the lin-benzohypoxanthines 
do not show an improvement of the PAMPA scores. Future design strategies must address 
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the polarity of the tricyclic scaffold focusing on the aminoimidazole portion. An approach, in 
which this part of the molecule is masked by appropriate functional groups turning it into a 
pro-drug, could help to achieve the desired partitioning.  
Considering the binding affinities across the series of lin-benzopurines, a rather flat 
structure–activity relationship is observed. Therefore, additional insight into the driving 
forces of binding was gained by factorizing the free binding energy into enthalpy–entropy 
contribution (Chapter 4). A modified crystallization protocol enabled to spot the flexible 2-
substituent of the analyzed 2-amino-lin-benzopurines in most cases yielding the basis to link 
structural features to the derived thermodynamic data. Crystal structures unravelled that 
the lin-benzohypoxanthines bind to TGT in a state closely similar to the apo enzyme showing 
Asp102 in an orientation oriented off from the binding pocket. In contrast to that, the lin-
benzoguanines induce the rotation of Asp102 towards the binding pocket. Thus, a proton is 
picked up by the aminopyrimidinone moiety of the parent scaffold then forming an 
additional bidentate salt-bridge to Asp102. Triggered by the movement of Asp102 several 
amino acid residues and secondary structure elements rearrange and transform the protein 
to a conformation as similarly found in the tRNA-substrate bound state. These changes were 
found to result in major differences determining the binding affinity in a biochemical assay, 
which yields an inhibitory constant (𝐾𝑖), and ITC measurements, from which a dissociation 
constant (𝐾𝑑 ) can be derived. In the biochemical assay the incorporation of radioactively-
labeled guanine into tRNA is measured. As a prerequisite, TGT is required in its substrate-
bound state. Thus, lin-benzohypoxanthines appear less potent since the protein has to be 
transformed into the substrate-bound state first. Contrary, ITC measurements record the 
change in heat released or absorbed during the binding reaction and a pure dissociation 
constant of the binding equilibrium to the required protein conformer is derived. Thereby, 
TGT binds the lin-benzohypoxanthines in its apo state showing an increased binding potency. 
  As expected, bindings of both series, lin-benzoguanines and lin-benzohypoxanthines, 
were found to be enthalpy-driven. Thereby, the lin-benzohypoxanthines exhibit a less 
pronounced enthalpic term due to their missing interaction to Asp102, which can be partly 
compensated by a crystallographically conserved water cluster located at the bottom of the 
guanine-34 recognition site. While the thermodynamic profiles of the lin-benzohypoxanthine 
series remains nearly unchanged, data for the lin-benzoguanine series are found to be quite 
diverse. Thus, assigning the contribution of the attached 2-substituent was hardly possible. 
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Obviously, the structural changes triggered by Asp102 in case of the lin-benzoguanines 
enable a cross-talk between ribose/uracil-33 subpocket addressed by the 2-substituent and 
the guanine-34 recognition site occupied by the parent scaffold. Helix αA located nearly 
perpendicular to the bound ligands was shown to play a crucial role in mediating the 
interactions between both pockets. After the lin-benzoguanines are recognized by the 
protein via Asp102 as substrate-like this helix is, amongst others, changing its position as 
observed similarly in tRNA∙TGT complexes. Accompanied by this movement, Tyr106 
penetrates deeper in the ribose/uracil-33 subpocket to experience whether this part of the 
protein is occupied. This procedure guarantees to differentiate correct from false substrates. 
Further design cycles should consider that ligands addressing the ribose/uracil-33 
subpocket have to be recognized as substrate-like triggering the rotation of Asp102 into the 
guanine-34 binding pocket in order to provoke the described cross-talk. Additionally, only 
the thus discriminated ligands are able to modulate binding affinity by forming bidentate 
salt-bridges to both aspartates, if their pKa values fall into a range appropriate to induce a 
protonation change. 
Based on the observations that 2-amino-lin-benzoguanines show a reduced occupancy 
combined with elevated temperature factors of the 2-substituent, a high flexibility of that 
part of the molecule was assumed. Therefore, we tested whether a binder with high residual 
mobility can avoid a loss in binding affinity compared to a binder adopting one ordered 
binding mode and therefore achieve an advantage as a more competent antibiotic less 
affected by resistant mutations (Chapter 5). After selecting Val262 within the ribose-33 
subpocket as mutation site, three different mutants were expressed (Val262Thr, Val262Asp, 
Val262Cys) and crystallized. Subsequently, the binding affinities (𝐾𝑑 ) of various 2-amino-lin-
benzoguanines were determined and discussed with respect to structural information 
derived from crystal structures of the TGT mutants in complex with reference 4a. 
Compared to the wild type, the analyzed 2-amino-lin-benzoguanines showed the 
same binding affinity towards variant Val262Thr. This result was expected since the 
properties of the pocket were only slightly changed. Contrary, potencies towards variant 
Val262Asp decreased significantly while the 𝐾𝑑  values towards variant Val262Cys increased. 
The observed changes could be related to the binding of the parent scaffold rather than to 
the different 2-substituents inducing disorder of the protein in proximal distance to the 
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mutation site. Only marginal differences could be ascribed to the properties of the 
substitution pattern in case of Val262Asp, most likely due to electrostatic attractions and 
repulsions, respectively. Nevertheless, this fact indicates that flexible portions of a drug are 
able to modulate binding affinity in the unfortunate situation of resistance mutations. 
In chapter 6 molecular dynamic simulations were used to predict the binding modes of 
extended 2-amino-lin-benzoguanines, which could not be sufficiently described by docking 
results in previous studies. Unfortunately, MD simulations succeeded only in one out of four 
cases to reliably describe the binding mode of the ligand in a way to match with the 
determined crystal structure. Nevertheless, subsequent crystal structure analyses using 
modified crystallization conditions resulted in reasonable difference electron density for all 
extended 2-amino-lin-benzoguanines. The refined data sets unravelled novel aspects 
important for the further design and characterization of TGT inhibitors:  
Firstly, using a modified crystallization protocol we were able to spot the 2-
subsituent of the extended 2-amino-lin-benzoguanines, which bind to the ribose-32 
subpocket that has never been occupied before. The collected data sets provide the basis for 
new synthesis strategies forming novel interactions within this part of the protein that is 
better shielded than its neighboring solvent-exposed environment. In that context, another 
ligand binding to the ribose-33 subpocket via a bidentate salt bridge showed a reduced 
binding potency. This example unravelled that solvent-exposed interactions formed between 
ligand and protein in the flat ribose-33 subpocket, if at all, hardly contribute to binding 
affinity since high desolvation costs have to be paid in this environment of high dielectric 
conditions. Therefore, further drug design cycles addressing this part of the protein have to 
account for an optimization of rather hydrophobic 2-substituents.  
Secondly, the results of this chapter emphasize the importance of the applied 
crystallization conditions. Poorly defined electron density does not always indicate ligands or 
substituents exhibiting high mobility in the protein-bound state. The applied crystallization 
protocol takes a major impact on the derived difference electron density and has to be 
considered in the discussion of the obtained structures. 
The class of 5-azacytosines was investigated as a novel scaffold to inhibit TGT with 
potentially increased bioavailabilty (Chapter 7). Similarly as the lin-benzopurines, also the 5-
azacytosines are deduced from the natural substrate guanine and were expected to 
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establish similar binding features. An attached phenyl ring serves as an anchor point for 
substituents reaching into the neighbored ribose-33 and ribose-34 subpockets. Compared to 
the lin-benzoguanines, this new class of inhibitors offers the advantage of better synthetic 
accessibility. The pKa value of its aminopyrimidinone moiety (N(5)), however, is found 
between the one of lin-benzohypoxanthines and lin-benzoguanines and represented a 
crucial issue to be analyzed in respect to its protonation behavior. 
 Unfortunately, the ligands show only binding affinities in the low micromolar range 
except of one compound decorated with a naphthyl moiety, which exhibits a binding 
potency in the one-digit micromolar range similar as the closely related guanine. Crystal 
growth proved to be difficult due to the low solubility of all compounds. Nevertheless, 
crystal structures could be solved for three out of five ligands. As expected, the 5-
azacytosine scaffold binds to the guanine-34 recognition site similarly as guanine, however, 
the key interaction to Asp102 that was proven to be of utmost importance for substrate 
recognition, ligand protonation, and pocket crosstalk is poorly established. The reason for 
the disturbance of this interaction can be deduced from the binding mode of the 6-phenyl-5-
azacytosines: Different from all known TGT inhibitors, they do not bind to the protein in a 
planar fashion since the attached phenyl ring rotates out of the plane defined by the 
heterocycle. In consequence, the – compared to lin-benzoguanines – low pKa cannot be 
shifted into a window appropriate for ligand protonation by the interactions formed to 
Asp102 and Asp156 and the drop in affinity can be explained. For the more potent naphthyl 
derivative a crystal structure with bound ligand could not be determined. Up to this point it 
remains unclear, whether the naphthyl substituent induces the conformational transition of 
Asp102 to form the desired bidentate salt bridge to the parent scaffold and thereby, induces 
the protonation step necessary to increase binding affinity. 
 Despite its promising potency, the naphthyl derivative is not an appropriate starting 
point for further optimization since it tends to form aggregates at higher concentrations 
providing significant problems in its handling during synthesis and subsequent analysis. 
Instead, further design cycles should concentrate on the closely related ammelines. An 
additional exocyclic amino functionality attached to the heterocylce does not only represent 
a linker region creating more space towards the side chain of Asp102 but also increases the 
pKa value about one logarithmic unit thus likely falling into a window that allows protonation 
of the parent scaffold. 
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8. Zusammenfassung und Ausblick 
 
Die vorliegende Arbeit behandelt das strukturbasierte Wirkstoffdesign, insbesondere die 
Charakterisierung und Optimierung selektiver Antibiotika gegen das Enzym tRNA-Guanin 
Transglykosylase. Die TGT spielt eine Schlüsselrolle in der Pathogenität von Shigellen, den 
Erregern der Shigellenruhr, indem sie eine Basenaustauschreakion katalysiert, die 
modifizierte tRNA liefert. Diese Modifizierung ist essenziell für Shigellen, um die Epithelzellen 
des Darms zu befallen. Weltweit steigen die Resistenzen von Shigellen gegen gängige 
Antibiotika an, sodass dringend neue Wirkstoffe zur Behandlung der Shigellenruhr 
insbesondere von Patienten in Entwicklungsländern benötigt werden. 
Kürzlich wurde das lin-Benzopurin-Grundgerüst als vielversprechender Ausgangspunkt für 
das strukturbasierte Design von TGT-Inhibitoren eingeführt. Zwei Klassen wurden als 
potente Inhibitoren im nanomolaren Bereich identifiziert – die lin-Benzoguanine und lin-
Benzohypoxanthine, die sich in einer exozyklischen Aminofunktion voneinander 
unterscheiden. Allerdings zeigen die untersuchten Moleküle noch keine idealen 
Eigenschaften in Bezug auf Metabolismus und Pharmakokinetik: Zum einen weisen sie eine 
geringe Permeation durch Zellmembranen in PAMPA-Messungen auf. Zum anderen ist ihr 
angefügter Substituent in 2-Position, der in der Ribose/Uracil-33 Tasche bindet, nur schwach 
durch Differenzelektronendichte in entsprechenden Kristallstrukturen definiert. Dies 
erschwert es eine Struktur–Wirkungsbeziehung aufzustellen. 
In einer umfassenden Studie wurde der erstgenannte Sachverhalt adressiert, indem der 
Protonierungszustand der lin-Benzopurine vor und nach der Komplexbildung betrachtet 
wurde. Verschiedene in vitro und in silico Methoden einschließlich Isothermaler 
Titrationskalorimetrie, ortsgerichteter Mutagenese und Poisson-Boltzmann-Berechnungen 
wurden angewendet, um die Protonierungsstelle zu identifizieren und zu verifizieren. 
Voraussetzung dafür ist die Etablierung von ITC-Messungen, die sich eignen die 
Pufferabhängigkeit der lin-Benzopurine zu analysieren, die wiederum Rückschlüsse auf die 
Protonenaufnahme bzw. –abgabe des betrachteten Systems erlaubt (Kapitel 2). 
Anschließend wurde die Robustheit dieser Versuchsbedingungen getestet, indem der 
Einfluss von Protein- und Ligandverunreinigungen auf die erhaltenen thermodynamischen 
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Daten untersucht wurde. Diese enthielten sowohl organische als auch anorganische 
Verunreinigungen. Verschuldet durch die geringe Löslichkeit  und ungünstige Polarität der 
lin-Benzopurine erschweren solche Verunreinigungen die Darstellung reiner Präparate. 
Zusammen mit Messungen an dem zweiten Modellsystem Trypsin wurde deutlich, dass 
Verunreinigungen des Proteins nicht zwangsläufig die thermodynamischen Eigenschaften 
von hochaffinen Liganden beeinflussen. Ihr Vorhandensein wird vielmehr in der 
Bindungsstöchiometrie widergespiegelt. Dieses Vorgehen muss jedoch mit Vorsicht 
betrachtet werden, insbesondere wenn unbekannte Bindungsreaktionen untersucht 
werden, da Rückschlüsse auf eine falsche Bindungsstöchiometrie der interagierenden 
Partner gezogen werden können. Im Gegensatz zu Proteinverunreinigungen beeinflussen 
verunreinigte Ligandpräparate die Aufspaltung in Enthalpie und Entropie signifikant, 
während die Freie Bindungsenergie größtenteils unberührt bleibt. Weist eine Verunreinigung 
ähnliche Bindungseigenschaften wie der beabsichtigte Ligand auf, kann das tatsächliche 
thermodynamische Profil nicht aus den ITC-Messungen abgeleitet werden und eine weitere 
Aufreinigung ist unumgänglich. Aber auch organische und anorganische Verunreinigungen, 
die nicht in der Lage sind mit dem Zielprotein zu interagieren, können sich drastisch auf die 
thermodynamischen Eigenschaften auswirken. Eine Elementaranalyse kann eine hilfreiche 
Methode darstellen, um die erhaltenen Daten so anzupassen, dass man eine gute 
Annäherung an die tatsächlichen enthalpischen und entropischen Beiträge erhält. Für dieses 
Vorgehen ist allerdings die genaue Kenntnis über die Zusammensetzung der Verunreinigung 
nötig. Jedoch sollte bei diesem Verfahren bedacht werden, dass nur geringfügige 
Abweichungen akzeptiert werden bis ein Unterschied der Daten als signifikant angesehen 
wird. Vor allem in Ligandserien, die unter Umständen nur marginale Änderungen in ihrer 
Bindingsenthalpie und –entropie zeigen, kann eine blinde Anpassung der Daten zu 
Missinterpretationen führen. Stattdessen sollte das Hauptaugenmerk auf geeigneten 
Aufreinigungsprotokollen liegen. Wenn eine vollständige Aufreinigung unmöglich sein sollte, 
sollten reverse Titrationen in Betracht gezogen werden. Jedoch birgt dieses Verfahren 
wiederum neue Problemstellungen wie den Einsatz von großen Mengen reinem Protein, das 
in dem angewendeten Puffersystem über die Dauer der Titration stabil in Lösung vorliegen 
muss. Zu diesem Zweck konnte gezeigt werden, dass die Methode der Dynamischen 
Lichtstreuung wertvolle Einblicke gibt, ob Protein- oder Ligandaggregationen die 
Experimente beeinflusst. 
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Die etablierte ITC-Methode wurde anschließend genutzt, um das Protonierungs-
verhalten während der Komplexbildung zwischen lin-Benzopurinen und TGT zu analysieren 
(Kapitel 3). Zunächst mit lin-Benzoguaninen durchgeführte Messungen suggerierten die 
Aufnahme von einem Proton, entweder durch das Protein oder den Liganden. Mit Fokus auf 
letzteren konnten mittels pKa-Berechnungen zwei basische Stickstoffe der Guanidinstruktur 
identifiziert werden, die sowohl in dem Aminoimidazol- als auch in dem 
Aminopyrimidinonteil des Grundgerüstes enthalten ist. Beide Teilstrukturen zeigten 
signifikante Änderungen ihres pKa-Wertes während der Komplexbildung. Obwohl weniger 
basisch, war eine Protonierung der Aminopyrimidinonstruktur wahrscheinlicher. Die 
erhaltenen Ergebnisse für die Aminoimidazolstruktur erlaubten es jedoch nicht, diese als 
Protonierungsort vollständig auszuschließen. Daher wurden verschiedene Liganden in 
weitere ITC-Experimenten einbezogen, die jeweils eines der basischen Strukturelemente 
aufgrund chemischer Modifikationen ausschließen. Überraschenderweise zeigen alle lin-
Benzoguanine eine deutliche Pufferabhängigkeit, während die lin-Benzohypoxanthine dieses 
Verhalten nicht aufweisen. Um dieses Result zu erklären, wurden Kristallstrukturen beider 
Inhibitorklassen herangezogen. Ein Hauptunterschied im Bindungsmodus der 
Aminopyrimidinonpartialstruktur konnte beobachtet werden: Während die lin-
Benzohypoxanthine an eine dem Apo-Enzym ähnelnde Konformation der TGT binden, bei 
der die Liganden mit nur einem Aspartat in der Guanin-34-Tasche interagieren, induziert die 
zusätzliche Aminogruppe im Falle der lin-Benzoguanine die Rotation einer zweiten 
Aspartatseitenkette in Richtung Bindetasche. Offensichtlich verursacht die negativ geladene 
Umgebung beider Aspartate in kurzer Distanz die Änderung des pKa-Wertes im Falle der lin-
Benzoguanine, die stark genug ist, um eine Protonenaufnahme zu begünstigen. Ist nur ein 
Aspartatrest zur Bindetasche orientiert, ist diese Änderung für eine Protonierung nicht 
ausreichend, wie für die lin-Benzohypoxanthine gezeigt. Diese Hypothese konnte durch 
Mutanten abgesichert werden, bei denen jeweils ein Aspartat- gegen einen Asparaginrest 
ausgetauscht wurde. In analogen ITC-Experimenten, in denen die lin-Benzoguanine zu der 
jeweiligen Asn-Mutante titriert wurden, konnte die zuvor festgestellte Pufferabhängigkeit 
nicht weiter beobachtet werden. In früheren in silico Studien, die dasselbe Thema 
adressierten, wurde die These aufgestellt, dass der Aminoimidazolteil des Grundgerüsts 
ebenfalls seine Protonierung im proteingebundenen Zustand ändern würde. Unseren ITC-
Messungen zufolge würde dieser Teil nur dann bei der Bindung protoniert, wenn eine 
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Aminosäureseitenkette gleichzeitig ein Proton abgibt. Der einzige Kandidat, der diese 
Eigenschaft aufweist, ist ein nahegelegener Glutamatrest, von dem bekannt ist, dass er 
seinen Protonierungszustand abhängig von dem gebundenen Liganden oder dem 
vorherrschenden pH-Wert der Umgebung ändern kann. pH-Soaking-Experimente ergaben, 
dass diese Seitenkette schon vor der Ligandbindung bei dem in den Messungen 
verwendeten pH-Wert deprotoniert vorliegt und daher die Aminoimidazolgruppe im 
ungeladenen Zustand verbleiben muss. Der Affinitätsgewinn, der zuvor dem 
Protonierungsereignis zugeschrieben wurde, konnte zwei parallel ausgebildeten H-Brücken 
zugeordnet werden, die unmittelbar zu zwei benachbarten C=O Gruppen des 
Proteinrückgrates gebildet werden. Auf diese Weise werden sekundär repulsive 
Interaktionen vermieden. 
PAMPA Messungen deckten auf, dass das Grundgerüst der lin-Benzoguanine einen zu 
polaren Charakter aufweist, um durch Zellmembranen zu wandern. Unter Berücksichtigung 
der vorliegenden Studien ist es nicht überraschend, dass die lin-Benzohypoxanthine keine 
Verbesserung des PAMPA-Scores zeigen. Zukünftige Design-Strategien müssen sich mit der 
Polarität des trizyklischen Grundgerüsts mit besonderem Fokus auf der 
Aminoimidazolstruktur beschäftigen. Durch einen Ansatz, in dem dieser Molekülteil durch 
geeignete funktionelle Gruppen maskiert ist und den Liganden so in ein Pro-Pharmakon 
überführt, könnte die gewünschte Partitionierung erreicht werden. 
Unter Berücksichtigung der Bindungsaffinitäten ist eine eher flache Struktur–
Wirkungsbeziehung über die Serien der lin-Benzopurine zu beobachten. Daher wurden 
zusätzliche Einblicke in die treibenden Kräfte der Bindung über die Aufspaltung der Freien 
Bindungsenergie in enthalpische und entropische Beiträge gewonnen (Kapitel 4). Ein 
modifiziertes Kristallisationsprotokoll ermöglichte es, den flexiblen 2-Substituenten der 
analysierten 2-Amino-lin-Benzoguanine in den meisten Fällen zu erkennen. Dies legte die 
Grundlage, um strukturelle Eigenschaften mit den erhaltenen thermodynamischen Daten in 
Verbindung zu setzen. Die Kristallstrukturen deckten auf, dass die lin-Benzohypoxanthine an 
einen Zustand der TGT binden, der dem Apo-Enzym ähnelt und Asp102 in einer der 
Bindetasche abgewandten Orientierung zeigt. Im Gegensatz dazu induzieren die lin-
Benzoguanine die Rotation von Asp102 zur Bindetasche. Dadurch wird ein Proton von der 
Aminopyrimidinonestruktur des Grundgerüsts aufgenommen und die Ausbildung einer 
 
141 8. Zusammenfassung und Ausblick 
zusätzlichen, zweizähnigen Salzbrücke zu Asp102 ermöglicht. Ausgelöst durch die Bewegung 
von Asp102 ordnen sich verschiedene Aminosäurereste und sekundäre Strukturelemente 
um, sodass das Protein in eine Konformation überführt wird, die dem tRNA gebundenen 
Zustand ähnelt. Diese Änderungen resultieren in wesentlichen Unterschieden zwischen der 
Bestimmung der Bindungsaffinitäten in einem biochemischen Assay, der eine 
Inhibitionskonstante (𝐾𝑖) liefert, und ITC-Messungen, aus denen man eine 
Dissoziationskonstante (𝐾𝑑 ) erhalten kann. Im biochemischen Assay wird der Einbau von 
radioaktiv markiertem Guanin in die tRNA gemessen. Als Voraussetzung wird die TGT in 
ihrem substratgebundenen Zustand benötigt. Dadurch erscheinen die lin-
Benzohypoxanthine weniger potent, da das Protein zunächst in die substratgebundene Form 
überführt werden muss. Im Gegensatz dazu erfassen ITC-Messungen die Änderungen der 
Wärme, die während der Bindung abgegeben oder aufgenommen wird und man erhält eine 
reine Dissoziationskonstante des Bindungsgleichgewichtes zwischen Ligand und benötigtem 
Proteinkonformer. Dabei bindet die TGT die lin-Benzohypoxanthine in ihrem Apo-Zustand, 
wodurch eine verbesserte Bindungsstärke verzeichnet wird.  
 Wie erwartet, binden beide Ligandserien, lin-Benzohypoxanthine und lin-
Benzoguanine, enthalpisch. Dabei weisen die lin-Benzohypoxanthine einen weniger 
ausgeprägten enthalpischen Beitrag auf, da die Interaktion zu Asp102 fehlt. Diese kann 
teilweise durch ein kristallographisch konserviertes Wassernetzwerk am Grunde der 
Guanine-34-Tasche kompensiert werden. Während die thermodynamischen Profile der lin-
Benzohypoxanthin-Serie fast unverändert bleiben, sind die Daten für die lin-Benzoguanine 
recht divers. Dadurch war es nur schwer möglich, den Beitrag des angefügten 2-
Substituenten zu bestimmen. Offensichtlich ermöglichen die strukturellen Änderungen 
induziert durch Asp102 im Falle der lin-Benzoguanine eine Kommunikation zwischen 
Ribose/Uracil-33-Tasche, die vom 2-Substituenten adressiert wird, und der Guanin-34-
Tasche, die das Ligandgrundgerüst besetzt. Helix αA, die fast orthogonal zu dem gebundenen 
Liganden steht, spielt eine entscheidende Rolle dabei, die Interaktionen zwischen den 
beiden Taschen zu vermitteln. Nachdem die lin-Benzoguanine über Asp102 als 
substratähnlich vom Protein erkannt werden, ändert unter anderem diese Helix ihre Position 
wie es auch in ähnlicher Art und Weise in tRNA·TGT Komplexen beobachtet wird. Begleitet 
von dieser Bewegung dringt Tyr106 tiefer in die Ribose/Uracil-33-Tasche vor und nimmt 
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wahr, ob dieser Teil des Proteins besetzt ist oder nicht. Dieses Vorgehen garantiert richtige 
von falschen Substraten zu unterscheiden.  
 Zukünftige Designzyklen sollten berücksichtigen, dass Liganden, die die Ribose/Uracil-
33-Tasche adressieren, als substratähnlich erkannt werden müssen und damit die Rotation 
von Asp102 in die Guanin-34-Tasche bewirken, sodass die beschriebene Kommunikation 
zwischen den Bindetaschen erfolgen kann. Zusätzlich sind nur die so unterschiedenen 
Liganden in der Lage die Bindungsaffinität durch zweizähnige Salzbrücken zu beiden 
Aspartaten zu modulieren, vorausgesetzt ihr pKa-Wert fällt in einen Bereich, der geeignet ist 
eine Protonierungsänderung zu bewirken. 
Basierend auf der Beobachtung, dass die 2-Amino-lin-Benzoguanine eine erniedrigte 
Besetzung in Verbindung mit erhöhten Temperaturfaktoren des 2-Substituenten zeigen, 
wurde eine hohe Flexibilität dieses Molekülteils angenommen. Darauf aufbauend wurde 
getestet, ob ein Ligand mit hoher residualer Beweglichkeit einen Bindungsverlust eher 
vermeiden kann als ein Ligand, der einen geordneten Bindungsmodus einnimmt, und so 
einen Vorteil als ein wirksameres Antibiotikum erzielen kann, das weniger von 
Resistenzentwicklungen betroffen ist (Kapitel 5). Nachdem Val262 inmitten der Ribose-33-
Tasche als Mutationsstelle ausgewählt wurde, folgte die Expression und Kristallisation drei 
verschiedener Mutanten (Val262Thr, Val262Asp, Val262Cys). Anschließend wurde die 
Bindungsaffinität (𝐾𝑑 ) verschiedener 2-Amino-lin-Benzoguanine bestimmt und in Bezug auf 
strukturellen Informationen diskutiert, die aus Kristallstrukturen der TGT-Mutanten im 
Komplex mit Ligand 4a erhalten wurden.   
 Verglichen mit dem Wildtyp zeigten die analysierten 2-Amino-lin-Benzoguanine die 
gleiche Bindungsaffinität zu Mutante Val262Thr. Dieses Ergebnis war wie erwartet, da die 
Eigenschaften der Tasche nur leicht verändert wurden. Im Gegensatz dazu verringerte sich 
die Potenz gegenüber Mutante Val262Asp signifikant während die 𝐾𝑑 -Werte zu Mutante 
Val262Cys anstiegen. Die beobachteten Änderungen konnten eher in Zusammenhang mit 
dem Grundgerüst als mit den verschiedenen 2-Substituenten gebracht werden, das 
Unordnung seitens des Proteins in naher Umgebung zur Mutationsstelle verursacht. Nur 
marginale Unterschiede konnten den Eigenschaften des Substitutionsmusters im Falle von 
Val262Asp zugeschrieben werden, die höchstwahrscheinlich auf elektrostatische 
Anziehungs- und Abstoßungskräfte zurückzuführen sind. Nichtsdestotrotz deutet dieser Fakt 
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an, dass flexible Teile eines Arzneistoffmoleküls dazu in der Lage sind, die Bindungsaffinität 
in der ungünstigen Situation einer Resistenzentwicklung durch Mutation zu modulieren. 
In Kapitel 6 wurden Molekulardynamiksimulationen genutzt, um den Bindungsmodus 
verlängerter 2-Amino-lin-Benzoguanine vorauszusagen, der nicht zufriedenstellend durch 
vorherige Dockingstudien beschrieben werden konnte. Unglücklicherweise konnte nur eine 
von vier MD-Simulationen den Bindungsmodus des Liganden zuverlässig voraussagen, sodass 
dieser mit dem der gelösten Kristallstruktur übereinstimmte. Nichtsdestotrotz resultierte die 
anschließende Kristallstrukturanalyse unter modifizierten Kristallisationsbedingungen in 
einer angemessenen Differenzelektronendichte für alle verlängerten 2-Amino-lin-
Benzoguanine. Die verfeinerten Datensätze deckten neuartige Aspekte auf, die entscheidend 
für das weitere Design und die Charakterisierung von TGT Inhibitoren sind: 
 Erstens waren wir dazu in der Lage mit einem modifizierten Kristallisationsprotokoll 
den 2-Substituenten der verlängerten 2-Amino-lin-Benzoguanine zu erkennen, der in der 
Ribose-32-Tasche bindet, die zuvor noch nie besetzt wurde. Die gesammelten Datensätze 
liefern die Grundlage für neue Synthesestrategien, durch die neuartige Interaktion in diesem 
Proteinteil geschlossen werden können, der besser abgeschirmt ist als seine benachbarte, 
solventexponierte Umgebung. In diesem Zusammenhang zeigte ein anderer Ligand, der in 
der Ribose-33-Tasche eine zweizähnige Salzbrücke zum Protein ausbildet, eine erniedrigte 
Bindungspotenz. Dieses Beispiel verdeutlicht, dass solventexponierte Interaktionen, die 
zwischen Ligand und Protein innerhalb der flachen Ribose-33-Tasche gebildet werden, wenn 
überhaupt nur wenig zur Bindungsaffinität beitragen, da hohe Desolvatisierungskosten in 
der Umgebung hoher Dielektizitätsverhätltnisse gezahlt werden müssen. Daher müssen 
zukünftige Wirkstoffdesignzyklen, die diesen Teil des Proteins adressieren, die Optimierung 
eher hydrophober 2-Substituenten berücksichtigen. 
 Zweitens unterstreichen die Ergebnisse dieses Kapitels die Wichtigkeit der 
verwendeten Kristallisationsbedingungen. Schlecht definierte Elektronendichte deutet nicht 
notwendigerweise auf Liganden oder Substituenten hin, die eine hohe Beweglichkeit im 
proteingebundenen Zustand besitzen. Das verwendete Kristallisationsprotokoll beeinflusst 
die erhaltene Differenzelektronendichte maßgeblich und muss in der Diskussion der 
erhaltenen Strukturen berücksichtigt werden.  
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Die Substanzklasse der 5-Azacytosine wurde als neuartiges Grundgerüst untersucht, das die 
TGT mit potentiell erhöhter Bioverfügbarkeit inhibiert (Kapitel 7). Ähnlich den lin-
Benzopurinen sind auch die 5-Azacytosine von dem natürlichen Substrat Guanin abgeleitet 
und vergleichbare Bindungseigenschaften wurden erwartet. Ein angefügter Phenylring dient 
als Ankerpunkt für Substituenten, die in die benachbarten Ribose-33 und Ribose-34-Taschen 
reichen. Im Vergleich zu den lin-Benzoguaninen bietet diese neue Inhibitorklasse den Vorteil 
der verbesserten synthetischen Zugänglichkeit. Der pKa-Wert ihrer Amino-
pyrimidinoneinheit (N(5)) liegt jedoch zwischen dem der lin-Benzohypoxanthine und lin-
Benzoguanine und stellt somit einen kritischen Sachverhalt dar, der in Bezug auf das 
Protonierungsverhalten der 5-Azacytosine genauer betrachtet werden muss. 
 Unglücklicherweise zeigen die Liganden nur Bindungsaffinitäten im niedrig 
mikromolaren Bereich. Ausnahme bildet ein Präparat, das mit einer Naphthyleinheit 
dekoriert ist und eine Bindungspotenz im einstellig mikromolaren Bereich aufweist, ähnlich 
dem nahe verwandten Guanin. Das Kristallwachstum stellte sich als schwierig heraus, da alle 
Präparate durch eine geringe Löslichkeit gekennzeichnet waren. Nichtsdestotrotz konnten 
Kristallstrukturen für drei der fünf Liganden gelöst werden. Wie erwartet bindet das 5-
Azacytosin-Grundgerüst in der Guanin-34-Bindungstasche ähnlich wie Guanin, jedoch ist die 
Interaktion zu Asp102 schwach ausgebildet, die sich als äußerst wichtig für die 
Substraterkennung, Ligandprotonierung und Kommunikation zwischen den Bindetaschen 
herausgestellt hat. Der Grund für die Störung dieser Interaktion kann von dem 
Bindungsmodus der 6-Phenyl-5-Azacytosine abgeleitet werden: Anders als alle bekannten 
TGT-Inhibitoren binden sie nicht in einer planaren Art und Weise an das Protein, da der 
angefügte Phenylring aus der Ebene rotiert, die durch den Heterozyklus definiert wird. In 
Folge wird der im Vergleich zu den lin-Benzoguaninen niedrigere pKa-Wert nicht durch die 
Interaktionen zu Asp102 und Asp156 in ein Fenster geeignet für die Ligandprotonierung 
verschoben und der Einbruch der Affinität kann dadurch erklärt werden. Für das potentere 
Naphthylderivat konnte keine Kristallstruktur mit dem gebundenen Liganden bestimmt 
werden. Bis zu diesem Zeitpunkt bleibt unklar, ob der Naphthylsubstituent einen 
konformationellen Wechsel von Asp102 veranlasst, um die gewünschte zweizähnige 
Salzbrücke zum Grundgerüst auszubilden und damit den Protonierungsschritt induziert, der 
für den Affinitätsgewinn nötig ist. 
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 Trotz der vielversprechenden Bindungsstärke ist das Naphthylderivat kein geeigneter 
Startpunkt für weitere Optimierungen, da es dazu neigt bei höheren Konzentrationen 
Aggregate zu bilden. Dies bereitet erhebliche Probleme im Umgang während der Synthese 
und nachgeschalteter Analyse. Stattdessen sollten sich zukünftige Designzyklen auf die nahe 
verwandten Ammeline konzentrieren. Eine zusätzliche Aminogruppe außerhalb des 
Heterozyklus stellt nicht nur eine Verbindungsregion dar, die einen größeren Abstand zu der 
Seitenkette von Asp102 schafft, sondern erhöht auch den pKa-Wert um eine logarithmische 
Einheit und fällt damit wahrscheinlich in einen Bereich, der die Protonierung des 
Grundgerüstes erlaubt. 
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9. Materials and Methods 
9.1 In-silico Methods 
9.1.1 pKa Calculations 
A consistent charge model was produced by a modified version of the charge distribution 
algorithm that initially was developed by Gasteiger and Marsili, named “partial equalization 
of orbital electronegativities” (PEOE) [Barken and Gasteiger, 1980]. According to previous 
studies on the target, a dielectric constant of ε = 20 was chosen to describe the properties of 
the binding pocket considering an implicit solvent model [Ritschel et al., 2009]. 
For the calculation of the pKa values all titratable groups within a radius of 12Å 
around the active site were considered for the site-site interaction portion of the pKa 
calculations (Cγ of Tyr106 was taken as center of the selection). Thereby, the following 
residues were identified as titratable groups: Lys52, Tyr72, His73, Asp/Asn102, Tyr106, 
Asp/Asn156, Glu157, Cys158, Tyr161, Glu173, Tyr226, Glu235, Asp238, Glu239, Asp245, 
Tyr258, Lys264, Asp266, Asp267, Asp280, Cys281, Tyr354, and Tyr381. With the program 
REDUCE, all hydrogens were added to the protein in which all acidic residues were 
deprotonated and basic ones were protonated [Word et al., 1999]. For the uncharged state 
of the ligand, SYBYL atom types were assigned and an explicit charge of 0 was set for the 
hydrogen atom of the titratable group prior to the partial charge calculation. 
After this preparation, the Poisson–Boltzmann calculation was started using the 
program MEAD [Bashford, 1997]. The resulting pKa shifts of the crucial amino acid residues 
are listed in Tables 3.3 – 3.4 at pH 7.8. A detailed list of all analyzed residues is shown in the 
appendix. 
 
9.1.2 Molecular Dynamic Simulation 
Molecular dynamic (MD) simulations were performed with the program AMBER11 [Case et 
al., 2005]. In chapter 6 the docking results (8.1.3) of the corresponding ligands served as 
starting coordinates, in chapter 7 the complex structure TGT∙9. Prior to the simulation, the 
pdb-file had to be modified: All crystallographically determined water molecules were 
extracted. Missing amino acids as well as the most probable conformer of missing side 
chains were added. In case of more than one visible conformation, the highest occupied one 
was kept during the simulation. Protonation states of histidines were inspected visually and 
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set as HID (hydrogen at δ-position, HIS#: 90, 257, 319, 332) or HIE (hydrogen at ε-position, 
HIS#: 73, 145, 333). The zinc ion was mimicked by four massless dummy atoms, each with a 
charge of +0.5 using the CaDA approach by Pang [Pang et al., 2000; Pang, 2001]. Cysteine 
residues involved in the binding of the zinc ion were set as CYM (CYS#: 308, 310, 313), 
histidines as HIN (HIS#:349).  
Due to the required computational time the calculations were based on only one TGT 
monomer. Parameters for the ligands were generated with the program antechamber using 
the general amber force field (gaff) [Wang et al., 2004], its charges were calculated via bond 
charge correction (bcc) [Jakalian et al., 2000; Jakalian et al., 2002]. Addition of hydrogen 
atoms to the protein, neutralization of the system by adding two sodium ions and solvation 
of the complex in a TIP3P water box was done with the tleap [Jorgensen et al., 1983]. 
After a minimization of the water box comprising 100 steps and the whole system 
comprising 500 steps performed with a generalized Born solvent model, all following 
simulations included periodic boundary conditions, the Particle Mesh Ewald procedure 
(PME) [Darden et al., 1993] and the SHAKE algorithm [Ryckaert et al., 1977] using the ff99SB 
force field [Hornak et al., 2006] with a cut-off of 10 Å. Thereby, the system is heated up to 
300 K stepwise (0 K ∙∙∙ 150 K ∙∙∙ 225 K ∙∙∙ 300 K) over a period of 150 ps fixing the TGT 
monomer with weak restraints (25 kcal ∙ mol−1 ∙ Å−2). Subsequently, the pressure is 
adjusted to 1 bar over a time scale of 50 ps followed by a productive simulation for 10 to 
100 ns using 2 fs time steps under NPT conditions. The trajectory derived under these 
conditions was further analyzed with the program ptraj, whereby every second frame was 
included into the analyses. The dialplot was generated using R. 
   
9.1.3 Docking 
Docking was performed using GOLD Suite v5.1 [The Cambridge Crystallographic Data Centre: 
Cambridge, U.K.], the default values for the genetic algorithm (GA) [Jones et al., 1997] and 
the scoring function ChemScore [Eldridge et al., 1997]. For each ligand 30 – 100 GA runs 
were performed with 100’000 operations. As a protein model the coordinates of the crystal 
structure 2QZR (chapter 6) and TGT∙8 (chapter 7) were used. Since Asp102 is present in two 
different conformations in TGT∙8, its side chain was kept flexible during docking. The binding 
site included all atoms within a distance of 10 Å to the sulfur of Met260. Ligands were drawn 
using the MOE builder. 
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9.2 Experimental Methods 
9.2.1 Chemicals 
 
Chemicals used in the context of this work are listed in table 9.1. 
 
Table 9.1 Used chemicals as well as their manufacturer in alphabetical order. 
Name Manufacturer 
Acetic Acid 100% 
Acrylamide/bisacrylamide (30% / 0.8%) 
Agar-agar 
Agarose 
Ammonium peroxydisulfate (APS) 
Ammonium sulfate 
Ampicillin 
Anhydrotetracycline hydrochloride 
Antarctic Phosphatase 
Biotinylated thrombin 
Bovine serum albumin (BSA) 
Bromphenol blue 
Chloramphenicol 
Chloroform:Isoamyl alcohol 24:1 
Complete™ mini protease inhibitor, EDTA free 
Coomassie Brilliant Blue R250 
d-Desthiobiotin 
Dimethylformamide 
Dimethylsulfoxide (DMSO) p. a. 
1,4-Dithiothreitol (DTT) 
EcoRV-HF® 
Ethanol 96% 
Ethylenediaminetetraacetate (EDTA) 
Glucose 
Glycerol 
[8-3H]-Guanine 
Guanine hydrochloride 
Hydrochloric acid 
2-(4-Hydroxyphenylazo)-benzoic acid (HABA) 
2-(4-(2-Hydroxyethyl)- 1-piperazinyl)-ethanesulfonic acid (Hepes) 
Isopropyl-β-D-thiogalactopyranoside (IPTG) 
Kanamycin sulfate 
Magnesium chloride hexahydrate 
6x Mass Ruler Loading Dye (R0621) 
ROTH 
ROTH 
ROTH 
Fluka 
ROTH 
ROTH 
ROTH 
Fluka 
New England BioLabs 
Novagen 
Sigma Aldrich 
Merck 
ROTH 
ROTH 
Roche 
ROTH 
IBA 
Merck 
ROTH 
ROTH 
New England BioLabs 
ROTH 
Merck 
ROTH 
Acros Organics 
Hartmann Analytics 
Sigma Aldrich 
Fisher Scientific 
Fluka 
ROTH 
ROTH 
AppliChem 
Merck 
Fermentas 
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β-Mercaptoethanol 
2-(N-Morpholino)ethanesulfonic acid (MES) 
Methanol p. a. 
NheI 
PageRuler™ Prestaint Protein Ladder (SM0671/2) 
Phenol:Chloroform:Isoamyl alcohol 25:24:1 
Polyethylene glycol MW 400 (PEG 400) 
Polyethylene glycol MW 8000 (PEG 8000) 
Protein assay dye reagent concentrate 
Rotiphorese® Gel 30 (Acrylamide:N,N-Methylenbisacrylamide 
37.5:1) 
Rotiphorese® 10x SDS-PAGE 
Rotiszint®eco plus 
Sodium chloride 
Sodium dodecyl sulfate 
Sodium hydroxide 
SYBR® Safe DNA gel stain 
T4 DNA Ligase 
Tetramethylenediamine (TEMED) 
Trichloroacetic acid (TCA) 
 N-(Tris(hydroxymethyl)methyl)glycine (Tricine) 
 2-Amino-2-(hydroxymethyl)-propane-1,3-diol (Tris) 
Tryptone 
Tween 20 
Yeast extract 
Merck 
ROTH 
Fluka 
New England BioLabs 
Fermentas 
ROTH 
Sigma Aldrich 
Fluka 
BioRad 
ROTH 
 
ROTH 
ROTH 
ROTH 
ROTH 
Grüssing 
invitrogen 
New England BioLabs 
ROTH 
Fluka 
Merck 
ROTH 
ROTH 
Sigma Aldrich 
ROTH 
 
 
9.2.2 Equipment 
 
Equipment used in this work is given in table 9.2. 
 
Table 9.2 Employed equipment as well as its manufacturer in alphabetical order. 
Device Manufacturer 
ÄKTA FPLC 
Autoklave type FVA2 
Centrifuge Avanti J-10 / J-25 
Centrifuge Biofuge fresco 
Centrifuge Biofuge pico 
Centrifuge Multifuge 3 
Dialysis membrane Zellu Trans 4,000 – 6,000 MWCO 
Elektrophoresis cell OWL EASYCAST™ B1A 
FiveEasy pH meter 
GE Healthcare 
Fedegari 
Beckman Coulter 
Heraeus 
Heraeus 
Heraeus 
ROTH 
Thermo Scientific 
Mettler Toledo 
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HERAsafe biological safety cabinet 
Incubator shaker Innova 4200 
Incubator shaker Innova 4230 
Incubator type B5060 EC-CO2 
iTC200 microcalorimeter 
Magnetic stirrer IKA-COMBIMAG REO 
Microskope Typ SZ 60 
Micro weighing scale type CP2P 
Mini Cycler™ PTC-150 
Nanodrop 2000c 
NAP-25 Sephadex column 
Phenyl Sepharose column XK16 
Pipettes 
Precision weighing scale type 404/13 
Q Sepharose column XK26 
Safe Imager™ Blue Light-Transilluminator 
Shaker Polymax 1040 
SDS-PAGE Mini-PROTEAN® Tetra Electrophoresis System 
SpectroSize™ 300 
Speed-Vac DNA mini 
Strep-Tactin Superflow Sepharose column 
Scintillation Counter TRI-CARB® 1900CA 
Thermomixer Comfort 2mL 
Ultrasonic Sonifier 250 
Ultrasonic bath Elmasonic S 10/(H) 
UV-Vis Spectrometer Smart Spec 3000 
Vakuum pump type N811KN.18 
Vivaspin® 20 centrifugal concentrator 30,000 MWCO 
Vortex mixer VF1 
Weighing machine type 572/45 
Zetasizer Nano ZS 
Thermo Scientific 
New Brunswick Scientific 
New Brunswick Scientific 
Heraeus 
GE Healthcare 
Janke & Kunkel 
Olympus 
Sartorius 
MJ Research 
Thermo Scientific 
GE Healthcare 
Amersham Bioscience 
Eppendorf 
Sauter 
Amersham Bioscience 
invitrogen 
Heidolph 
BioRad 
Molecular Dimensions 
Jouan Nordic 
IBA 
Packard 
Eppendorf 
Branson 
Elma 
BioRad 
KNF  
Sartorius 
Janke & Kunkel 
Kern 
Malvern Instruments 
 
 
9.2.3 Buffer, Solutions and Media 
 
Table 9.3 comprises a list of the buffers, solutions and media that were used in the context 
of this work. If not explicitly described, chemicals were dissolved in demineralized water. The 
desired pH value was achieved by the addition of sodium chloride solution (10 M) or 
hydrochloric acid (32%) using a FiveEasy pH meter. Buffers were freshly prepared and sterile 
filtered through a Millipore Steritop™ bottle top filter with a pore size of 0.22 µm before 
usage.   
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Table 9.3 Used buffer, solutions and media in alphabetical order. 
Name Composition 
Ampicillin solution 
Anhydrotetracycline solution 
APS solution 
Antarctic Phosphatase Reaction  
     Buffer (1x) 
Assay buffer 
Buffer A 
Buffer B 
Buffer C 
Buffer E 
 
Buffer R 
Buffer W 
Chloramphenicol solution 
Cryo buffer A 
 
Cryo buffer B 
 
Cryo buffer C 
 
Cryo buffer D 
 
Crystallisation buffer A 
Crystallisation buffer B 
CutSmart™ Buffer 
 
Destaining solution 
Dialysis buffer 
Guanine  solution 
IPTG stock solution 
ITC buffer A 
ITC buffer B 
ITC buffer C 
Kanamycin solution 
Laemmli buffer 
Luria-Bertani agar 
 
Luria-Bertani medium 
 
Makroseeding buffer 
High salt buffer 
Lysis buffer 
 
Running gel buffer 
100 mg/ml ampicillin, sterile filtered 
2 mg/ml anhydrotetracycline in DMF, sterile filtered 
10% (w/v) ammonium peroxydisulfate 
 
50 mM Bis-Tris-propane hydrochloride, 1 mM MgCl2, 0.1 mM ZnCl2 
200 mM HEPES, 20 mM MgCl2, 0.037% (v/v) Tween 20, pH 7.3 
10 mM Tris, 1 mM EDTA, 1 mM DTT, pH 7.8 
10 mM Tris, 1 mM EDTA, 1 mM DTT, 1 M NaCl, pH 7.8 
10 mM Tris, 1 mM EDTA, 1 mM DTT, 1 M (NH4)2SO4, pH 7.8 
100mM Tris, 150mM NaCl, 1mM EDTA, 2.5mM d-desthiobiotin, 
pH 7.8 
100mM Tris, 150mM NaCl, 1mM EDTA, 1 mM HABA, pH 7.8 
100mM Tris, 150mM NaCl, 1mM EDTA, pH 7.8 
34 mg/ml chloramphenicol in ethanol, sterile filtered 
50 mM MES, 0.3 M NaCl, 2 % (v/v) DMSO, 4 % (w/v) PEG8000, 30% 
(v/v) glycerole, pH 5.5 
50 mM Tris, 0.3 M NaCl, 2% (v/v) DMSO, 4% (w/v) PEG8000,  30% 
(v/v) glycerole, pH 8.5 
80 mM MES, 8% (v/v) DMSO, 10.4% (w/v) PEG8000, 20% (v/v) 
PEG 400, pH 5.5 
80 mM Tris, 8% (v/v) DMSO, 6.4% (w/v) PEG8000, 20% (v/v) 
PEG400, pH 7.8 
100 mM MES, 10% (v/v) DMSO, 11 – 13% (w/v) PEG8000, pH 5.5 
100 mM Tris, 10% (v/v) DMSO, 6 – 8% (w/v) PEG8000, pH 8.5 
50 mM potassium acetate, 20 mM Tris-acetate, 10 mM 
magnesium acetate, 100 μg/ml BSA 
10% (v/v) acetic acid, 40% (v/v) methanol 
10 mM Tris, 500 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.8 
188 µM guanine hydrochloride 
1 M IPTG, steril filtered 
50 mM HEPES, 200 mM NaCl, 0.037% (v/v)Tween 20, pH 7.8 
50 mM Tris, 200 mM NaCl, 0.037% (v/v) Tween 20, pH 7.8 
50 mM Tricine, 200 mM NaCl, 0.037% (v/v) Tween 20, pH 7.8 
30 mg/ml kanamycin sulfate 
0.25 M Tris, 2 M glyerole, 1% (w/v) SDS, pH 8.3 
1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, 1.5% 
(w/v) agar-agar, autoclaved 
1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, 
autoclaved 
100 mM Tris, 10% (v/v) DMSO, 5% (w/v) PEG 8000, pH 7.8 
10 mM Tris, 1 mM EDTA, 2 M NaCl, pH 7.8 
20 mM Tris ,10 mM EDTA, 1 mM DTT, 1 tablet/50 ml Complete™, 
pH 7.8 
1 M Tris, pH 8.8 
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SDS solution 
SDS sample buffer (4x) 
 
SOC medium 
 
Stacking gel buffer 
Staining solution 
 
T4 DNA Ligase Reaction Buffer 
TAE buffer (50x) 
TCA solution A 
TCA soution B 
Tween solution 
2xYT medium 
10% (w/v) SDS 
250 mM Tris, 8% (w/v) SDS, 40% (v/v) glycerole, 0.04% (w/v) 
bromphenol blue, 8% (w/v) β-mercaptoethanol, pH 6.8 
20% (w/v) tryptone, 5% (w/v) yeast extract, 0.5% (w/v) NaCl, 
10 mM MgCl2, 0.4% (w/v) glucose 
1 M Tris, pH 6.8 
10% (v/v) acetic acid, 40% (v/v) methanol, 1 g/l Coomassie Brilliant 
Blue R250 
50 mM Tris-HCl, 10 mM MgCl2, 1 mM ATP, 10 mM DTT 
2 M Tris, 50 mM EDTA, pH 7.8 
5% (w/v) trichloroacetic acid 
10% (w/v) trichloroacetic acid 
1% (w/v) Tween 20 
16% (w/v) tryptone, 10% (w/v) yeast extract, 5% (w/v) NaCl, 
autoclaved 
 
 
9.2.4 Bacterial Strains and Plasmids 
 
Plasmids and bacterial strains are given in Tables 9.4 and 9.5.  
 
Table 9.4 Used plasmid vectors as well as their characteristics and manufacturers in alphabetical order. 
Name Characteristics  Manufacturer 
pASK-IBA13plus-ZM10 
 
 
pET9d-ZM4 
 
 
pET9d-ZM4-D102N 
pET9d-ZM4-E235Q 
pPR-IBA2-ZM10 
 
 
 
pPR-IBA2-ZM10-D156N 
pPR-IBA2-ZM10-V262C 
pPR-IBA2-ZM10-V262D 
pPR-IBA2-ZM10-V262T 
ptRNA2 
Ampr, Cmr; Strep-tag II®; ColE1-origin, 
tet-promotor; inserted tgt-gene as 
1.2 kb BsaI fragment 
Cmr, Kmr; ColE1-origin, tac-promotor, 
coding for laqlqmalE lacZα; inserted tgt-
gene as 1.3 kb BamHI/NcoI fragment 
Cmr, Kmr; TGT-D102N 
Cmr, Kmr; TGT-E235Q 
Ampr, Cmr; Strep-tag II®; ColE1-origin, 
T7-promotor based expression; 
inserted tgt-gene as 1.2 kb NheI/EcoRV 
fragment 
Ampr, Cmr; TGT-D156N 
Ampr, Cmr; TGT-V262C 
Ampr, Cmr; TGT-V262D 
Ampr, Cmr; TGT-V262T 
Ampr; E. coli tRNATyr as BstNI fragment 
under control of T7-promotor in 
pTZ18U 
[Jakobi, 2013] 
 
 
[Reuter and Ficner, 1995] 
 
 
[Romier et al., 1997] 
[Tidten et al., 2007] 
This work 
 
 
 
This work 
This work 
This work 
This work 
[Curnow et al., 1993] 
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Table 9.5 Used E. coli host cells including their genotype and vendor in alphabetical order. 
Host cell Genotype    Vendor 
BL21(DE3)pLysS 
BL21-CodonPlus(DE3)-RIPL 
 
Rosetta 2(DE3) 
 
XL10-Gold 
 
F– dcm ompT hsdS(rB
–mB
–) gal λ(DE3) [pLysS Camr]  
F– ompT hsdS(rB
– mB
–) dcm+ Tetr gal λ(DE3) endA Hte  
[argU proL Camr] [argU ileY leuW Strep/Specr] 
F– ompT hsdSB(rB
– mB
–) gal dcm (DE3) pRARE23 
(Camr) 
Tetr∆(mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 endA1 
supE44 thi-1 recA1 gyrA96 relA1 lac Hte [F´ proAB 
lacIqZ∆M15 Tn10 (Tetr) Amy Camr] 
Stratagene 
Stratagene 
      
  Stratagene 
     
Stratagene 
 
 
9.2.5    Molecular biological methods 
9.2.5.1    Cloning 
 
In order to achieve a higher protein yield the sequence encoding the strep-tagged wild type 
TGT of the pASK-IBA13plus-ZM10 plasmid [Jakobi et al., 2014] was cloned into the T7-
promotor based expression vector pPR-IBA2 (Table 9.6). Therefore, the tgt-gene as well as 
the new vector were separately cut with the restriction enzymes NheI-HF®and EcoRV-HF®. 
For dephosphorylation the cut vectors were treated with Antarctic Phosphatase. 
 
Table 9.6 Composition of the digestion, dephosphorylation and ligation mixtures. 
Digestion Dephosphorylation Ligation 
pPR-IBA2 vector /  
pASK-IBA13plus-ZM10 
NheI-HF® 
EcoRV-HF®  
CutSmart™ Buffer 
(10x) 
ddH2O 
 
1 µg 
1  µl 
1  µl 
 
5  µl 
42  µl 
 
 
Antarctic Phosphatase 
 
Antarctic Phosphatase 
Reaction Buffer (1x) 
ddH2O 
 
 
1 µl 
 
 
6 µl 
3 µl 
pPR-IBA2 vector 
tgt-gene 
T4 DNA Ligase 
 
T4 DNA Ligase 
Reaction Buffer (10x) 
ddH2O 
0.5 µl 
9.5 µl 
1 µl 
 
 
2 µl 
7 µl 
 
The tgt-gene (373 kDa) was separated from the cut pASK-IBA13plus (840 kDa) by 
agarose gel electrophoresis and the corresponding band cut out of the gel. For the extraction 
of the DNA out of the gel the QIAquick Gel Extraction Kit (Qiagen) was used. Subsequently, 
the tgt-gene and the pPR-IBA2 vector were ligated for one hour at 37°C. For transformation 
10 µl of the sample were used. The resulting plasmid was named pPR-IBA2-ZM10. 
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9.2.5.2 Protein Expression and Purification 
9.2.5.2.1 Expression of the Z. mobilis tgt gene via the vector pET9d 
 
Bacterial cells BL21(DE3)pLysS transformed with pETZM4 [Reuter and Ficner, 1995] were 
grown in a pre-culture of 100 ml LB medium containing 30 mg/l kanamycin and 34 mg/ml 
chlorampenicol at 37°C and 220 rpm shaking overnight and transferred into two liters LB 
medium. The main culture was raised to an optical density at 600 nm (OD600) of 0.8 under 
the same conditions as listed for the pre-culture. Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) was added in a concentration of 1 mM to induce overproduction for 20 hours at 14°C. 
Cells were harvested by centrifugation (10000 rpm at 4°C) and resuspended in 50 ml lysis 
buffer. The suspension was sonicated six times for 90 seconds on ice and subsequently 
centrifuged for 1 hour at 20000 rpm (Beckman Coulter, J-25.50).  
The purification via FPLC comprised two steps: Firstly, the clear supernatant was 
applied onto a Q Sepharose XK26 (anion exchange column) previously conditioned on buffer 
A. After an initial washing step with buffer A the protein was eluted by a linear gradient 
reaching from 0 to 100% of buffer B at a flow rate of 4 ml/min (Figure 9.1A). Fractions 
containing TGT were identified by SDS gel electrophoresis [Laemmli, 1970].  
 
 
Figure 9.1 Chromatograms recorded during the purification of TGT wild type using the anion exchange column 
Q Sepharose XK26 (A) and the hydrophobic interaction column Phenyl Sepharose XK16 (B).  The UV absorption 
(blue line; proportional to the protein amount), the conductivity (black line; indicating the NaCl concentration) 
and the adjusted gradient (green line) are shown in dependence of the elution volume. The fractions containing 
the desired protein as confirmed by SDS PAGE are marked by a black bar. 
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Secondly, 1 M ammonium sulphate was added to the chosen TGT fractions, which 
were then loaded onto a Phenyl Sepharose XK16 (hydrophobic interaction column) 
previously conditioned on buffer C. The column was washed with buffer C and the protein 
was eluted by a linear gradient reaching from 0 to 100% of buffer A at a flow rate of 
2 ml/min (Figure 9.1B). Again, fractions containing the desired protein were identified by 
SDS gel electrophoresis and subsequently concentrated to a final concentration of at least 3 
mg/ml using VIVASPIN®20 centrifugal concentrators (Sartorius) with a cutoff of 30,000 Da. 
The final purification step was reached by micro-crystallization. Therefore, the 
protein solution was dialyzed against 5 l of buffer A. The precipitated protein was harvested 
by centrifugation and resolved with high salt buffer to the required concentration. The 
derived protein solution was stored at -20°C. 
 
 
9.2.5.2.2 Expression of the Z. mobilis tgt gene via the vector pPR-IBA2  
 
Bacterial cells BL21-CodonPlus(DE3)-RIPL (V262T, V262D, V262C) and Rosetta 2(DE3) 
(D156N) transformed with pPR-IBA2-ZM10 were grown in a pre-culture of 100 ml 2×YT 
medium containing 100 mg/l ampicillin and 34 mg/ml chlorampenicol at 37°C and 220 rpm 
shaking overnight and transferred into two liters 2×YT medium. The main culture was raised 
to an optical density at 600 nm (OD600) of 0.8 under the same conditions as listed for the pre-
culture. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added at a concentration of 1 mM 
to induce overproduction for 16 hours at 14°C. Cells were harvested by centrifugation 
(10000 rpm at 4°C) and resuspended in 50 ml lysis buffer. The suspension was sonicated six 
times for 90 seconds on ice and subsequently centrifuged for 1 hour at 20000 rpm (Beckman 
Coulter, J-25.50). 
In the course of this work it was observed that also nucleic acids bind to the Strep-
Tactin Superflow column the clear supernatant was firstly applied onto a Q SepharoseTM 
XK26 column previously conditioned on buffer A. After an initial washing step with buffer A 
the protein was eluted by a linear gradient reaching from 0 to 100% of buffer B at a flow rate 
of 4 ml/min (Figure 9.1A). Fractions containing TGT were identified by SDS gel 
electrophoresis [Laemmli, 1970] and loaded onto a Strep-Tactin Superflow column. After a 
stable UV signal was reached by a washing step with buffer W the protein was eluted with 
buffer E at a flow rate of 2 ml/min (Figure 9.2).  
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Figure 9.2 Chromatogram recorded during the purification of strep-tagged wild type TGT using the Strep-Tactin 
Superflow column. The UV absorption (blue line; proportional to the protein amount) is plotted in dependence 
of the elution volume. The fractions containing the desired protein as confirmed by SDS PAGE are marked by a 
black bar. 
 
Subsequently, the sample was dialyzed (cutoff 4,000 – 6,000) to higher salt 
conditions against dialysis-buffer for at least 4 hours. 
The strep-tag® II was removed via the Thrombin Cleavage Capture Kit (Novagen®) for 
16 hours at 20°C following the manufacturer’s instructions. Afterwards, the cleaved tag as 
well as the biotinylated Thrombin was captured using streptavidin agarose via filtration.  
For the stability of the protein it was of utmost importance to cleave the tag before 
concentrating the sample via VIVASPIN®20 centrifugal concentrators (Sartorius; 
30,000 MWCO) and exchanging the buffer to high salt conditions. The protein solution was 
stored at -20°C.  
 
 
9.2.5.3    Mutagenesis 
 
In order to generate mutated plasmids the QuikChange® Lightning Site-Directed Mutagenesis 
Kit (Stratagene) based on the principle of the polymerase chain reaction (PCR) was used. 
Oligonucleotide primers were designed following the vendor’s instructions and synthesized, 
purified and analysed by MWG Operon (Ebersberg). For the PCR reaction the protocol 
suggested by the manufacturer (Table 9.7) was applied using pPR-IBA2-ZM10 as a template. 
The oligonucleotide primers are listed in Table 9.8. 
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Table 9.7 Composition and applied protocol of the PCR reaction. 
Composition of the reaction:    Applied protocol: 
dsDNA template 
Primer forward 
Primer backward 
10x buffer 
dNTP mix 
ddH2O 
DNA polymerase 
10 – 100 ng   
125 ng   
125 ng   
5 µl 
1 µl 
ad 50 µl 
1 µl 
   Starting phase 
 
   Denaturation 
   Hybridisation 
   Synthesis 
 
   End phase 
120 s 
 
20 s 
10 s 
150 s 
 
300 s 
95°C 
 
95°C 
60°C 
68°C 
 
68°C 
 
 
 
 
 
RPT 18x 
 
After the reaction parental methylated and hemimethylated DNA was digested by 
Dpn I. Subsequently, 2 µl of the PCR product was transformed into XL10-GOLD cells during 
an incubation period of 30 minutes followed by a heat shock of 30 seconds at 42°C. To select 
only mutated plasmids the host cells were raised in SOC medium for one hour at 37°C, 
plated on LB agar containing 100 mg/l ampicillin and incubated over night at 37°C. Finally, a 
single clone was picked and transferred into 10 ml of LB medium containing 100 mg/l 
ampicillin. The resulting culture was shaken overnight at 220 rpm and 37°C. 
700 µl of the bacterial cell cultures were mixed with 300 µl glycerol and stored at -
80°C. The remaining culture was harvested for plasmid extraction using the peqGOLD 
Plasmid Miniprep KitII (PEQLAB Biotechnologie GmbH) following the manufacturer’s 
instructions. For the extracted and purified plasmid the presence of the desired mutation as 
well as the absence of any further mutations were confirmed by sequence analysis (Eurofins 
MWG Operon, Ebersberg). Subsequently, the plasmid was transformed into BL21-
CodonPlus(DE3)-RIPL or Rosetta 2(DE3) cells by heat shock for 20 seconds at 42°C followed 
by the selection routine as previously described. 
 
Tabelle 9.8  Used oligonucleotide primers in site-directed mutagenesis. 
Oligonucleotide primer Sequence 5‘- ... -3‘[a] 
D156N_forward 
D156N_backward 
V262C_forward 
V262C_backward 
V262D_forward 
V262D_backward 
V262T_forward 
V262T_backward 
5’-ATT GTT ATG GCA TTT AAT GAA TGT ACC CCG TAT-3’ 
5’-ATA CGG GGT ACA TTC ATT AAA TGC CAT AAC AAT-3’ 
5’-CAT TAT CTG ATG GGT TGT GGT AAA CCG GAT GAT-3’ 
5’-ATC ATC CGG TTT ACC ACA ACC CAT CAG ATA ATG-3’ 
5’-CAT TAT CTG ATG GGT GAT GGT AAA CCG GAT GAT-3’ 
5’-ATC ATC CGG TTT ACC ATC ACC CAT CAG ATA ATG-3’ 
5’-CAT TAT CTG ATG GGT ACT GGT AAA CCG GAT GAT-3’ 
5’-ATC ATC CGG TTT ACC AGT ACC CAT CAG ATA ATG-3’ 
a
The mutated codon is underlined.  
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9.2.5.4    In-vitro Transcription and Purification of E. coli tRNATyr 
 
The preparation of E. coli tRNATyr was carried out using the T7 RiboMAX™ Express Large 
Scale RNA Production System (Promega). Thereby, the synthesis reaction was performed 
using the ptRNA2 plasmid (Table 9.4), which was subsequently digested by RQ1 DNase. 
The purification comprised two extraction steps using a 2.1 ml mixture of 
phenol:chloroform:isoamyl alcohol 125:24:1 (v/v/v) followed by another extraction using a 1 
ml mixture of chloroform:isoamyl alcohol 24:1 (v/v). Subsequently, the sample was applied 
to a NAP-25 column and the eluate of approximately 1.5 ml evaporated overnight at 1 mbar 
and 34°C. The tRNA was resolved in HEPES buffer and monomerized by applying a 
temperature gradient reaching from 20°C to 70°C in 10°C steps each for 10 minutes. A final 
monomerization step at 70°C was performed for two hours after the addition of MgCl2 to a 
final concentration of 1 mM. Again, the sample was purified via a NAP-25 column and 
afterwards evaporated overnight under the previously mentioned conditions. The tRNA was 
resolved in assay buffer and the concentration adjusted to 200 µM using UV-Vis 
spectroscopy. 1 µM tRNATyr corresponds to an absorption of 0.703 𝐴260𝑛𝑚 .   
 
 
9.2.5.5    Agarose Gel Electrophoresis 
 
For gel electrophoresis a 1% (w/v) agarose gel was used. Thus, 0.5 g agarose were dissolved 
in 49.5 ml 1×TAE buffer by heating the suspension up in a microwave. 5 µl SYBR® Safe DNA 
gel stain solution were added directly before pouring the gel. 30 µl of the DNA sample were 
mixed with 5 µl 6×Mass Ruler Loading Dye and loaded on the gel. Fastruler™ DNA Ladder 
Middle Range and Fastruler™ DNA Ladder Low Range served as references. The gel was run 
for one hour at 100 V in 1×TAE buffer. Subsequently, bands became visible under UV light. 
 
 
9.2.5.6    Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
 
The identification and purity of TGT was analyzed via SDS-PAGE. For that purpose, gels were 
freshly prepared before usage consisting of an upper stacking and a lower running gel 
(Table 9.9).   
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Table 9.9 Stacking and running gel composition. 
 Stacking gel (2x) Running gel (2x) 
Acrylamide/bisacrylamide (30% / 0.8%) 
APS solution 
TEMED 
Stacking gel/running gel buffer 
SDS solution 
ddH2O 
1 ml 
60 µl 
6 µl 
1.2 ml 
60 µl 
3.75 ml 
3 ml 
60 µl 
6 µl 
2 ml 
60 µl 
0.95 ml 
 
30 µl of the sample were mixed with 10 µl 4×SDS sample buffer and incubated at 
95°C for 15 minutes. After centrifugation of the sample at 13000 rpm for one minute 15 µl 
were loaded to an SDS gel. The PageRuler™ Prestaint Protein Ladder served as a reference.    
SDS-PAGE was performed in Laemmli buffer at 130 V. Afterwards protein bands were 
uncovered by incubation the gel in staining solution overnight and exposing it to destaining 
solution for one hour, whereby each step was accompanied by gentle shaking.   
 
 
9.2.5.7    Determination of Protein and DNA Concentrations 
 
Concentrations of protein, DNA and tRNA solutions were determined by UV-Vis 
spectroscopy at 280 nm and 260 nm. Previous to the measurement a blank value was 
generated using the buffer free of any sample to be analyzed.  
After calculating the extinction coefficient with ProtParam the concentrations of 
protein solutions were calculated using Equation 9.1. For Z. mobilis TGT expressed without 
the strep-tag II an absorption of 0.778 𝐴280𝑛𝑚 correlates to a concentration of 1 mg/ml 
(23.4 µM). For the tagged variant an absorption of 0.875 𝐴280𝑛𝑚   corresponds to 1 mg/ml 
before and an absorption of 0.789 𝐴280𝑛𝑚   after cleavage. 
 
𝑐𝑃𝑟𝑜𝑡𝑒𝑖𝑛 =
𝐴280𝑛𝑚
𝜖𝜆 ∙𝑑
       
(Equation 9.1) 
 
The purity of protein samples could be concluded from the 𝐴260𝑛𝑚 /𝐴280𝑛𝑚  ratios 
listed in Table 9.10 [Sambrook and Russell, 2001]. 
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Table 9.10 Purity of protein samples derived by their 𝐴260𝑛𝑚 /𝐴280𝑛𝑚  ratio. 
Protein [%] Nucleic acid [%] 𝑨𝟐𝟔𝟎𝒏𝒎/𝑨𝟐𝟖𝟎𝒏𝒎 ratio 
100 0 0.57 
95 5 1.06 
90 10 1.32 
70 30 1.73 
 
Additionally, a Bradford assay was applied on the basis of protein-dye binding using 
bovine serum albumin in a concentration range of 0.2 to 0.9 mg/ml dissolved in the 
corresponding buffer as a standard. Both methods resulted in a closely similar protein 
concentration.  
 
The concentration of extracted and purified DNA was calculated according to Equation 9.2. 
 
𝑐𝐷𝑁𝐴 = 𝐴260𝑛𝑚 ∙ 50 μg/ml ∙ dilution factor       
(Equation 9.2) 
 
 
9.2.6    Enzyme Kinetics 
9.2.6.1    Trapping Experiment 
 
The base exchange mechanism allows two putative inhibition modes. Firstly, competitive 
binding is possible, which either allows tRNA or the small molecule ligand to bind to the 
active site. Secondly, a mixed binding mode can be observed in the case of small guanine-like 
inhibitors, allowing the formation of a tertiary complex after the tRNA is bound to the 
protein and guanine present in position 34 is cleaved and expelled from the binding pocket.   
To analyze the inhibition mode of the 5-azacytosine type inhibitors a trapping experiment 
was conducted as described by Xie et al., 2003.  
5 µM Z. mobilis TGT, 100 µM E. coli tRNATyr (ECY2) and 200 – 500 µM ligand depending 
on its solubility in 10 µL of 200 mM Hepes buffer pH 7.3 containing 20 mM MgCl2 were 
incubated for 1 h at room temperature. After that, 10 µL SDS buffer was added to the 
mixture and incubated for another hour to guarantee sufficient unfolding. 10 µL of each 
mixture were loaded onto a 15% SDS gel. The same conditions as described under 8.2.5.6 
were applied. After electrophoresis, protein bands were stained with Coomassie™ brilliant 
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blue R-250 (Bio-RAD). In case of a competitive inhibition mode only one band is visible at 43 
kDa. An uncompetitve binding mode is indicated by two bands. The additional band 
corresponds to the covalent tRNA-TGT complex. As a reference for uncompetitive binding 
2,6-diamino-3H-quinazolin-4-one (DAQ) was used [Brenk et al., 2004]. 
 
 
9.2.6.2    Enzyme Assay 
 
The method used for the kinetic characterization of TGT is based on the work of Grädler et 
al., 2001 and Stengl et al., 2005. Due to their low solubility the ligands were first dissolved in 
100% DMSO and subsequently diluted to the desired concentration containing 5% DMSO 
with assay buffer. The protein dissolved in the same buffer was added to the various ligand 
samples with a final concentration of 150 nM and incubated for 10 min at 37°C. Additionally, 
a reference without the ligand only containing DMSO and buffer was incubated under the 
same conditions. Subsequently, base exchange was started by the 1:1 addition of a similarly 
prepared solution containing E. coli tRNATyr (ECY2; 3 µM) and a mixture of guanine and 
radioactively labelled [8-3H]guanine (20 µM). 15 µL aliquots were removed from this mixture 
(76 µL) every two minutes and pipetted on Whatman GC-F glass microfiber filters. The 
reaction was immediately quenched in 10% (w/v) trichloroacetic acid solution at 0°C. In 
order to separate the tRNA from excess [8-3H]guanine not incorporated into tRNA, the glass 
microfiber filters were washed twice in a 5% (w/v) TCA solution for 10 min followed by an 
additional washing step using technical grade ethanol over 20 min. The labelled tRNA was 
captured in the filters during the described steps. Afterwards the filters were dried at 60°C 
for at least 30 min. The resulting count rate was obtained after the addition of 4 mL 
Rotiszent™ to each filter by liquid scintillation counting. 𝐾𝑖  values were determined using the 
method described by Dixon at least in duplicate [Dixon, 1953]. Thereby, the slope of the 
plotted count rates (GraFit 4.09™, Erithacus Software) yields the initial velocities at given 
inhibitor concentrations:  
 
𝑣𝑖 =
𝑣𝑚𝑎𝑥 ∙ 𝑆 
𝐾𝑚 ∙ 1+
 𝐼 
𝐾𝑖
 + 𝑆 
        
(Equation 9.3) 
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The reproducibility of the maximal velocity 𝑣0 defined by equation 9.3 [Michaelis and 
Menten, 1913] is low and therefore, has to be determined again for every series of 
measurements. The combination of equation 9.3 and 9.4 yields the inhibition constant 𝐾𝑖  
corresponding to equation 9.5. Thereby, a Michaelis-Menten constant of 0.9 µmol ∙ L−1 was 
used for data evaluation [Biela et al., 2013]. 
 
𝑣0 =
𝑣𝑚𝑎𝑥 ∙  𝑆 
𝐾𝑚 +  𝑆 
       (Equation 9.4) 
𝑣𝑖 =
𝑣𝑚𝑎𝑥 ∙ 𝑆 
𝐾𝑀 ∙ 1+
 𝐼 
𝐾𝑖
 + 𝑆 
       𝑣0 =
𝑣𝑚𝑎𝑥 ∙ 𝑆 
𝐾𝑀+ 𝑆 
       
𝑣0
𝑣𝑖
∙
𝐾𝑀+ 𝑆 
𝑀
=
1
𝐾𝑖
∙  𝐼 +  
 𝑆 
𝐾𝑀
+ 1        
(Equation 9.5) 
𝑣0   Initial velocity in absence of an inhibitor 
𝑣𝑖  Initial velocity in presence of an inhibitor 
𝐾𝑀  Michaelis-Menten constant of tRNA
Tyr
 
 𝑆  Concentration of tRNATyr 
 𝐼  Inhibitor concentration 
𝐾𝑖  Competitive inhibition constant 
 
 
9.2.6.3    Kinetic characterization 
 
Deviating from the described enzyme assay various E.coli tRNATyr concentrations (0.5 µM, 
1.0 µM, 1.5 µM, 3.0 µM, 6.0 µM 15.0 µM) were used for the kinetic characterization of the 
TGT mutants while keeping the guanine (15% radioactively labelled) and protein 
concentration (75 nM) fixed. This time the guanine / radioactively labelled guanine substrate 
(20 µM) was pre-incubated together with tRNA (150 nM) in assay buffer for 10 minutes at 
37°C. Subsequently, the protein dissolved in assay buffer was added in a 1:2 manner. 15 µl 
aliquots were removed from this mixture (76 µl) every four minutes over a total period of 16 
minutes and pipetted on Whatman GC-F glass microfiber filters. The reaction was 
immediately quenched in 10% (w/v) TCA solution at 0°C followed by the previously 
described washing steps. Afterwards the filters were dried at 60°C for at least 30 minutes. 
The resulting count rate was obtained after the addition of 4 ml Rotiszent™ to each filter by 
liquid scintillation counting. After converting the derived cpm signal into the amount of 
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incorporated radioactive guanine via a calibration line the initial velocities 𝑣0 for each tRNA 
concentration were plotted against the reaction time (GraFit 4.09™, Erithacus Software). 
Based on this plot a Michaelis-Menten curve was generated yielding the Michaelis-Menten 
constant 𝐾𝑀  as well as 𝑘𝑐𝑎𝑡  according to the Michaelis-Menten Equation 9.6. Measurements 
were at least carried out in duplicate. 
 
𝑣0 =
𝑘𝑐𝑎𝑡
[𝐸]
∙ 𝑆 
𝐾𝑀+ 𝑆 
       (Equation 9.6) 
𝑣0   Initial velocity 
𝑘𝑐𝑎𝑡  Catalytic constant of the base exchange 
𝐾𝑀  Michaelis-Menten constant of tRNA
Tyr
 
 𝑆  Concentration of tRNATyr 
 𝐸  Concentration of Z. mobilis TGT 
 
 
9.2.7    Isothermal Titration Calorimetry  
 
ITC measurements were performed using a Microcal iTC200 microcalorimeter system (GE 
Healthcare). The protein was dissolved in the experimental buffer to a final concentration of 
10 µM for the titrations of lin-benzoguanines, 20 µM for the titrations of lin-
benzohypoxanthines, and 30 µM for the titrations of the 5-azacytosine derivative 11, each 
containing 3% DMSO. Due to their low solubility the ligands were first dissolved in 100% 
DMSO and diluted with the buffer solution to a final DMSO concentration of 3%. The ligand 
concentration in the syringe was adjusted to 200 – 300 µM with the experimental buffer. To 
examine a potential buffer dependency of the binding process, experiments were carried out 
in three different buffer systems containing either 50 mM Hepes, Tris or Tricine, 200 mM 
NaCl and 0.037% Tween 20, pH 7.8 at least in duplicate. The experimentally determined 
enthalpy ∆𝐻𝑜𝑏𝑠  was plotted against the heat of ionization ∆𝐻𝑖𝑜𝑛  as reported in literature and 
fitted by linear regression [Christensen, 1976; Fukada and Takahashi, 1998]. The intercept of 
the y axis represents the enthalpy corrected for buffer contributions and the slope discloses 
the number of protons released or taken up per mole formed complex upon binding 
according to Equation 9.7. The positive slope for the measurements involving the lin-
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benzoguanine series indicated the uptake of one proton by the ligand. Therefore, enthalpy 
values were corrected for buffer dependency as described above. The lin-
benzohypoxanthine series did not show a significant proton uptake. Thus, the mean of three 
independent measurements was calculated. 
 
∆𝐻𝑜𝑏𝑠 = ∆𝐻𝑏𝑖𝑛𝑑 + 𝑛𝐻+ ∙ ∆𝐻𝑖𝑜𝑛        (Equation 9.7) 
 
All ITC experiments were run at 25°C after a stable baseline had been achieved. The 
reference cell contained filtered demineralized water. The initial delay before the injections 
were started and the spacing between each injection were adjusted to 180 s. The first 
injection contained 0.3 – 0.5 µL of the ligand solution followed by 14 – 24 injections of 1.0 – 
2.0 µL. A stirring speed of 1000 rpm was chosen. Raw data were collected as released heat 
per time. 
To analyze the raw data using the Origin 7.0 software, the baseline and integration 
limits were adjusted manually. After integrating the area under the peaks, the first data 
point was removed due to its reduced accuracy [Mizoue and Tellinghuisen, 2004]. The 
influence of the heat of dilution was corrected considering the heat contributions collected 
after saturation of the protein. 𝐾𝑑  as well as ∆𝐻
0 were extracted applying a single-site 
binding model as provided by the manufacturer. Subsequently, −𝑇∆𝑆0 was calculated 
according to the Gibbs-Helmholtz equation. 
 
 
9.2.8    Dynamic Light Scattering 
 
The potential aggregation behavior of the 5-azacytosine derivative 11 was determined by 
Dynamic Light Scattering (DLS) under assay conditions (200 mM, HEPES, 20 mM MgCl2, 
0.037% (v/v) Tween 20, 5% (v/v) DMSO, pH 7.3) at a final concentration of 20 µM using a 
SpectroSizeTM 300 (Molecular Dimensions Limited) equipped with an optical power of 
100 mW at a wavelength of 660 nm at 37°C. The scattered light was detected at a 90° angle. 
The given data comprised at least two measurements of 30 runs over 15 s. Clotrimazole 
served as a reference as a strong aggregator at a concentration of 100 µM in assay buffer 
containing 5% (v/v) DMSO [Seidler et al., 2003]. Count rate and autocorrelation function 
were plotted using the program R. 
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The calculation of the particle size was based on the Brownian motion. The bigger a 
particle, the slower is its movement through a medium and the slower is the change in its 
scattered light. This relationship is expressed by the Stokes-Einstein equation: 
 
𝑑 =
𝑘𝐵𝑇
3𝜋𝜂𝐷
       (Equation 9.8) 
𝑑 Hydrodynamic diameter 
𝑘𝐵  Boltzmann constant 
𝑇 Temperature in Kelvin 
𝜂 Viscosity of the medium 
𝐷 Diffusion coefficient 
 
 
9.2.9    X-ray Crystallography 
9.2.9.1    Z. mobilis TGT Crystallization 
 
Crystals were grown in the presence of the inhibitor using the sitting drop vapor diffusion 
method at 291 K. The protein solution was adjusted to 12 mg ∙ mL−1 by dilution with high 
salt buffer (10 mM Tris, 2 M NaCl, 1 mM EDTA, pH 7.8) and incubated with the inhibitor 
previously dissolved in 100% DMSO at a final concentration up to 1.5 mM depending on the 
solubility of the corresponding ligand. This solution was mixed with 1.5 µL reservoir solution 
(100 mM MES, pH 5.5, 10% (v/v) DMSO, 11 – 13% (w/v) PEG 8000) to a 3 µL droplet. The 
reservoir contained 1.0 mL of the above-mentioned solution. Within one week crystals 
showing an appropriate size for data collection were obtained.  
 
For crystals grown in the presence of a ligand which did not show an appropriate size 
or form sufficient for diffraction experiments a soaking protocol was applied (TGT∙3a, 
TGT∙5b, TGT Val262Thr∙4a, TGT Val262Asp∙4a, TGT Val262Cys∙4a, TGT∙7). For that purpose, 
crystals were grown in the absence of the ligand according to the previously described 
protocol. Instead of mixing the protein solution with the inhibitor before crystallization, pre-
grown apo crystals were transferred to a 3 µL droplet of reservoir solution mixed with the 
stock solution containing the desired ligand to a final concentration of 1 mM. The droplet 
was sealed against 1.0 mL reservoir solution and soaked into the crystal overnight. 
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9.2.9.2    pH Soaking 
 
For pH soaking a single crystal grown at pH 5.5 was transferred and incubated over a period 
of 5 min into droplets consisting of reservoir solution and buffer containing 100 mM Tris, 
pH 7.8, 10% (v/v) DMSO, 8% (w/v) PEG 8000 mixed in a 3:2, 1:2, and 2:3 manner, 
respectively. Subsequently, the crystal was equilibrated in a droplet of sole buffer pH 7.8 
overnight to guarantee a homogeneous pH over the whole crystal. As a cryoprotectant for 
the apo crystal 20% (v/v) PEG 400 (cryo buffer D) was used.   
 
 
9.2.9.3    Data Collection 
 
For data collection the crystals were transferred into the corresponding cryoprotectant 
solution (cryo buffers A – C, Table 8.3) for 20 seconds followed by immediate flash-freezing 
in liquid nitrogen. Due to their low affinity, the corresponding 5-azacytosine based ligands 
were added to the cryoprotectant solution in the same concentration as applied to the 
crystallization conditions to prevent diffusion out of the crystals. 
Data sets were collected at the BESSY II (Helmholtz-Zentrum, Berlin, Germany) 
beamline 14.2 at a wavelength of λ = 0.91841 Å and 14.3 at a wavelength of λ = 0.89460 Å 
both using a Rayonix MX225 CCD detector. Additionally, complex structures were collected 
at the PETRA III (EMBL, Hamburg, Germany) beamline P14 at a wavelength of λ = 1.23953 Å 
and λ = 0.97627 Å using a PILATUS 6M-F detector. To minimize radiation damage, all data 
sets were collected at cryo-conditions (100 K).  
All TGT crystals showed the monoclinic space group C2 containing one monomer in 
the asymmetric unit. Data sets TGT∙3a, TGT∙4a, TGT∙4b, TGT∙5a, TGT∙5b, TGT∙6a, TGT∙6b, TGT 
Val262Thr, TGT Val262Asp, TGT Val262Cys, TGT Val262Thr∙4a, TGT Val262Cys∙4a, TGT∙7, 
TGT∙7a, TGT∙8, TGT∙9, and TGT∙10 were processed and scaled with the HKL2000 package 
[Otwinowski and Minor, 1997]. Data processing and scaling for TGT Asp102Asn∙3a, 
Asp156Asn∙3a, TGT-apo pH 7.8, TGT∙7b, TGT∙7c, and TGT∙7d were performed with XDS and 
XSCALE [Kabsch, 2010], respectively. Data set TGT Val262Asp∙4a was processed with 
iMOSFLM 1.0.6 [Battye et al., 2011] and subsequently scaled with the program SCALA of the 
ccp4 program suite [Winn et al., 2011]. Cell dimensions, data collection and processing 
statistics are given in the appendix (Table 10.8). 
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9.2.9.4      Calculation of the Anomalous Map 
 
The anomalous electron density was generated using the program ANODE [Thorn and 
Sheldrick, 2011]. Unit-cell parameters, space-group notation, and atom coordinates were 
extracted from the pdb-files. Reflection indices,  𝐹𝐴  and α values originated from the 
reflection file derived with XPREP [Sheldrick, 2008]. 
 
 
9.2.9.5    Structure Determination and Refinement 
 
The coordinates of the TGT apo-structure 1PUD served as a starting model for molecular 
replacement using the program Phaser MR of the ccp4 program suite [McCoy, 2007]. 
Structures were refined using the program Phenix [Adams et al., 2010] starting with a first 
cycle of simulated annealing using default parameters. Further refinement cycles comprised 
the coordinate xyz, occupancy and individual B-factor refinement as well as applying metal 
restraints for the zinc ion. In case of the structures TGT∙3a, TGT∙6b, and TGT-apo pH 7.8 the 
weights between X-ray target and stereochemistry restraints were optimized in addition to 
individual atomic displacement parameter (ADP) weights refined for TGT∙3a, TGT∙4a, TGT∙4b, 
TGT∙5a, TGT∙5b, TGT∙6a, TGT∙6b, TGT∙7, TGT∙7a, TGT∙7b, TGT∙7c, TGT∙7d, and TGT-apo 
pH 7.8. The temperature factors of structures TGT∙3a, TGT∙4a, TGT-apo pH 7.8, TGT∙4b, 
TGT∙5a, TGT∙6a, TGT∙6b, TGT Val262Thr, TGT Val262Asp, TGT Val262Cys, TGT Val262Asp∙4a, 
TGT∙7, TGT∙7a, TGT∙7b, TGT∙7c, and TGT∙7d were refined anisotropically, while for structures 
TGT Asp102Asn∙3a, Asp156Asn∙3a, TGT∙5b, TGT Val262Thr∙4a, TGT Val262Cys∙4a, TGT∙8, 
TGT∙9, and TGT∙10 a TLS refinement was performed after selecting appropriate TLS groups 
with the phenix.find_tls_groups option [Painter and Merritt, 2006]. The calculation of the 
Rfree value comprised a 2 – 5% fraction of the data.  
For all structures amino acid side chains were fitted according to their σA-weighted 
2 𝐹𝑜  −  𝐹𝑐  and  𝐹𝑜  −  𝐹𝑐   electron density obtained in the program Coot [Emsley and 
Cowtan, 2004]. After the initial refinement cycles, the zinc ion as well as water and glycerol 
molecules were implemented in the model. For adding water molecules, the option “update 
waters” included in Phenix was used after increasing the hydrogen bond length threshold for 
the solvent-model and solvent-solvent contacts to 2.3 Å. The inserted molecules were 
visually reviewed afterwards. Ligand restraints were generated by the CSD based 
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gradeWebServer [http://grade.globalphasing.org] in case of 3a, 4a, 4b, 5a, 5b, 6a, 6b, 7b, 7c 
and 7d. Ligands were built and minimized using the program MOE [MOE 2012.10] and 
geometric restraints calculated subsequently by the program Monomer Library Sketcher 
[Winn et al., 2011] in case of 7, 7a, 8, 9, and 10. Multiple protein residue conformations 
were assigned in case a reasonable electron density was observed and were kept during 
refinement if the side chain with the lowest occupancy showed a value of at least 20%. In 
case of 4a, 4b, 5a, 5b, 6a, 6a, and 7b the occupancies of the 2-substituent were refined due 
to elevated B-factors observed for this portion. In the same manner the occupancies of 8, 9, 
and 10 were refined for the whole molecule. Ramachandran plots were generated with the 
program PROCHECK [Laskowski et al., 1993]. For the analysis of temperature factors the 
program Moleman was used [Kleywegt, 2001]. The burial of molecular ligand portions in the 
protein binding pocket was computed using the program MS [Connolly, 1983]. 
 
 
9.3 Synthesis  
 
Ligands were synthesized and purified as described in detail elsewhere [Hörtner et al., 2007; 
Barandun et al., 2012; Neeb et al., 2014; Neeb et al., 2014]. 
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10. Appendix 
10.1 Calculation of pKa Values of Titratable Groups of the TGT Active Site 
10.1.1 TGT Wild Type 
Table 10.1 Calculated pKa values of the amino acid residues within a 12 Å sphere around Cγ of Tyr106 of TGT 
wild type and 3a before and after complex formation. 
Residue pKa prior to complex formation
[a]                                pKa in complexed state 
  N3 N5 
CYS-281 10.40 10.32 10.25 
CYS-158 11.87 11.96 12.23 
ASP-156 5.44 4.40 3.02 
ASP-280 2.18 0.59 1.44 
ASP-266 3.24 3.21 3.24 
ASP-267 0.66 0.48 0.66 
ASP-245 3.80 3.79 3.80 
ASP-238 3.98 3.98 3.98 
ASP-102 1.63 1.64 -2.12 
LYS-52 8.75 8.74 8.71 
LYS-264 12.39 12.35 12.37 
HIS-73 4.08 3.97 3.98 
3a[b]  6.65 7.00 
GLU-235 4.20 3.55 4.30 
GLU-239 3.24 3.24 3.23 
GLU-173 4.57 4.58 4.60 
GLU-157 3.13 3.06 3.16 
TYR-72 12.02 11.96 11.93 
TYR-106 10.77 11.60 11.53 
TYR-226 11.66 11.67 11.67 
TYR-381 10.83 10.81 10.82 
TYR-354 15.55 15.53 15.52 
TYR-161 10.70 10.67 10.70 
TYR-258 16.51 16.76 16.65 
a
For the Poisson-Boltzmann calculations a dielectric constant of ε = 20 was applied. 
b
pKa values in aqueous 
solution according to Barandun et al., 2012. 
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10.1.2 TGT Asp102Asn 
Table 10.2 Calculated pKa values of the amino acid residues within a 12 Å sphere around Cγ of Tyr106 of TGT 
Asp102Asn and 3a before and after complex formation. 
Residue pKa prior to complex formation
[a] pKa in complexed state  
N5 
CYS-281 8.73 8.67 
CYS-158 10.40 11.00 
ASP-156 2.80 2.57 
ASP-280 1.37 1.19 
ASP-266 3.70 3.70 
ASP-267 0.47 0.52 
ASP-245 3.71 3.72 
ASP-238 3.90 3.89 
LYS-52 8.40 8.36 
LYS-264 12.97 12.97 
3a[b]  -1.14 
HIS-73 3.94 3.84 
GLU-235 3.67 4.00 
GLU-239 3.27 3.26 
GLU-173 4.40 4.41 
GLU-157 2.47 2.52 
TYR-72 11.17 11.06 
TYR-106 10.69 11.37 
TYR-226 10.83 10.83 
TYR-381 11.75 11.73 
TYR-354 14.59 14.59 
TYR-161 10.67 10.67 
TYR-258 15.58 15.55 
a, b
The same conditions are applied as denoted in Table 10.1. 
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10.1.3 TGT Asp156Asn 
Table 10.3 Calculated pKa values of the amino acid residues within a 12 Å sphere around Cγ of Tyr106 of TGT 
Asp156Asn and 3a before and after complex formation. 
Residue pKa prior to complex formation
[a] pKa in complexed state  
N5 
CYS-281 9.31 9.28 
CYS-158 10.46 10.76 
ASP-280 2.29 1.36 
ASP-266 3.42 3.40 
ASP-267 1.70 1.70 
ASP-245 3.97 3.95 
ASP-238 4.09 4.08 
ASP-102 1.29 -2.31 
LYS-52 8.66 8.64 
LYS-264 11.32 11.30 
3a[b]  5.32 
HIS-73 3.84 3.50 
GLU-235 4.37 4.31 
GLU-239 3.50 3.47 
GLU-173 4.55 4.52 
GLU-157 3.72 3.46 
TYR-72 10.83 10.77 
TYR-106 11.62 12.34 
TYR-226 11.36 11.36 
TYR-381 9.18 9.19 
TYR-354 14.44 14.45 
TYR-161 10.85 10.85 
TYR-258 16.34 16.52 
a, b
The same conditions are applied as denoted in Table 10.1. 
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10.2 Anomalous Density Data  
 
Table 10.4 Anomalous density data for TGT∙5a. 
Peak Height Nearest atom[a] [Å]  Peak Height Nearest atom[a] [Å] 
1 53.36 ZN_B:ZN1 0.04  33 4.39 C_A:TYR381 1.37 
2 8.69 SD_A:MET176 0.09  34 4.37 OD1_A:ASN304 1.34 
3 7.46 SD_A:MET153 0.34  35 4.36 CA_A:VAL322 1.36 
4 7.43 SD_A:MET278 0.32  36 4.35 OE2_A:GLU273 1.00 
5 7.27 SD_A:MET75 0.16  37 4.30 NH2_A:ARG211 0.65 
6 6.94 SD_A:MET250 0.16  38 4.27 C_A:SER205 0.42 
7 6.73 SG_A:CYS318 0.22  39 4.27 OG_A:SER371 1.66 
8 6.63 SG_A:CYS158 0.12  40 4.24 CA_A:GLY87 2.13 
9 6.53 O_S:HOH1 0.11  41 4.23 O_S:HOH14[b] 0.15 
10 6.43 SD_A:MET43 0.22  42 4.22 O_A:SER170 0.46 
11 6.23 SD_A:MET260 0.13  43 4.20 CA_A:LEU54 2.16 
12 6.00 SD_A:MET172 0.37  44 4.20 N_A:ASP96 1.09 
13 5.78 SD_A:MET240 0.28  45 4.18 NE_A:ARG34 2.24 
14 5.29 SG_A:CYS318 1.18  46 4.17 O_A:LEU357 1.72 
15 5.06 O_S:HOH2 0.61  47 4.17 CB_A:ALA352 1.58 
16 4.94 SG_A:CYS320 0.83  48 4.15 OE1_A:GLN372 4.30 
17 4.92 NZ_A:LYS312 1.40  49 4.13 O_S:HOH62 0.26 
18 4.90 N_A:CYS323 1.90  50 4.12 C_A:VAL269 0.73 
19 4.83 SD_A:MET358 0.11  51 4.12 O_A:GLU317 1.46 
20 4.70 SD_A:MET240 1.38  52 4.11 CG2_A:VAL206 1.43 
21 4.61 O_S:HOH369 1.36  53 4.11 O_S:HOH349 1.25 
22 4.60 SD_A:MET344 0.46  54 4.11 O_A:SER287 1.16 
23 4.58 CE1_A:HIS349 1.15  55 4.10 O_S:HOH359 1.55 
24 4.55 O_A:ALA383 5.09  56 4.09 O_S:HOH101 0.90 
25 4.54 CA_A:GLU235 1.14  57 4.08 O_S:HOH269 0.48 
26 4.50 O_S:HOH123 0.28  58 4.07 N_A:ARG132 3.42 
27 4.50 O_A:GLY230 0.31  59 4.06 N_A:GLU173 0.37 
28 4.44 O_S:HOH428 3.37  60 4.06 CD2_A:LEU89 2.06 
29 4.44 C_A:TRP95 1.08  61 4.03 NE1_A:TRP178 0.88 
30 4.42 O_S:HOH196 1.15  62 4.02 O_S:HOH203 0.91 
31 4.41 CB_A:ASP363 1.51  63 4.01 O_S:HOH269 3.96 
32 4.40 SD_A:MET109 0.30      
a
The nearest atom is listed in the form atom_chain:residue. 
b
Anomalous data for the identified chloride ion. 
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Table 10.6 Anomalous density data for TGT∙5b. 
Peak Height Nearest atom[a] [Å]  Peak Height Nearest atom[a] [Å] 
1 60.59 ZN_B:ZN1 0.03  20 4.37 O_F:HOH1 1.13 
2 7.01 SD_A:MET153 0.21  21 4.37 SD_A:MET346 0.19 
3 6.50 SD_A:MET43 0.42  22 4.31 O_A:ARG34 1.67 
4 6.50 SD_A:MET358 0.21  23 4.31 SD_A:MET172 0.19 
5 6.03 SD_A:MET344 0.38  24 4.30 O_A:SER366 1.59 
6 5.98 SD_A:MET278 0.14  25 4.30 SG_A:CYS281 0.48 
7 5.73 O_G:HOH1[b] 0.11  26 4.29 CA_A:GLY234 4.95 
8 5.24 SD_A:MET176 0.25  27 4.29 O_S:HOH292 3.36 
9 5.01 SD_A:MET250 0.34  28 4.25 CB_A:THR295 1.21 
10 4.92 O_S:HOH241 1.23  29 4.25 O_A:MET109 4.66 
11 4.77 O_S:HOH290 3.05  30 4.22 OD2_A:ASP238 7.99 
12 4.74 SG_A:CYS158 0.14  31 4.19 SG_A:CYS323 0.16 
13 4.66 SD_A:MET93 0.50  32 4.17 CA_A:SER287 1.17 
14 4.47 NH1_A:ARG34 4.05  33 4.16 CA_A:SER112 1.89 
15 4.42 CA_A:ARG303 0.92  34 4.15 N_A:SER17 0.83 
16 4.41 SD_A:MET260 0.43  35 4.10 O_S:HOH184 3.08 
17 4.41 N_A:LEU68 1.05  36 4.09 C_A:LYS125 1.76 
18 4.39 OD1_A:ASN290 2.21  37 4.09 CZ_A:PHE42 1.14 
19 4.37 O_F:HOH1 1.13  38 4.08 CB_A:SER205 2.01 
a
The nearest atom is listed in the form atom_chain:residue. 
b
Anomalous data for the identified chloride ion. 
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10.3 Thermodynamic Data of lin-Benzopurines 
 
Table 10.6 Raw data as well as thermodynamic profiles after correction for buffer distribution of the 
investigated ligands measured at 25 °C. 
Ligand 𝑲𝒅 𝒏𝑴  
∆𝑮𝟎 𝒌𝑱 ∙
𝒎𝒐𝒍−𝟏 [] 
buffer 
∆𝑯𝒐𝒃𝒔 𝒌𝑱 ∙
𝒎𝒐𝒍−𝟏 [a] 
−𝑻∆𝑺𝟎 𝒌𝑱 ∙
𝒎𝒐𝒍−𝟏 [a] 
3a 52.4 ± 6.9 -41.6 ± 0.3 Hepes -74.8 ± 1.8    33.2 ± 1.9[b] 
   Tricine -66.7 ± 0.1 25.1 ± 0.3 
   Tris -50.9 ± 0.9   9.3 ± 0.9 
    -97.4 ± 2.2    55.8 ± 2.2[c] 
3b 411.0 ± 63.8 -36.5 ± 0.3 Hepes -48.0 ± 0.2 11.5 ± 0.4 
   Tricine -47.7 ± 0.2 11.2 ± 0.5 
   Tris -47.6 ± 0.3 11.1 ± 0.5 
    -47.7 ± 0.3 11.2 ± 0.5 
4a 35.0 ± 6.9 -42.6 ± 0.5 Hepes -78.3 ± 1.2  35.7 ± 1.3 
   Tricine -65.8 ± 0.3  23.2 ± 0.6 
   Tris -51.9 ± 1.1    9.3 ± 1.2 
    -96.4 ± 4.0  53.8 ± 4.0 
4b 369.2 ± 25.3 -36.7 ± 0.2 Hepes -50.1 ± 0.4 13.4 ± 0.4 
   Tricine -49.3 ± 0.4 12.6 ± 0.4 
   Tris -47.4 ± 0.4 10.7 ± 0.4 
    -48.9 ± 1.4 12.2 ± 1.4 
5a 34.3 ± 6.5 -42.6 ± 0.5 Hepes -66.7 ± 0.5 24.1 ± 0.7 
   Tricine -56.9 ± 0.5 14.3 ± 0.7 
   Tris -48.8 ± 0.4   6.2 ± 0.6 
    -78.9 ± 3.7  36.3 ± 3.7 
5b 407.4 ± 46.0 -36.5 ± 0.3 Hepes n.d.    n.d.[d] 
   Tricine -50.6 ± 0.7 14.1 ± 0.8 
   Tris -50.6 ± 1.7 14.1 ± 1.8 
    -50.6 ± 1.4 14.1 ± 1.4 
6a 111.6 ± 11.8 -39.7 ± 0.3 Hepes -50.9 ± 0.6 11.2 ± 0.6 
   Tricine -44.0 ± 1.5   4.3 ± 1.5 
   Tris -31.2 ± 0.8 -8.5 ± 0.8 
    -66.3 ± 0.8 26.6 ± 0.9 
6b 1638.9 ± 204.7 -33.0 ± 0.3 Hepes -42.1 ± 0.4   9.1 ± 0.5 
   Tricine -41.8 ± 0.4   8.8 ± 0.5 
   Tris -42.3 ± 0.5   9.3 ± 0.6 
    -42.1 ± 0.3   9.1 ± 0.4 
a−𝑇∆𝑆0 was calculated according to the Gibbs-Helmholtz equation. bErrors were estimated by means of 
standard deviation for 𝐾𝑑  and ∆𝐺
0  comprising at least six measurements and for ∆𝐻𝑜𝑏𝑠  at least two. The error 
for −𝑇∆𝑆0 was calculated according to error propagation. cBuffer corrected data are displayed in bold. dNot 
determined. 
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10.4 Sequencing Results of the Strep-tagged TGT Variants after Cleavage 
 
D156N           GSMVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPET 60 
WT              GSMVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPET 60 
                ************************************************************ 
 
D156N           VRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQS 120 
WT              VRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQS 120 
                ************************************************************ 
 
D156N           EEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFNECTPYPATPSRAASSMERSMRW 180 
WT              EEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRW 180 
                *************************************:********************** 
 
D156N           AKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQD 240 
WT              AKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQD 240 
                ************************************************************ 
 
D156N           EMFRVLDFSVPMLPDDKPHYLMGVGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDG 300 
WT              EMFRVLDFSVPMLPDDKPHYLMGVGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDG 300 
                ************************************************************ 
 
D156N           PINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLM 360 
WT              PINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLM 360 
                ************************************************************ 
 
D156N           QKIRDSISEGRFSQFAQDFRARYFARNS 388 
WT              QKIRDSISEGRFSQFAQDFRARYFARNS 388 
                **************************** 
 
Scheme 10.1 Sequence alignment of mutant Asp156Asn. 
 
 
V262C           GSMVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPET 60 
WT              GSMVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPET 60 
                ************************************************************ 
 
V262C           VRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQS 120 
WT              VRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQS 120 
                ************************************************************ 
 
V262C           EEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRW 180 
WT              EEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRW 180 
                ************************************************************ 
 
V262C           AKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQD 240 
WT              AKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQD 240 
                ************************************************************ 
 
V262C           EMFRVLDFSVPMLPDDKPHYLMGCGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDG 300 
WT              EMFRVLDFSVPMLPDDKPHYLMGVGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDG 300 
                *********************** ************************************ 
 
V262C           PINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLM 360 
WT              PINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLM 360 
                ************************************************************ 
 
V262C           QKIRDSISEGRFSQFAQDFRARYFARNS 388 
WT              QKIRDSISEGRFSQFAQDFRARYFARNS 388 
                **************************** 
 
Scheme 10.2 Sequence alignment of mutant Val262Cys. 
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V262D           GSMVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPET 60 
WT              GSMVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPET 60 
                ************************************************************ 
 
V262D           VRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQS 120 
WT              VRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQS 120 
                ************************************************************ 
 
V262D           EEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRW 180 
WT              EEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRW 180 
                ************************************************************ 
 
V262D           AKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQD 240 
WT              AKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQD 240 
                ************************************************************ 
 
V262D           EMFRVLDFSVPMLPDDKPHYLMGDGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDG 300 
WT              EMFRVLDFSVPMLPDDKPHYLMGVGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDG 300 
                *********************** ************************************ 
 
V262D           PINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLM 360 
WT              PINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLM 360 
                ************************************************************ 
 
V262D           QKIRDSISEGRFSQFAQDFRARYFARNS 388 
WT              QKIRDSISEGRFSQFAQDFRARYFARNS 388 
                **************************** 
 
Scheme 10.3 Sequence alignment of mutant Val262Asp. 
 
 
V262T           GSMVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPET 60 
WT              GSMVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPET 60 
                ************************************************************ 
 
V262T           VRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQS 120 
WT              VRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQS 120 
                ************************************************************ 
 
V262T           EEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRW 180 
WT              EEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRW 180 
                ************************************************************ 
 
V262T           AKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQD 240 
WT              AKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQD 240 
                ************************************************************ 
 
V262T           EMFRVLDFSVPMLPDDKPHYLMGTGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDG 300 
WT              EMFRVLDFSVPMLPDDKPHYLMGVGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDG 300 
                ***********************.************************************ 
 
V262T           PINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLM 360 
WT              PINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLM 360 
                ************************************************************ 
 
V262T           QKIRDSISEGRFSQFAQDFRARYFARNS 388 
WT              QKIRDSISEGRFSQFAQDFRARYFARNS 388 
                **************************** 
 
Scheme 10.4 Sequence alignment of mutant Val262Thr. 
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10.5 Mass Spectra of the Strep-tagged TGT Variants after Cleavage 
 
 
 Figure 10.1 Mass spectrum of TGT Asp156Asn (theoretical mass: 43012.8 Da).  
 
 
 Figure 10.2 Mass spectrum of TGT Val262Cys (theoretical mass: 43017.8 Da). 
 
  
 Figure 10.3 Mass spectrum of TGT Val262Asp (theoretical mass: 43029.7 Da). 
 
 
 Figure 10.4 Mass spectrum of TGT Val262Thr (theoretical mass: 43015.8 Da). 
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10.6 Enzyme Kinetics of the Strep-tagged TGT Variants after Cleavage 
 
Table 10.7 Initial velocities, Michaelis-Menten plot and kinetic data of the different TGT variants. 
TGT Wild Type 
[Jakobi, 2013] 
                KM (tRNA)                 4.8   µM 
               kcat                                      1.2 10
-2 s-1 
 
TGT D156N 
 
 
 
 
 
               KM (tRNA)                 5.25 µM 
               kcat                                      3.4 10
-3 s-1 
 
TGT V262C Active (multiple measurements did not yield an evaluable result) 
 
TGT V262D 
 
 
 
 
 
               KM (tRNA)                 6.49 µM 
               kcat                                      4.0 10
-3 s-1 
 
TGT V262T 
 
 
 
 
 
               KM (tRNA)                 3.52 µM 
               kcat                                      5.3 10
-3 s-1 
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10.7 Data Collection and Refinement Statistics 
 
Table 10.8 Data collection, processing and refinement statistics for the investigated TGT-ligand-complexes. 
Crystal data TGT∙3a Asp102Asn∙3a Asp156Asn∙3a TGT∙4a Apo pH 7.8 
PDB ID 4PUK 4PUL 4PUM 4PUJ 4PUN 
A) Data collection and processing      
Collection site BESSY 14.2 PETRA P14 PETRA P14 BESSY 14.2 PETRA P14 
No. crystals used 1 1 1 1 1 
λ *Å+ 0.91841 1.23953 1.23953 0.91841 0.97627 
Space group C2 C2 C2 C2 C2 
Unit cell parameters      
a [Å] 90.8 89.7 89.7 90.6 90.5 
b [Å] 65.0 64.2 64.7 64.8 64.7 
c [Å] 71.0 70.4 70.8 71.0 69.9 
β *°+ 96.3 92.9 93.1 96.2 96.0 
B) Diffraction data
[a]
      
Resolution range [Å] 30 - 1.49 80 - 1.65 80 - 1.93 30 - 1.42 50 - 1.25 
 (1.52 - 1.49) (1.85 - 1.65) (1.98 - 1.93) (1.44 - 1.42) (1.30 - 1.25) 
Unique reflections 66573 43729 30236 76897 107127 
 (3339) (9984) (2238) (3785) (11652) 
R(I)sym [%]
[b]
 5.1 (48.1)  2.9 (27.5)  4.7 (50.5) 5.7 (50.5) 3.0 (50.0) 
Completeness [%] 99.4 91.6 99.0 99.3 96.8 
 (98.8) (73.8) (99.4) (98.4) (95.3) 
Redundancy 5.1 (4.9) 3.1 (2.6) 4.7 (4.6) 5.2 (5.1) 3.3 (3.3) 
I/σ (I) 29.3 (3.4) 22.3 (3.8)  21.6 (3.4) 28.6 (3.9) 18.0 (2.7) 
Wilson B-factor [Å
2
] 15.7 22.4 25.8 12.8 14.5 
Matthews Coefficient [Å
3
/Da] 2.4 2.4 2.4 2.4 2.4 
C) Refinement      
PHENIX version 1.8.4_1496 1.8.1_1168 1.8.1_1168 1.8.4_1496 1.8.4_1496 
Resolution range [Å] 27.3 - 1.49 70.3 - 1.65 70.7 - 1.93 29.5 - 1.42 45.0 - 1.25 
Reflections used for Rfree  
Reflections used for Rwork 
2000 
64506  
1312 
42417  
1512 
28724  
2000 
74896 
5357 
101770 
Final R values
[a]
      
Rfree  [%]
[c]
 17.2 18.9 20.2 16.0 16.2 
Rwork [%]
[d]
 13.9 16.7 15.9 12.9 13.9 
No. of atoms (non-hydrogen)      
Protein atoms 2922 2829 2854 2911 2920 
Water molecules 365 261 219 388 373 
Ligand atoms 17 17 17 24 --- 
RMSD, angle [°] 1.3 1.1 1.1 1.0 1.4 
RMSD, bond [Å] 0.014 0.008 0.009 0.007 0.013 
Ramachandran plot
[e]
      
Most favoured regions [%] 95.3 95.9 95.9 94.2 94.0 
Additionally allowed regions [%] 4.4 3.8 3.8 5.4 5.6 
Generously allowed regions [%] 0.3 0.3 0.3 0.3 0.3 
Mean B-factors [Å
2
]      
Protein atoms 19.4 24.6 25.1 14.3 18.5 
Water molecules 33.3 33.7 31.0 32.5 29.8 
Ligand atoms 16.7 22.6 24.9 13.8 --- 
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Crystal data TGT∙4b TGT∙5a TGT∙5b TGT∙6a TGT∙6b 
PDB ID 4Q4R 4Q4O 4Q4P 4Q4S 4Q4Q 
A) Data collection and processing      
Collection site BESSY 14.2 BESSY 14.2 BESSY 14.3 BESSY 14.2 BESSY 14.2 
No. crystals used 1 1 1 1 1 
λ *Å+ 0.91841 0.91841 0.89460 0.91841 0.91841 
Space group C2 C2 C2 C2 C2 
Unit cell parameters      
a [Å] 89.9 89.8 90.0 90.9 91.3 
b [Å] 64.8 64.7 64.9 64.9 64.9 
c [Å] 70.8 70.7 70.7 70.5 70.4 
β *°+ 93.1 93.4 93.3 95.9 96.1 
B) Diffraction data
[a]
      
Resolution range [Å] 30 - 1.45 30 - 1.35 30 - 1.54 30 - 1.25 30 - 1.41 
 (1.48 - 1.45) (1.37 - 1.35) (1.57 - 1.54) (1.27 - 1.25) (1.43 - 1.41) 
Unique reflections 71426 87189 60063 109841 78370 
 (3566) (4254) (2924) (5550) (3931) 
R(I)sym [%]
[b]
 8.6 (46.5) 4.6 (38.8)  6.7 (30.2)  4.7 (45.5) 7.1 (49.1) 
Completeness [%] 99.6 98.8 99.8 97.5 99.8 
 (99.9) (98.3) (99.5) (98.8) (99.9) 
Redundancy 3.1 (3.0) 2.1 (2.0) 3.7 (3.0) 2.4 (2.3) 2.9 (2.9) 
I/σ (I) 12.2 (2.2) 15.4 (2.0) 18.9 (3.6) 19.0 (2.1) 15.6 (3.1) 
Wilson B-factor [Å
2
] 17.3 14.9 17.5 11.9 10.7 
Matthews Coefficient [Å
3
/Da] 2.4 2.4 2.4 2.4 2.4 
C) Refinement      
PHENIX version 1.8.4_1496 1.8.4_1496 1.8.4_1496 1.8.4_1496 1.8.4_1496 
Resolution range [Å] 29.8 - 1.45 27.1 - 1.35 27.2 - 1.54 22.6 - 1.25 25.2 - 1.41 
Reflections used for Rfree  
Reflections used for Rwork 
3607 
67805 
4379 
82794 
3033 
57026 
1991 
107849 
1675 
76695 
Final R values
[a]
      
Rfree  [%]
[c]
 17.2 16.2 17.0 17.2 16.1 
Rwork [%]
[d]
 13.6 13.7 15.2 13.2 12.5 
No. of atoms (non-hydrogen)      
Protein atoms 2865 2923 2851 2892 2914 
Water molecules 282 389 330 310 351 
Ligand atoms 23 24 23 17 21 
RMSD, angle [°] 1.0 1.1 1.1 1.0 0.9 
RMSD, bond [Å] 0.007 0.007 0.008 0.006 0.006 
Ramachandran plot
[e]
      
Most favoured regions [%] 95.1 95.2 96.1 94.2 96.5 
Additionally allowed regions [%] 4.5 4.4 3.6 5.1 3.2 
Generously allowed regions [%] 0.3 0.3 0.3 0.6 0.3 
Mean B-factors [Å
2
]      
Protein atoms 21.8 17.1 21.1 17.9 16.3 
Water molecules 35.3 31.9 33.0 32.8 31.3 
Ligand atoms 21.5 15.6 19.4 12.5 15.7
[f]
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Crystal data Val262Thr Val262Asp Val262Cys Val262Thr∙4a Val262Asp∙4a 
PDB ID 4Q8M 4IPP 4Q8N 4Q8O 4Q4P 
A) Data collection and processing      
Collection site BESSY 14.2 BESSY 14.2 BESSY 14.2 BESSY 14.2 BESSY 14.2 
No. crystals used 1 1 1 1 1 
λ *Å+ 0.91841 0.91841 0.91841 0.91841 0.91841 
Space group C2 C2 C2 C2 C2 
Unit cell parameters      
a [Å] 90.4 91.0 91.9 91.3 91.4 
b [Å] 64.8 65.1 65.3 64.9 65.0 
c [Å] 70.3 70.3 70.2 71.4 70.4 
β *°+ 95.6 96.2 96.5 96.6 96.1 
B) Diffraction data
[a]
      
Resolution range [Å] 30 - 1.24 30 - 1.33 30 - 1.45 30 - 1.89 25.3 - 1.45 
 (1.26 - 1.24) (1.35 - 1.33) (1.48 - 1.45) (1.92 - 1.89) (1.53 - 1.45) 
Unique reflections 113077 93075 72428 32679 72559 
 (5575) (4631) (3585) (1625) (10548) 
R(I)sym [%]
[b]
 4.8 (48.0) 5.2 (24.4)  5.8 (47.1) 7.9 (43.4) 10.0 (49.5) 
Completeness [%] 99.3 99.4 99.0 97.9 99.9 
 (98.5) (99.9) (99.7) (96.3) (99.9) 
Redundancy 3.3 (3.3) 3.0 (3.0) 3.2 (3.0) 3.2 (3.2) 3.7 (3.7) 
I/σ (I) 23.2 (2.5) 20.4 (4.4) 18.3 (2.7) 15.1 (2.9) 8.3 (2.9) 
Wilson B-factor [Å
2
] 12.1 11.6 14.4 21.1 12.5 
Matthews Coefficient [Å
3
/Da] 2.4 2.4 2.4 2.4 2.4 
C) Refinement      
PHENIX version 1.8.4_1496 1.8.1_1168 1.8.4_1496 1.8.4_1496 1.8.4_1496 
Resolution range [Å] 17.5 - 1.24 19.0 - 1.33 20.8 - 1.45 23.6 - 1.89 23.3 - 1.45 
Reflections used for Rfree  
Reflections used for Rwork 
2000 
111076 
2000 
91075 
1983 
70443 
1652 
31018 
3657 
68901 
Final R values
[a]
      
Rfree  [%]
[c]
 16.0 15.0 15.5 19.1 16.5 
Rwork [%]
[d]
 14.2 13.3 13.4 15.6 13.8 
No. of atoms (non-hydrogen)      
Protein atoms 2903 2926 2830 2838 2875 
Water molecules 301 408 343 252 319 
Ligand atoms --- --- --- 24 24 
RMSD, angle [°] 1.1 1.1 1.0 1.1 1.0 
RMSD, bond [Å] 0.007 0.008 0.007 0.009 0.007 
Ramachandran plot
[e]
      
Most favoured regions [%] 95.3 94.4 94.3 94.6 94.6 
Additionally allowed regions [%] 4.4 5.3 5.4 5.1 5.1 
Generously allowed regions [%] 0.3 0.3 0.3 0.3 0.3 
Mean B-factors [Å
2
]      
Protein atoms 17.1 13.8 19.8 24.1 17.1 
Water molecules 32.7 28.2 35.0 32.9 32.0 
Ligand atoms --- --- --- 27.9 21.0 
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Crystal data Val262Cys∙4a TGT∙7 TGT∙7a TGT∙7b (1) TGT∙7b (2) 
PDB ID 4Q8Q 4Q8T 4Q8U --- --- 
A) Data collection and processing      
Collection site BESSY 14.2 BESSY 14.2 BESSY 14.2 PETRA P14 PETRA P14 
No. crystals used 1 1 1 1 1 
λ *Å+ 0.91841 0.91841 0.91841 0.97627 0.97627 
Space group C2 C2 C2 C2 C2 
Unit cell parameters      
a [Å] 91.4 90.2 89.8 89.8 90.2 
b [Å] 65.0 64.6 64.5 64.7 64.8 
c [Å] 70.3 71.0 70.9 70.6 70.3 
β *°+ 96.0 93.2 93.2 96.1 96.2 
B) Diffraction data
[a]
      
Resolution range [Å] 30 - 1.72 30 - 1.40 30 - 1.31 50 - 1.20 80 - 1.20 
 (1.75 - 1.72) (1.42 - 1.40) (1.33 - 1.31) (1.24 - 1.20) (1.24 - 1.20) 
Unique reflections 37958 80321 96126 122015 123477 
 (1991) (3968) (4340) (11647) (11058) 
R(I)sym [%]
[b]
 9.9 (37.4) 5.8 (48.9) 4.8 (47.4)  3.0 (50.5)  2.9 (49.2) 
Completeness [%] 87.5 99.9  99.1 97.4 98.3 
 (91.0) (98.3) (89.9) (90.5) (94.4) 
Redundancy 2.6 (2.5) 4.2 (3.8) 3.3 (2.9) 3.3 (2.8) 3.3 (2.8) 
I/σ (I) 9.4 (2.4) 22.7 (2.4) 21.8 (2.0) 20.3 (2.4) 19.8 (2.2) 
Wilson B-factor [Å
2
] 15.4 17.1 15.8 12.7 12.8 
Matthews Coefficient [Å
3
/Da] 2.4 2.4 2.4 2.4 2.4 
C) Refinement      
PHENIX version 1.8.4_1496 1.8.4_1496 1.8.4_1496 1.8.4_1496 1.8.4_1496 
Resolution range [Å] 29.5 - 1.72 29.8 - 1.40 18.1 - 1.31 44.6 - 1.20 69.9 - 1.20 
Reflections used for Rfree  
Reflections used for Rwork 
1898 
36060 
1949 
78372 
4815 
91306 
6101 
115914 
6174 
117303 
Final R values
[a]
      
Rfree  [%]
[c]
 20.5 15.4 16.2 16.8 15.9 
Rwork [%]
[d]
 17.3 13.8 14.0 14.4 13.8 
No. of atoms (non-hydrogen)      
Protein atoms 2762 2899 2892 2936 2937 
Water molecules 293 311 330 361 354 
Ligand atoms 17 24 28 24 27 
RMSD, angle [°] 1.0 1.1 1.1 1.1 1.1 
RMSD, bond [Å] 0.008 0.007 0.007 0.007 0.007 
Ramachandran plot
[e]
      
Most favoured regions [%] 94.1 95.3 94.9 95.3 94.9 
Additionally allowed regions [%] 5.6 4.4 4.7 4.4 4.8 
Generously allowed regions [%] 0.3 0.3 0.3 0.3 0.3 
Mean B-factors [Å
2
]      
Protein atoms 19.4 20.7 18.8 16.4 16.4 
Water molecules 29.3 33.8 32.8 29.2 29.6 
Ligand atoms 16.1 22.6 21.2 14.9
[f]
 18.6 
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Crystal data TGT∙7c TGT∙7d TGT∙8 TGT∙9 TGT∙10 
PDB ID 4Q8V 4Q8W 4Q4M --- --- 
A) Data collection and processing      
Collection site BESSY 14.2 PETRA P14 BESSY 14.3 BESSY 14.3 BESSY 14.2 
No. crystals used 1 1 1 1 1 
λ *Å+ 0.91841 0.97627 0.89460 0.89460 0.91841 
Space group C2 C2 C2 C2 C2 
Unit cell parameters      
a [Å] 91.2 89.8 88.5 88.8 89.8 
b [Å] 65.1 64.7 63.9 64.6 64.2 
c [Å] 70.8 70.7 70.4 70.5 70.6 
β *°+ 96.3 96.3 93.0 93.5 93.1 
B) Diffraction data
[a]
      
Resolution range [Å] 50 - 1.40 80 - 1.14 30 - 1.62 30 - 1.84 30 - 1.76 
 (1.48 - 1.40) (1.19 - 1.14) (1.65 - 1.62) (1.87 - 1.84) (1.79 - 1.76) 
Unique reflections 79794 134549 48799 35510 38423 
 (12619) (15089) (2059) (1778) (1860) 
R(I)sym [%]
[b]
 6.2 (48.3) 2.8 (30.9) 5.0 (30.0) 15.9 (50.0)  12.9 (46.7) 
Completeness [%] 97.8 92.0 98.0 99.9 97.7  
 (95.8) (80.0) (82.6) (100.0) (96.3) 
Redundancy 2.9 (2.9) 5.7 (5.0) 3.1 (2.0) 3.7 (3.6) 2.3 (2.3) 
I/σ (I) 11.0 (2.0) 27.8 (4.7) 21.5 (2.8) 8.3 (2.9) 7.4 (2.2) 
Wilson B-factor [Å
2
] 12.1 11.6 15.6 20.9 21.4 
Matthews Coefficient [Å
3
/Da] 2.4 2.4 2.3 2.4 2.4 
C) Refinement      
PHENIX version 1.8.4_1496 1.8.4_1496 1.8.4_1496 1.8.1_1168 1.8.1_1168 
Resolution range [Å] 21.8 - 1.40 70.3 - 1.14 26.8 - 1.62 28.7 - 1.84 29.7 - 1.76 
Reflections used for Rfree  
Reflections used for Rwork 
3990 
75804 
6728 
127821  
2467 
46332 
1725 
32928 
1922 
36501 
Final R values
[a]
      
Rfree  [%]
[c]
 16.3 15.0 18.9 19.3 19.1 
Rwork [%]
[d]
 13.1 13.4 15.7 15.8 16.2 
No. of atoms (non-hydrogen)      
Protein atoms 2913 2927 2847 2828 2839 
Water molecules 384 376 339 323 273 
Ligand atoms 26 27 14 16 14 
RMSD, angle [°] 1.1 1.1 1.1 1.1 1.1 
RMSD, bond [Å] 0.007 0.007 0.008 0.008 0.008 
Ramachandran plot
[e]
      
Most favoured regions [%] 95.0 94.9 94.5 95.5 94.6 
Additionally allowed regions [%] 4.7 4.8 5.2 4.2 5.1 
Generously allowed regions [%] 0.3 0.3 0.3 0.3 0.3 
Mean B-factors [Å
2
]      
Protein atoms 14.6 15.1 19.6 21.5 27.0 
Water molecules 29.4 28.0 31.9 31.4 36.1 
Ligand atoms 13.0 15.5 26.4 36.3 48.3 
a
Values in parentheses are statistics for the highest resolution shell. 
b𝑅(𝐼)𝑠𝑦𝑚 =     𝐼𝑖 𝑕 −  𝐼(𝑕)  /𝑖𝑕
  𝐼𝑖(𝑕)𝑖𝑕  𝑥100, in which  𝐼(𝑕)  is the mean of the 𝐼(𝑕) observation of reflection 𝑕. 
c𝑅𝑤𝑜𝑟𝑘 =   𝐹𝑜 − 𝐹𝑐 /𝑕𝑘𝑙
  𝐹𝑜 𝑕𝑘𝑙 . 
d𝑅𝑓𝑟𝑒𝑒 was calculated as shown for 𝑅𝑤𝑜𝑟𝑘 but on refinement-excluded 2 - 5 % of data. 
e
Statistics from 
PROCHECK [Laskowski et al., 1993]. 
f
Averaged value of the two observed conformations. 
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